id,text,AMR3_structbart_L_amr,split,source_set,gold_amr,text_detok,elit_amr,elit_smatch,AMR3_structbart_L_smatch,gpt_3.5_turbo_0613_amr,gpt4_0613_amr,gpt_3.5_turbo_0613_smatch,gpt4_0613_smatch
a_pmid_2234_3622.61,"Mechanistic biomarker studies of the effects of selumetinib in human tumour xenograft models have shown that, in addition to pERK1/2 downregulation, a sustained exposure to the agent results in an increase in downstream apoptotic signalling and a decrease in cell cycle progression (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>).","(s / show-01
    :ARG0 (s3 / study-01
        :ARG1 (a2 / affect-01
            :ARG0 (p2 / protein
                :name (n / name
                    :op1 ""selumetinib""))
            :ARG1 (m2 / model-01
                :ARG1 (x / xenograft
                    :mod (c / cell
                        :mod (h / human)))))
        :ARG1-of (m / mechanize-01)
        :mod (b / biomarker))
    :ARG1 (r / result-01
        :ARG1 (e2 / expose-01
            :ARG1-of (s4 / sustain-01)
            :ARG2 (a3 / agent))
        :ARG1-of (a / add-02
            :ARG2 (d3 / down-03
                :ARG1 (e / enzyme
                    :name (n2 / name
                        :op1 ""pERK"")
                    :op2 ""1/2"")))
        :ARG2 (a4 / and
            :op1 (i / increase-01
                :ARG1 (s2 / signal-07
                    :ARG1 (a5 / apoptotic)
                    :mod (d4 / downstream)))
            :op2 (d2 / decrease-01
                :ARG1 (p / progress-01
                    :ARG1 (c3 / cycle-02
                        :ARG1 (c2 / cell))))))
    :ARG1-of (p4 / publication-91
        :ARG4 (p3 / publication
            :name (n3 / name
                :op1 ""Jew""))
        :time (d / date-entity
            :year 2007)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (s2 / study-01
            :ARG1 (a / affect-01
                  :ARG0 (s3 / small-molecule :name (n3 / name :op1 ""selumetinib""))
                  :ARG1 (m2 / model
                        :mod (x / xenograft
                              :mod (t / tumor))
                        :mod (h / human)))
            :mod (b / biomarker
                  :mod (m / mechanistic)))
      :ARG1 (r / result-01
            :ARG1 (e / expose-01
                  :ARG2 s3
                  :ARG1-of (s4 / sustain-01))
            :ARG2 (a7 / and
                  :op1 (d2 / downregulate-01
                        :ARG1 (e2 / enzyme :name (n / name :op1 ""ERK1/2"")
                              :ARG3-of (p / phosphorylate-01)))
                  :op2 (i / increase-01
                        :ARG1 (s5 / signal-07
                              :mod (a5 / apoptosis)
                              :location (d4 / downstream)))
                  :op3 (d3 / decrease-01
                        :ARG1 (p2 / progress-01
                              :ARG1 (c / cycle-02
                                    :ARG1 (c2 / cell))))))
      :ARG1-of (d5 / describe-01
            :ARG0 (p5 / publication-91
                  :ARG0 (a3 / and
                        :op1 (p3 / person :name (n2 / name :op1 ""Davies""))
                        :op2 (p4 / person
                              :mod (o / other)))
                  :time (d / date-entity :year 2007))))","Mechanistic biomarker studies of the effects of selumetinib in human tumour xenograft models have shown that, in addition to pERK1/2 downregulation, a sustained exposure to the agent results in an increase in downstream apoptotic signalling and a decrease in cell cycle progression (<xref ref-type=""bibr"" rid=""bib6"">Davies <i>et al</i>, 2007</xref>).","(z1 / show-01
    :ARG0 (z2 / study-01
              :ARG1 (z3 / affect-01
                        :ARG0 (z4 / small-molecule
                                  :wiki ""Selumetinib""
                                  :name (z5 / name
                                            :op1 ""selumetinib""))
                        :ARG1 (z6 / model
                                  :mod (z7 / xenograft
                                           :mod (z8 / tumor
                                                    :mod (z9 / human)))
                                  :mod (z10 / cell-cycle
                                            :wiki ""Xenograft""
                                            :name (z11 / name
                                                       :op1 ""xenograft""))))
              :mod (z12 / biomarker
                        :mod (z13 / mechanism)))
    :ARG1 (z14 / result-01
               :ARG1 (z15 / expose-01
                          :ARG2 z4
                          :ARG1-of (z16 / sustain-01))
               :ARG2 (z17 / and
                          :op1 (z18 / increase-01
                                    :ARG1 (z19 / signal-07
                                               :ARG1 (z20 / apoptotic-01
                                                          :mod (z21 / downstream))))
                          :op2 (z22 / decrease-01
                                    :ARG1 (z23 / progress-01
                                               :ARG1 (z24 / cycle-02
                                                          :ARG1 (z25 / cell)))))
               :ARG1-of (z26 / add-02
                             :ARG2 (z27 / down-03
                                        :ARG1 (z28 / protein
                                                   :wiki ""PERK1/2""
                                                   :name (z29 / name
                                                              :op1 ""pERK1/2""))))))",0.5857142857142857,0.513888888888889,"(m / mechanism-01
        :ARG0 (s / study-01
              :ARG1 (b / biomarker
                    :mod (m2 / mechanistic)
                    :mod (e / effect-01
                          :ARG1 (s2 / selumetinib)
                          :ARG2 (m3 / model
                                :mod (t / tumour)
                                :mod (x / xenograft))))
              :ARG2 (s3 / show-01
                    :ARG1 (a / addition
                          :op1 (d / downregulation
                                :ARG1 (p / pERK1/2))
                          :op2 (e2 / exposure-01
                                :ARG1 (a2 / agent)))
                    :ARG2 (i / increase-01
                          :ARG1 (s4 / signalling
                                :ARG1-of (a3 / apoptotic))
                          :ARG2 (d2 / decrease-01
                                :ARG1 (p2 / progression
                                      :mod (c / cell)
                                      :mod (c2 / cycle))))))","(s / study-01
    :ARG0 (b / biomarker
        :mod (m / mechanistic))
    :ARG1 (e / effect-01
        :ARG0 (s2 / selumetinib)
        :ARG1 (m2 / model
            :mod (x / xenograft)
            :mod (t / tumor
                :mod (h / human))))
    :ARG2-of (s3 / show-01
        :ARG1 (a / and
            :op1 (d / downregulate-01
                :ARG0 (p / pERK1/2)
                :accompanier (a2 / addition))
            :op2 (e2 / expose-01
                :ARG0 (a3 / agent)
                :ARG1 (s4 / sustain)
                :result (a4 / and
                    :op1 (i / increase-01
                        :ARG1 (s5 / signal-01
                            :mod (a5 / apoptotic)
                            :direction (d2 / downstream)))
                    :op2 (d3 / decrease-01
                        :ARG1 (p2 / progress-01
                            :ARG1 (c / cycle
                                :mod (c2 / cell))))))))
    :source (d4 / document
        :name (n / name :op1 ""Davies"" :op2 ""et"" :op3 ""al"" :op4 "", 2007"")
        :mod (x2 / xref
            :mod (b2 / bibr)
            :mod (r / rid :op1 ""bib6""))))",-1.0,-1.0
a_pmid_2234_3622.75,"IHC analysis and histological scoring was performed on all the tissues collected to examine, selumetinib effects (pERK1/2), DNA damage (<i>γ</i>H2A.X), apoptosis (cleaved caspase 3) and the cell cycle (pHH3) (scoring data not shown).","(p / perform-02
    :ARG1 (a4 / and
        :op1 (a3 / analyze-01
            :ARG1 (t / tissue
                :ARG1-of (c2 / collect-01
                    :purpose (e4 / examine-01
                        :ARG0 a4
                        :ARG1 (a5 / and
                            :op1 (a / affect-01
                                :ARG1 (e / enzyme
                                    :name (n / name
                                        :op1 ""selumetinib""))
                                :example (e2 / enzyme
                                    :name (n2 / name
                                        :op1 ""pERK""
                                        :op2 ""1/2"")))
                            :op2 (d / damage-01
                                :ARG1 (n6 / nucleic-acid
                                    :name (n3 / name
                                        :op1 ""DNA"")))
                            :op3 (a6 / apoptosis
                                :ARG1-of (m / mean-01
                                    :ARG2 (p2 / protein
                                        :name (n5 / name
                                            :op1 ""pHH3""))
                                    :ARG2 (e3 / enzyme
                                        :name (n4 / name
                                            :op1 ""caspase""
                                            :op2 3)
                                        :ARG1-of (k / kill-01))))
                            :op4 (c3 / cycle-02
                                :ARG1 (c / cell))
                            :op5 (d2 / data
                                :ARG1-of (s4 / show-01
                                    :polarity -)
                                :topic (s3 / score-01)))))
                :mod (a2 / all))
            :ARG1-of (s / say-01
                :degree (h / high-02)))
        :op2 (s2 / score-01
            :mod (h2 / history)))
    :ARG2 t)
",test,bio_amr0.8,"(p / perform-02
      :ARG1 (a5 / and
            :op1 (a6 / analyze-01
                  :mod (i / immunohistochemistry))
            :op2 (s2 / score-01
                  :ARG3 (h / histology)))
      :location (t / tissue
            :mod (a7 / all)
            :ARG1-of (c3 / collect-01
                  :purpose (a4 / and
                        :op1 (e / examine-01
                              :ARG1 (a3 / affect-01
                                    :ARG0 (s / small-molecule
                                          :name (n5 / name :op1 ""selumetinib""))
                                    :ARG2 (e2 / enzyme
                                          :name (n / name :op1 ""ERK1/2"")
                                          :ARG3-of (p2 / phosphorylate-01))))
                        :op2 (e3 / examine-01
                              :ARG1 (d / damage-01
                                    :ARG1 (n7 / nucleic-acid :wiki ""DNA""
                                          :name (n8 / name :op1 ""DNA"")))
                              :instrument (p5 / protein
                                    :name (n2 / name :op1 ""γH2A.X"")))
                        :op3 (e4 / examine-01
                              :ARG1 (a2 / apoptosis)
                              :instrument (p6 / protein
                                    :name (n3 / name :op1 ""Cleaved"" :op2 ""Caspase"" :op3 3)))
                        :op4 (e5 / examine-01
                              :ARG1 (c / cycle-02
                                    :ARG1 (c2 / cell))
                              :instrument (p4 / protein
                                    :name (n4 / name :op1 ""HH3"")
                                    :ARG3-of (p3 / phosphorylate-01))))))
      :ARG1-of (s3 / show-01 :polarity -
            :ARG0 (d3 / data
                  :mod (s4 / score-01))))","IHC analysis and histological scoring was performed on all the tissues collected to examine, selumetinib effects (pERK1/2), DNA damage (<i>γ</i>H2A.X), apoptosis (cleaved caspase 3) and the cell cycle (pHH3) (scoring data not shown).","(z1 / perform-02
    :ARG1 (z2 / and
              :op1 (z3 / analyze-01
                       :ARG1 (z4 / small-molecule
                                 :wiki ""Inositol_trisphosphate_receptor""
                                 :name (z5 / name
                                           :op1 ""IHC"")))
              :op2 (z6 / score-01
                       :ARG1 z4
                       :mod (z7 / histology)))
    :ARG2 (z8 / tissue
              :mod (z9 / all)
              :ARG1-of (z10 / collect-01
                            :purpose (z11 / examine-01
                                          :ARG1 z8))
              :example (z12 / and
                            :op1 (z13 / affect-01
                                      :ARG0 (z14 / small-molecule
                                                 :wiki ""Protease_kinase_1/2""
                                                 :name (z15 / name
                                                            :op1 ""pERK1/2"")))
                            :op2 (z16 / damage-01
                                      :ARG1 (z17 / nucleic-acid
                                                 :wiki ""DNA""
                                                 :name (z18 / name
                                                            :op1 ""DNA""))
                                      :ARG2 (z19 / small-molecule
                                                 :wiki ""Histidine-activated_protein_kinase""
                                                 :name (z20 / name
                                                            :op1 ""H2A.X"")))
                            :op3 (z21 / apoptose-00
                                      :ARG1-of (z22 / mean-01
                                                    :ARG2 (z23 / enzyme
                                                               :wiki ""Caspase_3""
                                                               :name (z24 / name
                                                                          :op1 ""caspase""
                                                                          :op2 ""3"")
                                                               :ARG1-of (z25 / cut-01))))
                            :op4 (z26 / cycle-02
                                      :ARG1 (z27 / cell)
                                      :ARG2 (z28 / enzyme
                                                 :wiki ""PHLDA3""
                                                 :name (z29 / name
                                                            :op1 ""pHH3"")))
                            :op5 (z30 / data
                                      :ARG0-of (z31 / score-01)
                                      :ARG1-of (z32 / show-01
                                                    :polarity -)))))",0.4444444444444445,0.4487179487179487,"(m / multi-sentence
        :snt1 (p / perform-01
            :ARG0 (a / analysis
                  :mod (i / ihc))
            :ARG1 (s / score-01
                  :ARG0 a
                  :ARG1 (h / histological)
                  :ARG2 (t / tissue
                        :ARG0-of (c / collect-01)))
            :ARG2 (e / examine-01
                  :ARG1 t
                  :ARG2 (e2 / effect-01
                        :ARG1 (s2 / selumetinib)
                        :ARG2 (p2 / protein
                              :ARG0-of (p3 / phosphorylate-01
                                    :ARG1 (e3 / erk1/2))))
                        :ARG2 (d / damage-01
                              :ARG1 (d2 / dna)
                              :ARG2 (h2 / h2a.x))
                        :ARG2 (a2 / apoptosis-01
                              :ARG1 (c2 / caspase-03)
                              :ARG2 (c3 / cleave-01))
                        :ARG2 (c4 / cycle-01
                              :ARG1 (c5 / cell)
                              :ARG2 (h3 / hh3))))
        :snt2 (s4 / show-01
            :ARG1 (d3 / data
                  :mod (s5 / score-01))
            :ARG2 (n / not)))","(p / perform-01
    :ARG0 (a / analysis
        :mod (i / IHC))
    :ARG1 (s / score-01
        :ARG1 (h / histology))
    :ARG2 (t / tissue
        :quant (a2 / all)
        :ARG1-of (c / collect-01))
    :purpose (e / examine-01
        :ARG1 (e2 / effect
            :ARG0 (s2 / selumetinib)
            :ARG1 (p / pERK1/2)
            :ARG2 (d / damage
                :ARG1 (d2 / DNA)
                :mod (g / γH2A.X))
            :ARG3 (a3 / apoptosis
                :mod (c2 / cleaved-caspase-3))
            :ARG4 (c3 / cell-cycle
                :mod (p2 / pHH3))))
    :mod (s3 / score-01
        :ARG1 (d3 / data)
        :ARG2 (s4 / show-01 :polarity -)))",-1.0,-1.0
a_pmid_2234_3622.92,When selumetinib was administered alone levels of pHH3 decreased at several measurement points compared with controls (PD2 <i>P</i><0.0005; PD4 <i>P</i><0.005; PD5 <i>P</i><0.0005; PD6 <i>P</i><0.0005) consistent with the inhibition of the MEK/ERK pathway resulting in a G1/S arrest.,"(d / decrease-01
    :ARG1 (l / level
        :mod (p3 / protein
            :name (n2 / name
                :op1 3
                :op1 ""serotonin"")))
    :ARG1-of (c / compare-01
        :ARG2 (c3 / control-01
            :ARG1 (p4 / protein
                :name (n3 / name
                    :op1 ""PD2""
                    :op1 ""PD6""))))
    :ARG1-of (c2 / consistent-01
        :ARG2 (i / inhibit-01
            :ARG0 p4
            :ARG1 (p / pathway
                :mod (p5 / protein
                    :name (n5 / name
                        :op1 ""ERK""
                        :op1 ""G1""))
                :mod (e / enzyme
                    :name (n4 / name
                        :op1 ""MEK"")))
            :ARG1-of (r / result-01
                :ARG2 (a3 / arrest-01
                    :ARG1 p5))))
    :ARG2 (p2 / point
        :quant (s / several)
        :mod (m / measure-01))
    :condition (a / administer-01
        :ARG1 (s2 / small-molecule
            :name (n / name
                :op1 ""selumetinib""))
        :manner (a2 / alone)))
",test,bio_amr0.8,"(d / decrease-01
      :ARG1 (l / level
            :quant-of (p7 / protein :name (n3 / name :op1 ""HH3"")
                  :ARG3-of (p8 / phosphorylate-01)))
      :time (a / administer-01
            :ARG1 (s / small-molecule :name (n8 / name :op1 ""selumetinib"")
                  :mod (a3 / alone)))
      :time (p2 / point
            :quant (s2 / several)
            :mod (m3 / measure-01)
            :ARG1-of (m4 / mean-01
                  :ARG2 (a4 / and
                        :op1 (t / thing :name (n4 / name :op1 ""PD2""))
                        :op2 (t2 / thing :name (n5 / name :op1 ""PD4""))
                        :op3 (t4 / thing :name (n6 / name :op1 ""PD5""))
                        :op4 (t5 / thing :name (n7 / name :op1 ""PD6"")))))
      :compared-to (c / control)
      :ARG1-of (c2 / consistent-01
            :ARG2 (i / inhibit-01
                  :ARG1 (p / pathway :name (n / name :op1 ""MEK/ERK""))
                  :ARG1-of (r / result-01
                        :ARG2 (a2 / arrest-02
                              :time (e / event :name (n2 / name :op1 ""G1/S""))))))
      :ARG1-of (s3 / statistical-test-91
            :ARG2 (l2 / less-than :op1 0.0005)))",When selumetinib was administered alone levels of pHH3 decreased at several measurement points compared with controls (PD2 <i>P</i><0.0005; PD4 <i>P</i><0.005; PD5 <i>P</i><0.0005; PD6 <i>P</i><0.0005) consistent with the inhibition of the MEK/ERK pathway resulting in a G1/S arrest.,"(z1 / decrease-01
    :ARG1 (z2 / level
              :consist-of (z3 / small-molecule
                              :wiki ""Proteus_protein_kinase_3""
                              :name (z4 / name
                                        :op1 ""pHH3"")))
    :time (z5 / administer-01
              :ARG1 (z6 / small-molecule
                        :wiki ""Selumetinib""
                        :name (z7 / name
                                  :op1 ""selumetinib""))
              :manner (z8 / alone))
    :ARG1-of (z9 / compare-01
                 :ARG2 (z10 / point
                            :quant (z11 / several)
                            :ARG2-of (z12 / measure-01)))
    :ARG1-of (z13 / compare-01
                  :ARG2 (z14 / control-01
                             :ARG1 (z15 / and
                                        :op1 (z16 / small-molecule
                                                  :wiki ""PHLDA""
                                                  :name (z17 / name
                                                             :op1 ""PD2""
                                                             :op2 ""P""))
                                        :op2 (z18 / small-molecule
                                                  :wiki ""PHLDA4""
                                                  :name (z19 / name
                                                             :op1 ""PD4""
                                                             :op2 ""P""))
                                        :op3 (z20 / small-molecule
                                                  :wiki ""PHLDA5""
                                                  :name (z21 / name
                                                             :op1 ""PD5""
                                                             :op2 ""P""))
                                        :op4 (z22 / small-molecule
                                                  :wiki ""PHLDA6""
                                                  :name (z23 / name
                                                             :op1 ""PD6""
                                                             :op2 ""P"")))
                             :ARG1-of (z24 / consistent-01
                                           :ARG2 (z25 / inhibit-01
                                                      :ARG1 (z26 / pathway
                                                                 :mod (z27 / slash
                                                                           :op1 (z28 / enzyme
                                                                                     :wiki ""Mitogen/activated_protein_kinase_kinase""
                                                                                     :name (z29 / name
                                                                                                :op1 ""MEK/ERK""))
                                                                           :op2 (z30 / enzyme
                                                                                     :wiki ""Mitogen/activated_protein_kinase""
                                                                                     :name (z31 / name
                                                                                                :op1 ""G1/S""))))
                                                      :ARG0-of (z32 / result-01
                                                                    :ARG2 (z33 / arrest-01
                                                                               :ARG2 (z34 / enzyme
                                                                                          :wiki ""Mitogen/activated_protein_kinase""
                                                                                          :name (z35 / name
                                                                                                     :op1 ""G1/S"")))))))))",0.4431137724550898,0.3909774436090225,"(s / sentence
        :ARG0 (a / administer-01
              :ARG1 (s2 / selumetinib)
              :ARG2 (l / level
                    :mod (a2 / alone)))
        :ARG1 (d / decrease-01
              :ARG1 (p / pHH3)
              :ARG2 (m / measurement-point
                    :mod (s3 / several)
                    :mod (c / compare-01
                          :ARG1 (c2 / control))))
        :ARG2 (c2 / consistent
              :ARG1 (i / inhibit-01
                    :ARG1 (p2 / pathway
                          :mod (m2 / MEK/ERK)))
              :ARG2 (a3 / arrest-01
                    :ARG1 (g / G1/S)
                    :ARG2 (r / result-01))))","(w / when
    :ARG1 (a / administer-01
        :ARG0 (s / selumetinib)
        :ARG1 (a2 / alone)))
    :ARG2 (d / decrease-01
        :ARG0 (l / level
            :poss (p / pHH3))
        :time (m / measure-01
            :ARG1 (p2 / point
                :quant (s2 / several)))
        :compared-to (c / control)
        :ARG1-of (c2 / compare-01
            :ARG2 (p3 / PD2
                :value ""<i>P</i><0.0005"")
            :ARG3 (p4 / PD4
                :value ""<i>P</i><0.005"")
            :ARG4 (p5 / PD5
                :value ""<i>P</i><0.0005"")
            :ARG5 (p6 / PD6
                :value ""<i>P</i><0.0005"")))
    :mod (c3 / consistent-02
        :ARG1 (i / inhibit-01
            :ARG0 (p7 / pathway
                :name (n / name
                    :op1 ""MEK""
                    :op2 ""/""
                    :op3 ""ERK""))
            :result (a3 / arrest-01
                :ARG1 (g / G1/S)))))",-1.0,-1.0
a_pmid_2234_3622.95,"In comparison, tumour tissue analysed in the same study after the chronic dosing schedule of selumetinib did not demonstrate an increase in cleaved caspase 3 levels in the combination group when compared with the single agents alone.","(c4 / compare-01
    :ARG2 (d / demonstrate-01
        :ARG0 (t / tissue
            :ARG1-of (a4 / analyze-01
                :location (s4 / study-01
                    :ARG1-of (s / same-01))
                :time (a / after
                    :op1 (s2 / schedule-01
                        :ARG1 (d2 / dose-01
                            :ARG1 (p / product
                                :name (n / name
                                    :op1 ""selumetinib"")))
                        :mod (c2 / chronic))))
            :part-of (t2 / tumor))
        :ARG1 (i / increase-01
            :ARG1 (l2 / level
                :ARG0-of (l / leaf-02)
                :mod 3)
            :ARG1-of (c5 / compare-01
                :ARG2 (a2 / agent
                    :ARG1-of (s3 / single-02)
                    :mod (a3 / alone)))
            :location (g / group
                :ARG3-of (c3 / combine-01)))
        :polarity -)
    :rel (c / caspase))
",test,bio_amr0.8,"(c / compare-01
      :ARG1 (d / demonstrate-01 :polarity -
            :ARG0 (t / tissue
                  :source (t2 / tumor)
                  :ARG1-of (a3 / analyze-01
                        :ARG0 (s2 / study-01
                              :ARG1-of (s3 / same-01)
                              :time (a4 / after
                                    :op1 (s4 / schedule-01
                                          :ARG1 (d2 / dose-01
                                                :ARG2 (s5 / small-molecule :name (n2 / name :op1 ""selumetinib""))
                                                :mod (c4 / chronic)))))))
            :ARG1 (i / increase-01
                  :ARG1 (l / level
                        :location (g / group
                              :mod (c2 / combine-01))
                        :quant-of (p / protein :name (n / name :op1 ""cleaved"" :op2 ""caspase"" :op3 ""3""))))
            :time (c3 / compare-01
                  :ARG2 (a / agent
                        :ARG1-of (s / single-02))
                  :mod (a2 / alone))))","In comparison, tumour tissue analysed in the same study after the chronic dosing schedule of selumetinib did not demonstrate an increase in cleaved caspase 3 levels in the combination group when compared with the single agents alone.","(z1 / compare-01
    :ARG1 (z2 / demonstrate-01
              :polarity -
              :ARG0 (z3 / tissue
                        :part-of (z4 / tumor)
                        :ARG1-of (z5 / analyze-01
                                     :location (z6 / study
                                                   :ARG1-of (z7 / same-01))
                                     :time (z8 / after
                                               :op1 (z9 / schedule-01
                                                        :ARG1 (z10 / dose-01
                                                                   :ARG1 (z11 / small-molecule
                                                                              :wiki ""Selumetinib""
                                                                              :name (z12 / name
                                                                                         :op1 ""selumetinib""))
                                                                   :mod (z13 / chronic))))))
              :ARG1 (z14 / increase-01
                         :ARG1 (z15 / level
                                    :mod (z16 / enzyme
                                              :wiki ""Caspase_3""
                                              :name (z17 / name
                                                         :op1 ""caspase""
                                                         :op2 3)
                                              :ARG1-of (z18 / cleave-01)))
                         :location (z19 / group
                                        :mod (z20 / combine-01)))
              :condition (z21 / compare-01
                              :ARG1 z5
                              :ARG2 (z22 / group
                                         :mod (z23 / agent
                                                   :ARG1-of (z24 / single-02)
                                                   :mod (z25 / alone))))))",0.6111111111111113,0.6262626262626263,"(m / multi-sentence
        :snt1 (c / compare-01
            :ARG1 (t / tissue
                  :mod (t2 / tumour))
            :ARG2 (a / analyse-01
                  :ARG1 t
                  :ARG2 (s / study
                        :mod (s2 / same)
                        :ARG1 (d / dose-01
                              :ARG1 (s3 / schedule
                                    :mod (c2 / chronic)
                                    :ARG0 (s4 / selumetinib))))
                        :ARG2 (g / group
                              :mod (c3 / combination)
                              :ARG1-of (i / increase-01
                                    :ARG1 (l / level
                                          :mod (c4 / cleaved)
                                          :ARG1 (c5 / caspase-03)))))))
        :snt2 (c6 / compare-01
            :ARG1 (a2 / agent
                  :mod (s5 / single))
            :ARG2 (a3 / alone)))","(c / compare-01
    :ARG1 (a / analyze-01
        :ARG0 (t / tissue
            :mod (t2 / tumor))
        :ARG1 (s / study
            :mod (s2 / same))
        :time (a2 / after
            :op1 (d / dose-01
                :ARG1 (s3 / schedule
                    :mod (c2 / chronic))
                :ARG2 (s4 / selumetinib))))
    :ARG2 (i / increase-01
        :ARG1 (l / level
            :mod (c3 / caspase
                :mod (c4 / cleave-01)
                :mod (n / numeral :value 3)))
        :location (g / group
            :mod (c5 / combine-01))
        :time (w / when
            :op1 (c6 / compare-01
                :ARG1 g
                :ARG2 (a3 / agent
                    :mod (s5 / single)
                    :mod (a4 / alone-01))))))
    :mod (i2 / in)
    :mod (c7 / comparison))",-1.0,-1.0
bel_pmid_1008_0909.24618,"It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)","(m5 / multi-sentence
    :rel (i / induce-01
        :ARG0 (e / enzyme
            :name (n2 / name
                :op1 ""TPO""))
        :ARG2 (a / activate-01
            :ARG1 (a3 / and
                :op1 (p3 / protein
                    :name (n3 / name))
                :op2 (e2 / enzyme
                    :name (n4 / name)
                    :name (n5 / name
                        :op1 ""5A""))
                :op2 (s2 / small-molecule
                    :name (n6 / name
                        :op1 ""STAT3""
                        :op1 ""tyrosine"")))))
    :rel 38
    :rel 5B
    :rel (n / name)
    :rel 26
    :rel 28
    :rel 30
    :rel 37
    :snt1 (d2 / difficult
        :domain (i2 / interpret-01
            :ARG1 (r3 / role
                :purpose (d / develop-02
                    :ARG1 (m / megakaryocyte))
                :mod (b2 / biology)
                :poss (s / signal-07))))
    :snt2 (r2 / report-01
        :location (l / line
            :quant (m6 / multiple)
            :mod (c / cell)))
    :snt3 (c2 / contrast-01
        :ARG2 (f / find-01
            :ARG0 (w / we)
            :ARG1 (h / have-degree-91
                :ARG1 s2
                :ARG2 (p2 / pronounced-02
                    :location (a4 / and
                        :op1 (p / phosphorylate-01
                            :ARG1 ""tyrosine"")
                        :op2 (a2 / activity-06
                            :ARG1 (b / bind-01
                                :ARG1 (n8 / nucleic-acid
                                    :name (n7 / name
                                        :op1 ""DNA""
                                        :op1 ""STAT5""))))))
                :ARG3 (m3 / more
                    :quant (m4 / much))
                :ARG4 (s3 / small-molecule
                    :name n7)
                :ARG6 32)
            :time (e3 / examine-01
                :ARG0 w
                :ARG1 (e4 / extract-01
                    :ARG1 (m2 / megakaryocyte
                        :mod (m7 / murine))
                    :ARG1-of (r / refine-01))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (d / difficult
            :domain (i / interpret-01
                  :ARG1 (r / role
                        :mod (p2 / physiologic)
                        :poss (s / signal-07
                              :ARG0 (p3 / protein :name (n / name :op1 ""STAT"")))
                        :purpose (d2 / develop-02
                              :ARG1 (c / cell :name (n2 / name :op1 ""megakaryocyte""))))))
      :snt2 (r2 / report-01
            :ARG1 (i2 / induce-01
                  :ARG0 (p4 / protein :name (n3 / name :op1 ""TPO""))
                  :ARG2 (a / activate-01
                        :ARG1 (a2 / and
                              :op1 (p5 / protein :name (n4 / name :op1 ""STAT3""))
                              :op2 (p6 / protein :name (n5 / name :op1 ""STAT5""))
                              :mod (b / both))))
            :ARG1-of (d3 / describe-01
                  :ARG0 (a3 / and
                        :op1 (f / figure :mod ""5A"")
                        :op2 (f2 / figure :mod ""5B"")
                        :op3 (p7 / publication
                              :ARG1-of (c2 / cite-01
                                    :ARG2 (a4 / and :op1 26 :op2 28 :op3 30 :op4 37 :op5 38)))))
            :location (c5 / cell-line
                  :quant (m5 / multiple)))
      :snt3 (c6 / contrast-01
            :ARG2 (f3 / find-01
                  :ARG0 (w / we)
                  :ARG1 (p / pronounced-02
                        :ARG1 (p9 / protein :name (n6 / name :op1 ""STAT3""))
                        :degree (m2 / more
                              :quant (m3 / much))
                        :condition (a5 / and
                              :op1 (p10 / phosphorylate-01
                                    :ARG1 (a6 / amino-acid :name (n7 / name :op1 ""tyrosine"")))
                              :op2 (a7 / activity-06
                                    :ARG1 (b2 / bind-01
                                          :ARG1 (n9 / nucleic-acid :wiki ""DNA"" :name (n10 / name :op1 ""DNA""))))
                              :mod (b3 / both))
                        :compared-to (p11 / protein :name (n8 / name :op1 ""STAT5"")))
                  :time (e / examine-01
                        :ARG1 (t / thing
                              :ARG1-of (e2 / extract-01
                                    :ARG2 (m6 / megakaryocyte
                                          :mod (m4 / murine))
                                    :ARG1-of (p13 / purify-01)))))
            :ARG1-of (d5 / describe-01
                  :ARG0 (p12 / publication
                        :ARG1-of (c3 / cite-01
                              :ARG2 32)))))","It has been difficult to interpret the physiologic role of STAT signaling in megakaryocyte development. In multiple cell lines it was reported that TPO induced activation of both STAT3 and STAT5 (5A and 5B) (26, 28?30, 37, 38)....However, when purified murine megakaryocyte extracts were examined, we found that STAT3 was much more pronounced in both tyrosine phosphorylation and DNA binding activity than STAT5 (32)","(z1 / difficult
    :domain (z2 / interpret-01
                :ARG1 (z3 / role
                          :mod (z4 / physiologic)
                          :poss (z5 / signal-07
                                    :ARG0 (z6 / protein
                                              :wiki ""STAT_(t3000 / threonine)""
                                              :name (z7 / name
                                                        :op1 ""STAT"")))
                          :purpose (z8 / develop-02
                                       :ARG1 (z9 / megakaryocyte)))))",0.1948051948051948,0.4937238493723849,"(m / multi-sentence
        :snt1 (d / difficult-02
            :ARG1 (i / interpret-01
                  :ARG0 (r / role
                        :mod (p / physiologic))
                  :ARG1 (s / signaling
                        :ARG1-of (s2 / STAT
                              :ARG1-of (d2 / develop-01
                                    :ARG1 (m / megakaryocyte)))))
        :snt2 (r2 / report-01
            :ARG0 (i2 / it)
            :ARG1 (a / activation
                  :ARG1-of (i3 / induce-01
                        :ARG1 (t / TPO))
                  :ARG2 (a2 / and
                        :op1 (s3 / STAT3)
                        :op2 (s4 / STAT5
                              :op1 (n / name :op1 ""5A"")
                              :op2 (n2 / name :op1 ""5B""))))
        :snt3 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (e2 / extract
                  :mod (m2 / megakaryocyte)
                  :ARG1-of (p2 / purify-01
                        :ARG1 w))
            :ARG2 (p3 / pronounced-01
                  :ARG1 (s5 / STAT3)
                  :ARG2 (a3 / activity
                        :ARG1-of (b / bind-01
                              :ARG1 (d3 / DNA)
                              :ARG2 w)))
            :ARG3 (p4 / pronounced-01
                  :ARG1 (s6 / STAT5)
                  :ARG2 (a4 / activity
                        :ARG1-of (b2 / bind-01
                              :ARG1 (d4 / DNA)
                              :ARG2 w))))
        :snt4 (m3 / much
            :ARG1 (p5 / pronounced-01
                  :ARG1 s5
                  :ARG2 (p6 / phosphorylation
                        :ARG1-of (t2 / tyrosine)))
            :ARG2 (p7 / pronounced-01
                  :ARG1 s6
                  :ARG2 (p8 / phosphorylation
                        :ARG1-of (t3 / tyrosine))))
        :snt5 (c / compare-01
            :ARG1 (s7 / STAT3)
            :ARG2 (s8 / STAT5))
        :snt6 (c2 / compare-01
            :ARG1 (s9 / STAT3)
            :ARG2 (s10 / STAT5)))","(i / interpret-01
    :ARG1 (r / role
        :ARG1-of (p / physiologic-01)
        :ARG2 (s / signal-01
            :ARG1-of (s2 / STAT)
            :ARG2-of (d / develop-01
                :ARG1 (m / megakaryocyte))))
    :ARG0 (i2 / it)
    :mod (d2 / difficult)
    :time (b / be-03
        :ARG1 i2
        :time (p2 / past)))
(and / and
    :op1 (r2 / report-01
        :ARG0 (i3 / it)
        :ARG1 (a / activate-01
            :ARG0 (t / TPO)
            :ARG1 (s3 / STAT3)
            :ARG2 (s4 / STAT5)
            :ARG3 (s5 / STAT5
                :mod (5 / 5A))
            :ARG4 (s6 / STAT5
                :mod (5 / 5B)))
        :location (l / line
            :mod (c / cell)
            :quant (m2 / multiple)))
    :op2 (f / find-01
        :ARG0 (w / we)
        :ARG1 (p3 / pronounce-01
            :ARG1 (s7 / STAT3)
            :degree (m3 / more)
            :compared-to (s8 / STAT5)
            :ARG2-of (a2 / and
                :op1 (p4 / phosphorylation-01
                    :ARG1 (t2 / tyrosine))
                :op2 (b2 / bind-01
                    :ARG1 (d3 / DNA)
                    :ARG2 s7)))
        :location (e / extract-01
            :ARG1-of (p5 / purify-01)
            :ARG2-of (m4 / megakaryocyte))
        :time (w2 / when)))
(and / and
    :op1 (h / however)
    :op2 f)",-1.0,-1.0
bel_pmid_1019_4465.23766,"The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.","(m3 / multi-sentence
    :rel (s / several
        :op2 (p4 / protein
            :ord (s4 / string-entity
                :value ""IP3"")))
    :rel (p2 / presume-01)
    :snt1 (c2 / contrast-01
        :ARG1 (k / know-01
            :ARG1 (e / enzyme
                :ARG0-of (t / target-01
                    :ARG1 (p3 / protein
                        :name (n / name
                            :op1 2)
                        :ARG2-of (e7 / express-03))
                    :ARG1 (l / law
                        :name (n5 / name
                            :op2 ""low""
                            :op3 ""after""
                            :op4 ""year""
                            :op5 1)))
                :mod (p / physiology))
            :polarity -)
        :ARG2 (m2 / moderate-01
            :ARG0 e7
            :ARG1 (a3 / and
                :op1 (b / bond-01
                    :ARG1 (c / cell))
                :op2 (m / migrate-01
                    :ARG1 c)
                :op3 (a / activate-01
                    :ARG0 (i2 / insulin)
                    :ARG1 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""Ras"")
                        :mod (e3 / enzyme
                            :name (n3 / name
                                :op1 ""fund""
                                :op2 ""pathway"")))))))
    :snt2 (s3 / show-01
        :ARG1 (a5 / associate-01
            :ARG1 (a4 / and
                :op1 (e4 / enzyme
                    :name (n4 / name
                        :op1 ""IP3""
                        :op1 ""RXRXXpS"")
                    :mod (s5 / string-entity
                        :value ""E""
                        :value ""z""))
                :op2 e4)
            :ARG2 (r / region
                :name n5
                :ARG1-of (i / include-91
                    :ARG2 (e5 / enzyme
                        :quant (s2 / several)
                        :part-of ""fund""
                        :part-of l))
                :domain e4
                :part-of (e6 / enzyme
                    :name n5)))
        :mod (a2 / also)))
",test,bio_amr0.8,"(m3 / multi-sentence
      :snt1 (c / contrast-01
            :ARG1 (k / know-01 :polarity -
                  :ARG1 (s / substrate
                        :mod (p2 / physiology)
                        :topic (p3 / protein :name (n2 / name :op1 ""SHP-2""))))
            :ARG2 (a / and
                  :op1 (m / modulate-01
                        :ARG0 (o / overexpress-01
                              :ARG1 p3)
                        :ARG1 (a4 / and
                              :op1 (a2 / and
                                    :op1 (a3 / adhere-01
                                          :ARG1 (c2 / cell))
                                    :op2 (m2 / migrate-01
                                          :ARG0 c2))
                              :op2 (a5 / activate-01
                                    :ARG0 (i3 / insulin)
                                    :ARG1 (p4 / pathway :name (n3 / name :op1 ""Ras/MAP-kinase"")))))))
      :snt2 (s2 / show-01
            :ARG1 (a8 / associate-01
                  :ARG1 (i / isoform
                        :mod (p / protein :name (n / name :op1 ""14-3-3""))
                        :ARG1-of (d / describe-01
                              :ARG2 (a7 / and
                                    :op1 (p5 / protein :name (n4 / name :op1 ""14-3-3β""))
                                    :op2 (p8 / protein :name (n5 / name :op1 ""14-3-3ε""))
                                    :op3 (p9 / protein :name (n8 / name :op1 ""14-3-3ζ""))))
                        :quant (s3 / several))
                  :ARG2 (p6 / protein :name (n6 / name :op1 ""IRS-1""))
                  :instrument (m5 / motif
                        :ARG1-of (i2 / include-91
                              :ARG2 (m4 / motif :name (n7 / name :op1 ""RXRXXpS"")
                                    :part-of p6))
                        :ARG1-of (p7 / presume-01)))
            :mod (a6 / also)))","The physiological substrates for SHP- 2 are not known, but overexpression of SHP-2 modulates cell adhesion and migration, as well as insulin activation of the Ras/MAP-kinase pathway Several isoforms of 14-3-3 proteins (b, e, and z) have also been shown to associate with IRS-1, presumably through one of the several RXRXXpS motifs of IRS-1.","(z1 / contrast-01
    :ARG1 (z2 / know-01
              :polarity -
              :ARG1 (z3 / thing
                        :ARG2-of (z4 / catalyze-01
                                     :ARG1 (z5 / protein
                                               :wiki ""Selective_serotonin_reuptake_inhibitor""
                                               :name (z6 / name
                                                         :op1 ""SHP-2""))
                                     :mod (z7 / physiology))))
    :ARG2 (z8 / show-01
              :ARG1 (z9 / associate-01
                        :ARG1 (z10 / protein
                                   :mod (z11 / isoform
                                             :quant (z12 / several)
                                             :example (z13 / and
                                                           :op1 (z14 / protein
                                                                     :wiki ""BRAF-14""
                                                                     :name (z15 / name
                                                                                :op1 ""b""))
                                                           :op2 (z16 / protein
                                                                     :wiki ""E""
                                                                     :name (z17 / name
                                                                                :op1 ""e""))
                                                           :op3 (z18 / protein
                                                                     :wiki ""Z""
                                                                     :name (z19 / name
                                                                                :op1 ""z"")))))
                        :ARG2 (z20 / protein
                                   :wiki ""IRS-1""
                                   :name (z21 / name
                                              :op1 ""IRS-1"")
                                   :part z24)
                        :manner (z22 / motif
                                     :quant 1
                                     :ARG1-of (z23 / include-91
                                                   :ARG2 (z24 / motif
                                                              :wiki ""RXRXXpS""
                                                              :name (z25 / name
                                                                         :op1 ""RXRXXpS"")
                                                              :quant (z26 / several))))))
    :mod (z27 / also))",0.3558282208588957,0.387434554973822,"(m / multi-sentence
        :snt1 (k / know-01
            :ARG1 (s / substrate
                  :mod (p / physiological))
            :ARG0 (n / not))
        :snt2 (m2 / modulate-01
            :ARG0 (o / overexpression)
            :ARG1 (s2 / SHP-2)
            :ARG2 (a / adhesion)
            :ARG2 (m3 / migration))
        :snt3 (a2 / associate-01
            :ARG0 (s3 / show-01
                  :ARG1 (i / isoform)
                  :ARG2 (p2 / protein
                        :mod (n2 / name :op1 ""14-3-3"")
                        :mod (b / b)
                        :mod (e / e)
                        :mod (z / z))))
            :ARG1 (w / with
                  :ARG2 (i2 / IRS-1
                        :mod (p3 / presumably)
                        :mod (m4 / motif
                              :mod (r / RXRXXpS)
                              :mod (s4 / several))))))","(p / physiological-01
    :ARG1 (s / substrate
        :mod (s2 / SHP-2))
    :ARG1-of (k / know-01 :polarity -)
    :ARG1-of (c / contrast-01
        :ARG2 (m / multi-sentence
            :snt1 (o / overexpression
                :ARG1 s2
                :ARG1-of (m2 / modulate-01
                    :ARG2 (a / and
                        :op1 (c2 / cell-adhesion)
                        :op2 (m3 / migration-01))
                    :ARG1-of (a2 / as-well-as
                        :op1 (a3 / activate-01
                            :ARG0 (i / insulin)
                            :ARG1 (p2 / pathway
                                :mod (r / Ras/MAP-kinase)))))
            :snt2 (h / have-org-role-91
                :ARG0 (i2 / isoform
                    :mod (p3 / protein
                        :name (n / name :op1 ""14-3-3"")))
                :ARG1 (a4 / associate-01
                    :ARG0 i2
                    :ARG1 (i3 / IRS-1)
                    :ARG1-of (p4 / presume-01
                        :ARG2 (o2 / one
                            :quant (s3 / several)
                            :mod (m4 / motif
                                :mod (r2 / RXRXXpS)
                                :part-of i3)))
                :ARG2 (a5 / and
                    :op1 (b / b)
                    :op2 (e / e)
                    :op3 (z / z))))))",-1.0,-1.0
bel_pmid_1034_7197.8888,Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.,"(b / block-01
    :ARG0 (e4 / express-03
        :ARG1 (a / and
            :op1 (c / construct-01
                :ARG0-of (d / dominate-01)
                :ARG1-of (e5 / express-03))
            :op2 (c2 / construct-01
                :ARG1 (n3 / name
                    :op1 ""SF""
                    :op1 ""Met""
                    :op1 ""Sos1""
                    :op2 ""serotonin"")))
        :ARG2 (e3 / enzyme
            :name n3))
    :ARG1 (r / reduce-01
        :ARG0 (s / slash
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""HGF""
                    :op1 ""Grb2""))
            :op2 (e2 / enzyme
                :name (n2 / name
                    :op2 ""Treaty"")))
        :ARG1 (p / promote-02
            :ARG1 (u / urokinase))
        :path e3)
    :rel (n4 / negative-02
        :ARG0-of d))
",test,bio_amr0.8,"(b / block-01
      :ARG0 (c / coexpress-01
            :ARG2 (c2 / construct-01
                  :ARG1 (a / and
                        :op1 (p / protein :name (n / name :op1 ""Grb2"")
                              :ARG2-of (m / mutate-01 :mod ""-/-"")
                              :ARG0-of (d / dominate-01))
                        :op2 (e / express-03
                              :ARG2 (p2 / protein :name (n2 / name :op1 ""Sos1""))))))
      :ARG1 (i / induce-01
            :ARG0 (p3 / protein :name (n3 / name :op1 ""HGF/SF""))
            :ARG2 (m2 / molecular-physical-entity
                  :ARG0-of (p4 / promote-01
                        :ARG1 (e2 / enzyme :name (n4 / name :op1 ""urokinase""))))
            :medium (r / receptor :name (n5 / name :op1 ""Met""))))",Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct.,"(z1 / block-01
    :ARG0 (z2 / coexpress-01
              :ARG1 (z3 / construct
                        :mod (z4 / express-02
                                 :ARG1 (z5 / enzyme
                                           :wiki ""Grb2""
                                           :name (z6 / name
                                                     :op1 ""Grb2"")
                                           :ARG1-of (z7 / negative-05
                                                        :ARG0-of (z8 / dominate-01))))
                        :mod (z9 / express-101
                                 :ARG1 (z10 / enzyme
                                            :wiki ""Sos1""
                                            :name (z11 / name
                                                       :op1 ""Sos1"")
                                            :ARG1-of (z12 / negative-05)))))
    :ARG1 (z13 / induce-01
               :ARG0 (z14 / slash
                          :op1 (z15 / small-molecule
                                    :wiki ""Histidine-rich_glycoprotein""
                                    :name (z16 / name
                                               :op1 ""HGF/SF""))
                          :op2 (z17 / protein
                                    :wiki ""Met_receptor""
                                    :name (z18 / name
                                               :op1 ""Met""
                                               :op2 ""receptor"")))
               :ARG1 (z19 / protein
                          :ARG0-of (z20 / promote-02
                                        :ARG1 (z21 / urokinase)))))",0.3333333333333333,0.3076923076923077,"(m / multi-sentence
        :snt1 (b / block-01
            :ARG0 (i / induction
                  :ARG1 (p / promoter
                        :mod (u / urokinase)))
            :ARG1 (b2 / by
                  :ARG0 (c / co-expression
                        :ARG1 (g / Grb2
                              :mod (d / dominant-negative))
                        :ARG2 (e / expression
                              :ARG1 (c2 / construct
                                    :ARG1 (s / Sos1)))))
            :ARG2 (b3 / by
                  :ARG0 (h / HGF/SF)
                  :ARG1 (r / receptor
                        :ARG1-of (b4 / block-01
                              :ARG0 i
                              :ARG1 p))))
        :snt2 (b5 / be-01
            :ARG1 (b6 / block-01
                  :ARG0 (i2 / induction
                        :ARG1 (p2 / promoter
                              :mod (u2 / urokinase)))
                  :ARG1 (b7 / by
                        :ARG0 (c3 / co-expression
                              :ARG1 (g2 / Grb2
                                    :mod (d2 / dominant-negative))
                              :ARG2 (e2 / expression
                                    :ARG1 (c4 / construct
                                          :ARG1 (s2 / Sos1)))))
                  :ARG2 (b8 / by
                        :ARG0 (h2 / HGF/SF)
                        :ARG1 (r2 / receptor))))","(i / induce-01
    :ARG0 (p / promoter
        :mod (u / urokinase))
    :ARG1 (b / block-01
        :ARG0 (c / co-express-01
            :ARG1 (g / Grb2
                :mod (d / dominant-negative))
            :ARG2 (s / Sos1)
            :ARG1-of (e / express-01
                :ARG2 (c2 / construct
                    :mod (e2 / expression))))
        :ARG1 (r / receptor
            :mod (m / Met)
            :ARG1-of (v / via-01
                :ARG2 (h / HGF/SF))))
    :time (w / when))",-1.0,-1.0
bel_pmid_1034_7197.20912,"Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.","(a / abate-01
    :ARG0 (o / or
        :op1 (e7 / express-01
            :ARG1 (m / mutate-01
                :ARG0-of (a2 / activity-06
                    :ARG1-of (p / phosphorylate-01))
                :ARG1 (a4 / and
                    :op1 (e2 / enzyme
                        :name (n / name
                            :op1 ""ha""))
                    :op2 (e3 / enzyme
                        :name (n2 / name
                            :op1 ""RhoA""))
                    :op3 (e4 / enzyme
                        :name (n3 / name
                            :op1 ""B-Raf""))
                    :op4 (p3 / protein
                        :name (n4 / name
                            :op1 ""Erk2"")))))
        :op2 (a3 / add-02
            :ARG1 (e5 / enzyme
                :name (n5 / name
                    :op1 ""PD"")
                :ARG0-of (i / inhibit-01)
                :ARG1-of (s2 / specific-02))))
    :ARG1 (s3 / stimulate-01
        :ARG0 (s / slash
            :op1 (e6 / enzyme
                :name (n6 / name
                    :op1 ""HGF""))
            :op2 (t / thing
                :name (n7 / name
                    :op1 ""urokinase""))
            :op2 (t2 / thing
                :name (n8 / name
                    :op1 ""SF"")))
        :ARG1 (p2 / promote-02
            :ARG1 ""urokinase""))
    :mod (f / further)
    :rel (e / Mek1)
    :rel 098059)
",test,bio_amr0.8,"(a / and
      :op2 (a2 / abrogate-01
            :ARG1 (s / stimulate-01
                  :ARG0 (p / protein :name (n / name :op1 ""HGF/SF""))
                  :ARG1 (m / molecular-physical-entity
                        :ARG0-of (p2 / promote-01
                              :ARG1 (e / enzyme :name (n2 / name :op1 ""urokinase"")))))
            :ARG2 (o / or
                  :op1 (e2 / express-03
                        :ARG2 (m2 / mutate-01
                              :ARG1 (a3 / and
                                    :op1 (e6 / enzyme :name (n3 / name :op1 ""Ha-Ras""))
                                    :op2 (p4 / protein :name (n4 / name :op1 ""RhoA""))
                                    :op3 (e3 / enzyme :name (n5 / name :op1 ""c-Raf""))
                                    :op3 (e4 / enzyme :name (n6 / name :op1 ""Erk2"")))
                              :ARG1-of (a4 / activate-01 :polarity -
                                    :manner (c / catalytic))))
                  :op2 (a5 / add-02
                        :ARG1 (m3 / molecular-physical-entity :name (n7 / name :op1 ""PD-098059"")
                              :ARG0-of (i / inhibit-01
                                    :ARG1-of (s2 / specific-02
                                          :ARG2 (e5 / enzyme :name (n8 / name :op1 ""Mek1"")))))))))","Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF.","(z1 / abrogate-01
    :ARG0 (z2 / or
              :op1 (z3 / express-03
                       :ARG1 (z4 / mutant
                                 :ARG1-of (z5 / activity-06
                                              :polarity -
                                              :ARG0 (z6 / catalyze-01))
                                 :mod (z7 / gene
                                          :wiki ""Ha-Ras""
                                          :name (z8 / name
                                                    :op1 ""Ha-Ras""))
                                 :mod (z9 / amino-acid
                                          :wiki ""RhoA""
                                          :name (z10 / name
                                                     :op1 ""RhoA""))
                                 :mod (z11 / amino-acid
                                           :wiki ""C-Raf""
                                           :name (z12 / name
                                                      :op1 ""c-Raf""))
                                 :mod (z13 / enzyme
                                           :wiki ""Erk2""
                                           :name (z14 / name
                                                      :op1 ""Erk2"")))))
    :op2 (z15 / add-02
              :ARG1 (z16 / enzyme
                         :wiki ""Cyclin-dependent_protein""
                         :wiki ""Cyclin-dependent_protein_kinase""
                         :name (z17 / name
                                    :op1 ""PD""
                                    :op2 ""98059"")
                         :ARG0-of (z18 / inhibit-01
                                       :ARG1 (z19 / enzyme
                                                  :wiki ""Mek1""
                                                  :name (z20 / name
                                                             :op1 ""Mek1""))
                                       :ARG1-of (z21 / specific-02)))))",0.3174603174603175,0.2836879432624113,"(m / multi-sentence
        :snt1 (e / expression-01
            :ARG1 (m2 / mutant
                  :mod (i / inactive)
                  :mod (c / catalytically))
            :ARG0 (h / Ha-Ras)
            :ARG0-of (a / and
                  :op1 (r / RhoA)
                  :op2 (c2 / c-Raf)
                  :op3 (e2 / Erk2))
            :ARG1-of (a2 / abrogate-01
                  :ARG0 (a3 / addition)
                  :ARG1 (i2 / inhibitor
                        :mod (s / specific)
                        :ARG1 (p / PD-098059)
                        :ARG2 (m3 / Mek1)))
            :ARG1-of (s / stimulate-01
                  :ARG0 (p2 / promoter
                        :mod (u / urokinase))
                  :ARG1 (h2 / HGF/SF)))
        :snt2 (n / none))","(e / express-01
    :ARG1 (m / mutant
        :mod (i / inactive)
        :mod (c / catalytic)
        :ARG1-of (a / and
            :op1 (p / protein :wiki ""H-Ras"" :name (n / name :op1 ""Ha-Ras""))
            :op2 (p2 / protein :wiki ""RhoA"" :name (n2 / name :op1 ""RhoA""))
            :op3 (p3 / protein :wiki ""C-Raf"" :name (n3 / name :op1 ""c-Raf""))
            :op4 (p4 / protein :wiki ""ERK"" :name (n4 / name :op1 ""Erk2""))))
    :ARG2 (a2 / addition
        :ARG1 (i2 / inhibit-01
            :ARG0 (c2 / compound :wiki ""PD_098059"" :name (n5 / name :op1 ""PD"" :op2 ""098059""))
            :ARG1 (p5 / protein :wiki ""Mitogen-activated_protein_kinase_kinase"" :name (n6 / name :op1 ""Mek1""))))
    :concession (s / stimulate-01
        :ARG0 (c3 / compound :wiki ""Hepatocyte_growth_factor"" :name (n7 / name :op1 ""HGF"" :op2 ""/"" :op3 ""SF""))
        :ARG1 (p6 / promoter
            :mod (u / urokinase))))
    :mod (f / further))",-1.0,-1.0
bel_pmid_1036_2713.24360,"SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).","(c2 / contrast-01
    :ARG1 (s3 / suppress-01
        :ARG0 (d2 / disease
            :name (n / name
                :op1 ""SOD"")
            :ARG1-of (r / rate-entity-91
                :ARG2 (v / volume-quantity
                    :quant 250
                    :unit (m / milligram))))
        :ARG1 (a / and
            :ARG1-of (i / induce-01
                :ARG2 (s2 / small-molecule
                    :name (n5 / name
                        :op1 ""XO"")))
            :op1 (p / produce-01)
            :op2 (e / enzyme
                :name (n3 / name
                    :op1 6))
            :op2 (e2 / express-03
                :ARG1 (p2 / protein
                    :name (n4 / name
                        :op1 ""mRNA""))))
        :ARG1-of (s / significant-02))
    :ARG2 (m3 / modulate-01
        :ARG0 (r2 / rate-entity-91
            :ARG1 (c / catalase)
            :ARG2 (v2 / volume-quantity
                :quant 500
                :unit (m2 / milliliter)))
        :ARG1 (r3 / respond-01
            :ARG1 s2)
        :polarity -)
    :rel (d / describe-01
        :ARG0 (f / figure
            :ARG1-of d
            :mod 4))
    :rel (n2 / name)
    :rel 6)
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (s / suppress-01
            :ARG0 (e / enzyme :name (n / name :op1 ""SOD"")
                  :quant (c2 / concentration-quantity :quant 250
                        :unit (u / unit-per-milliliter)))
            :ARG1 (a / and
                  :op1 (p / produce-01
                        :ARG1 (p2 / protein :name (n2 / name :op1 ""IL-6"")))
                  :op2 (e2 / express-03
                        :ARG1 (n5 / nucleic-acid :name (n3 / name :op1 ""mRNA"")
                              :ARG0-of (e5 / encode-01
                                    :ARG1 p2)))
                  :ARG2-of (i / induce-01
                        :ARG0 (e3 / enzyme :name (n4 / name :op1 ""XO""))))
            :ARG1-of (s2 / significant-02))
      :ARG2 (m / modulate-01 :polarity -
            :ARG0 (e4 / enzyme :name (n6 / name :op1 ""catalase"")
                  :quant (c3 / concentration-quantity :quant 500
                        :unit u))
            :ARG1 (r2 / respond-01
                  :ARG0 p2
                  :ARG1 e3))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod 4)))","SOD (250 U/ml) significantly suppressed the IL-6 production and IL-6 mRNA expression induced by XO, whereas catalase (500 U/ml) did not modulate the IL-6 response to XO (Fig. 4).","(z1 / contrast-01
    :ARG1 (z2 / suppress-01
              :ARG0 (z3 / small-molecule
                        :wiki ""Selective_serotonin_reuptake_inhibitor""
                        :name (z4 / name
                                  :op1 ""SOD"")
                        :ARG1-of (z5 / rate-entity-91
                                     :ARG2 (z6 / volume-quantity
                                               :quant 250
                                               :unit (z7 / milligram))))
              :ARG1 (z8 / and
                        :op1 (z9 / produce-01
                                 :ARG1 (z10 / protein
                                            :wiki ""Inositol_trisphosphate""
                                            :name (z11 / name
                                                       :op1 ""IL-6"")))
                        :op2 (z12 / express-02
                                  :ARG1 (z13 / protein
                                             :wiki ""Mitogen-activated_protein_kinase""
                                             :name (z14 / name
                                                        :op1 ""IL-6""
                                                        :op2 ""mRNA"")))
                        :ARG1-of (z15 / induce-01
                                      :ARG0 (z16 / small-molecule
                                                 :wiki ""XO_(g3000 / gene)""
                                                 :name (z17 / name
                                                            :op1 ""XO"")))))
    :ARG1-of (z18 / significant-02))",0.4074074074074074,0.5238095238095237,"(s / suppress-01
        :ARG1 (p / production
              :ARG1-of (i / induce-01
                    :ARG1 (e / expression
                          :ARG1-of (m / mRNA
                                :mod (i2 / IL-6))))
              :ARG0 (s2 / SOD
                    :quant (u / unit
                          :op1 250
                          :op2 U/ml)))
        :ARG2 (x / XO)
        :ARG3 (r / response
              :ARG1-of (m2 / modulate-01
                    :ARG1 (i3 / IL-6)
                    :ARG2 (c / catalase
                          :quant (u2 / unit
                                :op1 500
                                :op2 U/ml))))
        :ARG4 (f / figure
              :op1 ""4""))","(s / suppress-01
    :ARG0 (s2 / substance :name (n / name :op1 ""SOD""))
    :ARG1 (p / produce-01
        :ARG0 (s3 / substance :name (n2 / name :op1 ""IL-6""))
        :ARG1 (s3 / substance :name (n2 / name :op1 ""IL-6""))
        :ARG2 (e / express-01
            :ARG0 (m / mRNA)
            :ARG1 s3))
    :ARG2 (i / induce-01
        :ARG0 (s4 / substance :name (n3 / name :op1 ""XO""))
        :ARG1 p)
    :degree (s5 / significant)
    :mod (u / unit :quant 250 :unit ""U/ml""))
(c / contrast-01
    :ARG1 s
    :ARG2 (m2 / modulate-01 :polarity -
        :ARG0 (s6 / substance :name (n4 / name :op1 ""catalase""))
        :ARG1 (r / respond-01
            :ARG0 s3
            :ARG1 (s7 / substance :name (n5 / name :op1 ""XO""))))
    :mod (u2 / unit :quant 500 :unit ""U/ml""))
(r2 / refer-01
    :ARG1 m2
    :ARG2 (f / figure :name (n6 / name :op1 ""4"")))",-1.0,-1.0
bel_pmid_1036_2713.24538,"TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(c / capable-01
    :ARG0-of (d / depend-01)
    :ARG1 (d4 / dose-01
        :ARG1 (s / small-molecule
            :name (n / name
                :op1 ""A"")))
    :ARG1-of (d2 / describe-01)
    :ARG1-of (d3 / describe-01
        :ARG0 (a2 / and
            :op1 (f / figure
                :mod 4A)
            :op2 (f2 / figure
                :mod 4B)
            :op3 (f3 / figure
                :mod 4C)))
    :ARG2 (i / induce-01
        :ARG0 d4)
    :rel (n2 / name
        :ARG2 (r / release-01
            :ARG0 (a / and
                :op1 (c2 / cell
                    :name (n3 / name
                        :op1 ""RS-24""))
                :op2 (c3 / cell
                    :name (n4 / name
                        :op1 ""Dem""))))
        :op1 ""6""))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (i / induce-01
            :ARG0 (p2 / protein :name (n / name :op1 ""TNF-α""))
            :ARG2 (r / release-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6""))
                  :ARG2 (a / and
                        :op1 (c / cell :name (n3 / name :op1 ""NHBE""))
                        :op2 (c2 / cell :name (n4 / name :op1 ""HS-24"")))))
      :manner (d / depend-01
            :ARG0 p2
            :ARG1 (d2 / dose))
      :ARG1-of (d3 / describe-01
            :ARG0 (a2 / and
                  :op1 (f / figure :mod ""5A"")
                  :op2 (f2 / figure :mod ""5C""))))","TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(z1 / possible-01
    :ARG1 (z2 / induce-01
              :ARG0 (z3 / dose-01
                        :ARG2 (z4 / small-molecule
                                  :wiki ""TNF-a""
                                  :name (z5 / name
                                            :op1 ""TNF-a"")))
              :ARG1 (z6 / release-01
                        :ARG1 (z7 / small-molecule
                                  :wiki ""IL-6""
                                  :name (z8 / name
                                            :op1 ""IL-6""))
                        :ARG2 (z9 / and
                                  :op1 (z10 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z11 / name
                                                       :op1 ""NHBE""))
                                  :op2 (z12 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z13 / name
                                                       :op1 ""HS-24""))))))",0.32,0.3571428571428571,"(s / sentence
        :snt (c / cause-01
            :ARG0 (w / was
                  :ARG1 (c2 / capable-01
                        :ARG1 (i / induce-01
                              :ARG1 (r / release-01
                                    :ARG0 (c3 / cell
                                          :mod (n / nhbe)
                                          :mod (h / hs-24))
                                    :ARG1 (i2 / il-6)))
                              :ARG0 (t / tnfa)
                              :ARG2 (d / dependently
                                    :degree (d2 / dose))))
                        :ARG2 (f / from
                              :ARG0 c3
                              :ARG1 (f2 / fig
                                    :op1 ""5""
                                    :op2 (l / list
                                          :op1 ""A""
                                          :op2 ""C""))))))","(i / induce-01
    :ARG0 (c / capable-01
        :ARG1 (t / thing :name (n / name :op1 ""TNF-a""))
        :degree (d / depend-01
            :ARG1 (d2 / dose)))
    :ARG1 (r / release-01
        :ARG0 t
        :ARG1 (t2 / thing :name (n2 / name :op1 ""IL-6""))
        :ARG2 (c2 / cell
            :mod (a / and
                :op1 (c3 / cell :name (n3 / name :op1 ""NHBE""))
                :op2 (c4 / cell :name (n4 / name :op1 ""HS-24""))))))
    :location (f / figure
        :name (n5 / name :op1 ""5"")
        :mod (a2 / and
            :op1 ""A""
            :op2 ""C"")))",-1.0,-1.0
bel_pmid_1036_2713.39154,"TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(c / capable-01
    :ARG0-of (d / depend-01)
    :ARG1 (d4 / dose-01
        :ARG1 (s / small-molecule
            :name (n / name
                :op1 ""A"")))
    :ARG1-of (d2 / describe-01)
    :ARG1-of (d3 / describe-01
        :ARG0 (a2 / and
            :op1 (f / figure
                :mod 4A)
            :op2 (f2 / figure
                :mod 4B)
            :op3 (f3 / figure
                :mod 4C)))
    :ARG2 (i / induce-01
        :ARG0 d4)
    :rel (n2 / name
        :ARG2 (r / release-01
            :ARG0 (a / and
                :op1 (c2 / cell
                    :name (n3 / name
                        :op1 ""RS-24""))
                :op2 (c3 / cell
                    :name (n4 / name
                        :op1 ""Dem""))))
        :op1 ""6""))
",test,bio_amr0.8,"(p / possible-01
      :ARG1 (i / induce-01
            :ARG0 (p2 / protein :name (n / name :op1 ""TNF-α""))
            :ARG2 (r / release-01
                  :ARG1 (p3 / protein :name (n2 / name :op1 ""IL-6""))
                  :ARG2 (a / and
                        :op1 (c / cell :name (n3 / name :op1 ""NHBE""))
                        :op2 (c2 / cell :name (n4 / name :op1 ""HS-24"")))))
      :manner (d / depend-01
            :ARG0 p2
            :ARG1 (d2 / dose))
      :ARG1-of (d3 / describe-01
            :ARG0 (a2 / and
                  :op1 (f / figure :mod ""5A"")
                  :op2 (f2 / figure :mod ""5C""))))","TNF-a was dose dependently capable of inducing IL-6 release from NHBE and HS-24 cells (Fig. 5, A and C).","(z1 / possible-01
    :ARG1 (z2 / induce-01
              :ARG0 (z3 / dose-01
                        :ARG2 (z4 / small-molecule
                                  :wiki ""TNF-a""
                                  :name (z5 / name
                                            :op1 ""TNF-a"")))
              :ARG1 (z6 / release-01
                        :ARG1 (z7 / small-molecule
                                  :wiki ""IL-6""
                                  :name (z8 / name
                                            :op1 ""IL-6""))
                        :ARG2 (z9 / and
                                  :op1 (z10 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z11 / name
                                                       :op1 ""NHBE""))
                                  :op2 (z12 / cell
                                            :wiki ""Mitogen-activated_protein_kinase""
                                            :name (z13 / name
                                                       :op1 ""HS-24""))))))",0.4533333333333333,0.3571428571428571,"(s / sentence
        :snt (c / cause-01
            :ARG0 (w / was
                  :ARG1 (c2 / capable-01
                        :ARG1 (i / induce-01
                              :ARG1 (r / release-01
                                    :ARG0 (c3 / cell
                                          :mod (n / nhbe)
                                          :mod (h / hs-24))
                                    :ARG1 (i2 / il-6)))
                              :ARG0 (t / tnfa)
                              :ARG2 (d / dependently
                                    :degree (d2 / dose))))
                        :ARG2 (f / from
                              :ARG0 c3
                              :ARG1 (f2 / fig
                                    :op1 ""5""
                                    :op2 (l / list
                                          :op1 ""A""
                                          :op2 ""C""))))))","(i / induce-01
    :ARG0 (c / capable-01
        :ARG1 (t / thing :name (n / name :op1 ""TNF-a""))
        :degree (d / depend-01
            :ARG1 (d2 / dose)))
    :ARG1 (r / release-01
        :ARG0 t
        :ARG1 (t2 / thing :name (n2 / name :op1 ""IL-6""))
        :ARG2 (c2 / cell
            :mod (a / and
                :op1 (c3 / cell :name (n3 / name :op1 ""NHBE""))
                :op2 (c4 / cell :name (n4 / name :op1 ""HS-24""))))))
    :location (f / figure
        :name (n5 / name :op1 ""5"")
        :mod (a2 / and
            :op1 ""A""
            :op2 ""C"")))",-1.0,-1.0
bel_pmid_1040_9724.23704,"This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130.","(s / show-01
    :ARG0 (s4 / study-01
        :mod (t / this))
    :ARG1 (e5 / event
        :ARG0-of (s2 / signal-07)
        :ARG1-of (a3 / associate-01
            :ARG2 (a / ""activate-01""
                :ARG0 (e4 / enzyme
                    :name (n5 / name
                        :op1 a
                        :op2 (e2 / ""enzyme""
                            :name (n4 / name
                                :op1 ""MAP""
                                :op1 ""fund""
                                :op2 ""kinases""))
                        :op3 ""1/2"")
                    :part-of a)
                :ARG1 e2))
        :domain (a2 / and
            :ARG1-of (c2 / contrast-01
                :ARG2 (p2 / phosphorylate-01
                    :polarity -))
            :op1 (r / recruit-01
                :ARG1 (s3 / small-molecule
                    :name (n2 / name
                        :op1 2)
                    :name (n3 / name
                        :op1 ""SHC"")))
            :op2 (p / phosphorylate-01
                :ARG1 (e / enzyme
                    :name (n / name
                        :op1 ""tyrosine""))
                :ARG1 s3))
        :location (c / cell
            :mod (h / hepatoma))
        :mod (p3 / primary))
    :rel (e3 / enzyme
        :name (n6 / name
            :op1 ""gp""
            :op2 130)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (s2 / study-01
            :mod (t / this))
      :ARG1 (e / event
            :ARG0-of (s3 / signal-07)
            :mod (p / primary)
            :domain (a / and
                  :op1 (r / recruit-01
                        :ARG1 (p2 / protein :name (n / name :op1 ""SHP-2"")))
                  :op2 (p3 / phosphorylate-01
                        :ARG1 p2
                        :ARG2 (t2 / tyrosine))
                  :ARG1-of (c / contrast-01
                        :ARG2 (a2 / and
                              :op1 (r2 / recruit-01 :polarity -
                                    :ARG1 (p4 / protein :name (n2 / name :op1 ""SHC"")))
                              :op2 (p5 / phosphorylate-01 :polarity -
                                    :ARG1 p4
                                    :ARG2 t2))))
            :ARG1-of (a3 / associate-01
                  :ARG2 (a4 / activate-01
                        :ARG0 (p6 / protein :name (n3 / name :op1 ""gp130""))
                        :ARG1 (p7 / protein-family :name (n4 / name :op1 ""MAP"" :op2 ""kinase"")))
                  :location (c2 / cell
                        :mod (m / medical-condition :name (n6 / name :op1 ""hepatoma""))))))","This study shows that in hepatoma cells, the recruitment and tyrosine phosphorylation of SHP-2, but not SHC, is the primary signaling event associated with the activation of MAP kinases (ERK1/2) by gp130.","(z1 / show-01
    :ARG0 (z2 / study-01
              :mod (z3 / this))
    :ARG1 (z4 / event
              :ARG0-of (z5 / signify-01)
              :mod (z6 / primary)
              :ARG1-of (z7 / associate-01
                           :ARG2 (z8 / activate-01
                                     :ARG0 (z9 / enzyme
                                               :wiki ""PHLDA1/2""
                                               :name (z10 / name
                                                          :op1 ""gp130""))
                                     :ARG1 (z11 / kinase
                                                :wiki ""Mitogen-activated_protein_kinase""
                                                :name (z12 / name
                                                           :op1 ""MAP""
                                                           :op2 ""kinases""
                                                           :op3 ""1/2""))))
              :domain (z13 / contrast-01
                           :ARG1 (z14 / and
                                      :op1 (z15 / recruit-01
                                                :ARG1 (z16 / protein
                                                           :wiki ""Selective_serotonin_reuptake_inhibitor""
                                                           :name (z17 / name
                                                                      :op1 ""SHP-2"")))
                                      :op2 (z18 / phosphorylate-01
                                                :ARG1 (z19 / protein
                                                           :wiki ""Serine""
                                                           :name (z20 / name
                                                                      :op1 ""SHC""))))
                           :ARG2 (z21 / phosphorylate-01
                                      :ARG1 z19
                                      :ARG2 (z22 / tyrosine)))
              :location (z23 / cell
                             :part-of (z24 / hepatoma))))",0.564516129032258,0.534351145038168,"(s / show-01
        :ARG0 (s2 / study)
        :ARG1 (e / event
              :ARG0 (a / associate-01
                    :ARG1 (e2 / event
                          :ARG0 (a2 / activate-01
                                :ARG0 (k / kinase
                                      :ARG0-of (m / map)
                                      :ARG1 (e3 / erk1/2))
                                :ARG1 (g / gp130)))
                          :ARG1 (s3 / signal-01
                                :ARG0 (r / recruit-01
                                      :ARG1 (p / phosphorylate-01
                                            :ARG0 (t / tyrosine)
                                            :ARG1 (s4 / shp-2)))
                                :ARG1 (c / cell
                                      :mod (h / hepatoma))))
                    :ARG2 (e4 / event
                          :ARG0 (a3 / associate-01
                                :ARG1 (e5 / event
                                      :ARG0 (a4 / activate-01
                                            :ARG0 (k2 / kinase
                                                  :ARG0-of m
                                                  :ARG1 e3)
                                            :ARG1 (s5 / shc)))
                                :ARG1 (s6 / signal-01
                                      :ARG0 r
                                      :ARG1 c))))","(s / show-01
    :ARG0 (s2 / study
        :mod (t / this))
    :ARG1 (a / associate-01
        :ARG1 (e / event
            :mod (p / primary)
            :mod (s3 / signal)
            :ARG1-of (r / recruit-01)
            :ARG1-of (p2 / phosphorylate-01
                :ARG2 (t2 / tyrosine)))
        :ARG2 (a2 / activate-01
            :ARG1 (k / kinase
                :mod (m / MAP)
                :example (e2 / ERK1/2))
            :ARG0 (g / gp130)))
    :location (c / cell
        :mod (h / hepatoma))
    :condition (b / but
        :op1 (r2 / recruit-01
            :ARG1 (s4 / SHP-2))
        :op2 (n / not
            :op1 (r3 / recruit-01
                :ARG1 (s5 / SHC)))))",-1.0,-1.0
bel_pmid_1044_6041.18018,"PTP-PEST has a COOH-terminal extension that anchors it to the cytosolic aspect of the endoplasmic reticulum. Integrin-mediated adhesion activates calpain, a protease that cleaves this extension and allows the phosphatase to relocate to focal adhesions (21).","(m2 / multi-sentence
    :rel (s / ""small-molecule""
        :name (n3 / name
            :op1 ""endoplasmic""
            :op1 ""human""
            :op2 ""reticulum""
            :part-of s))
    :rel (i2 / ionize-01)
    :snt1 (h / have-03
        :ARG0 (p2 / protein
            :name (n / name
                :op1 ""P""))
        :ARG1 (e2 / extend-01
            :ARG0-of (a3 / anchor-01
                :ARG1 p2
                :ARG2 (a4 / aspect
                    :ARG1-of (i / ionize-01
                        :value 2+)))
            :ARG1 p2
            :mod (t / terminal
                :name (n2 / name
                    :op1 ""COOH""))))
    :snt2 (a / activate-01
        :ARG0 (b / bind-01
            :ARG1-of (m / mediate-01
                :ARG0 (i3 / ionize-01)))
        :ARG1 (p / protease
            :name (n4 / name
                :op1 ""calpain"")
            :ARG0-of (a2 / allow-01
                :ARG1 (r / relocate-01
                    :ARG1 (e / enzyme
                        :name (n5 / name
                            :op1 ""phosphatase""))
                    :ARG2 (d / deposit
                        :ARG1-of (d2 / describe-01
                            :ARG0 (p3 / publication
                                :ARG1-of (c / cite-01
                                    :ARG2 21)))
                        :ARG2-of (f / focus-01)))))))
",test,bio_amr0.8,"(m / multi-sentence
      :snt1 (h / have-03
            :ARG0 (e4 / enzyme :name (n / name :op1 ""PTP-PEST""))
            :ARG1 (e / extend-01
                  :mod (p2 / protein-segment :name (n2 / name :op1 ""COOH-terminus""))
                  :ARG0-of (a / anchor-01
                        :ARG1 e4
                        :location (a2 / aspect
                              :mod (c / cytosol)
                              :part-of (r / reticulum
                                    :mod (e2 / endoplasm))))))
      :snt2 (a3 / activate-01
            :ARG0 (a4 / adhere-01
                  :ARG1-of (m2 / mediate-01
                        :ARG0 (p3 / protein :name (n5 / name :op1 ""integrin""))))
            :ARG1 (p / protease :name (n6 / name :op1 ""calpain"")
                  :ARG0-of (c2 / cleave-01
                        :ARG1 (e5 / extend-01
                              :mod (t / this)))
                  :ARG0-of (a5 / allow-01
                        :ARG1 (r2 / relocate-01
                              :ARG1 (e3 / enzyme :name (n4 / name :op1 ""phosphatase""))
                              :ARG2 (a6 / adhere-01
                                    :mod (f / focal)))))
            :ARG1-of (d / describe-01
                  :ARG0 (p5 / publication
                        :ARG1-of (c3 / cite-01
                              :ARG2 21)))))","PTP-PEST has a COOH-terminal extension that anchors it to the cytosolic aspect of the endoplasmic reticulum. Integrin-mediated adhesion activates calpain, a protease that cleaves this extension and allows the phosphatase to relocate to focal adhesions (21).","(z1 / have-03
    :ARG0 (z2 / protein
              :wiki ""PTP-PEST""
              :name (z3 / name
                        :op1 ""PTP-PEST""))
    :ARG1 (z4 / extend-01
              :ARG1 z2
              :ARG2 (z5 / terminus
                        :mod (z6 / string-entity
                                 :value ""COOH""))
              :ARG0-of (z7 / anchor-01
                           :ARG1 z2
                           :ARG2 (z8 / aspect
                                     :mod (z9 / cytosolic)
                                     :part-of (z10 / reticulum
                                                   :mod (z11 / endoplasmic))))))",0.3125,0.5401459854014599,"(m / multi-sentence
        :snt1 (h / have-03
            :ARG0 (p / PTP-PEST)
            :ARG1 (e / extension
                  :mod (c / COOH-terminal))
            :ARG2 (a / anchor-01
                  :ARG1 p
                  :ARG2 (a2 / aspect
                        :mod (c2 / cytosolic)
                        :mod (e2 / endoplasmic
                              :mod (r / reticulum)))))
        :snt2 (a3 / activate-01
            :ARG0 (a4 / adhesion
                  :mod (m / mediate-01
                        :ARG1 (i / integrin)))
            :ARG1 (c3 / calpain)
            :ARG2 (p2 / protease
                  :ARG1 c3
                  :ARG2 (c4 / cleave-01
                        :ARG1 (e3 / extension)
                        :ARG2 (a5 / allow-01
                              :ARG0 (p3 / phosphatase)
                              :ARG1 (r2 / relocate-01
                                    :ARG0 p3
                                    :ARG2 (a6 / adhesion
                                          :mod (f / focal)))))))","(p / possess-01
    :ARG0 (p2 / protein :name (n / name :op1 ""PTP-PEST""))
    :ARG1 (e / extension
        :mod (c / COOH-terminal)
        :ARG1-of (a / anchor-01
            :ARG2 (a2 / aspect
                :mod (c2 / cytosolic)
                :part (e2 / endoplasmic-reticulum)))))
(s / multi-sentence
    :snt1 (a3 / activate-01
        :ARG0 (a4 / adhesion
            :mod (i / integrin-mediated))
        :ARG1 (c3 / calpain
            :mod (p3 / protease)))
    :snt2 (c4 / cleave-01
        :ARG0 c3
        :ARG1 e)
    :snt3 (a5 / allow-01
        :ARG0 c4
        :ARG1 (r / relocate-01
            :ARG0 (p4 / phosphatase)
            :ARG1 (a6 / adhesion
                :mod (f / focal))))))",-1.0,-1.0
pmid_1592_8660.87,"In order to assess the level of expression and the activation (by phosphorylation) of members of the MAPK pathway downstream of <i>RAS</i> and <i>BRAF</i>, Western blot analysis was performed on uveal melanoma cell lines (<xref ref-type=""table"" rid=""tbl2"">Table 2A</xref>).","(p2 / perform-02
    :purpose (a5 / assess-01
        :ARG1 (a3 / and
            :op1 (l / level
                :extent-of (e / express-03
                    :ARG1 (m / member
                        :part-of (p / pathway
                            :name (n / name
                                :op1 ""MAPK"")
                            :mod (d4 / downstream
                                :op1 (a4 / and
                                    :op1 (d2 / disease
                                        :name (n2 / name
                                            :op1 ""BRAF""))))))))
            :op2 (a / activate-01
                :ARG1 m
                :manner (p3 / phosphorylate-01))))
    :ARG1 (a2 / analyze-01
        :ARG1-of (d / describe-01
            :ARG0 (t / table
                :mod 2))
        :manner (t2 / test-01
            :mod (w / world-region
                :name (n3 / name
                    :op1 ""West""))))
    :ARG1 (l2 / line
        :mod (c / cell)
        :mod (d3 / disease
            :name (n4 / name
                :op1 ""uveal""
                :op2 ""melanoma""))))
",test,bio_amr0.8,"(p3 / perform-01
      :ARG1 (i2 / immunoblot-01
            :ARG2 (c / cell-line
                  :mod (m2 / medical-condition :name (n2 / name :op1 ""melanoma"")
                        :mod (u / uveal)))
            :purpose (a2 / assess-01
                  :ARG1 (a3 / and
                        :op1 (l / level
                              :degree-of (e / express-03
                                    :ARG2 (m / member
                                          :ARG1-of (i / include-91
                                                :ARG2 (p2 / pathway :name (n3 / name :op1 ""MAPK""))))
                                    :location (r / relative-position
                                          :op1 (g / gene :name (n4 / name :op1 ""RAS""))
                                          :op2 (g2 / gene :name (n5 / name :op1 ""BRAF""))
                                          :direction (d2 / downstream))))
                        :op2 (a4 / activate-01
                              :ARG0 (p / phosphorylate-01)
                              :ARG1 m
                              :location r)))
            :ARG1-of (d3 / describe-01
                  :ARG0 (t2 / table :mod ""2A""))))","In order to assess the level of expression and the activation (by phosphorylation) of members of the MAPK pathway downstream of <i>RAS</i> and <i>BRAF</i>, Western blot analysis was performed on uveal melanoma cell lines (<xref ref-type=""table"" rid=""tbl2"">Table 2A</xref>).","(z1 / perform-02
    :ARG1 (z2 / analyze-01
              :instrument (z3 / blot
                              :mod (z4 / world-region
                                       :wiki ""Western_world""
                                       :name (z5 / name
                                                 :op1 ""West""))))
    :ARG2 (z6 / cell
              :mod (z7 / melanoma
                       :mod (z8 / uveal))
              :mod (z9 / line))
    :purpose (z10 / assess-01
                  :ARG1 (z11 / and
                             :op1 (z12 / level
                                       :degree-of (z13 / express-01
                                                       :ARG1 z6))
                             :op2 (z14 / activate-01
                                       :ARG1 (z15 / member
                                                  :ARG0-of (z16 / have-org-role-91
                                                                :ARG1 (z17 / pathway
                                                                           :wiki ""MAPK""
                                                                           :name (z18 / name
                                                                                      :op1 ""MAPK"")
                                                                           :mod (z19 / downstream
                                                                                     :op1 (z20 / and
                                                                                               :op1 (z21 / enzyme
                                                                                                         :wiki ""BRAF_(g3000 / gene)""
                                                                                                         :name (z22 / name
                                                                                                                    :op1 ""RAS""))
                                                                                               :op2 (z23 / enzyme
                                                                                                         :wiki ""BRAF_(g3001 / gene)""
                                                                                                         :name (z24 / name
                                                                                                                    :op1 ""BRAF"")))))
                                                                :ARG2 (z25 / member))))
                             :manner (z26 / phosphorylate-01
                                          :ARG1 z15))))",0.3620689655172414,0.4259259259259259,"(m / multi-sentence
        :snt1 (a / assess-01
            :ARG0 (o / order
                  :ARG1 (l / level
                        :ARG1-of (e / expression-01)
                        :ARG2 (a2 / activation
                              :ARG1-of (m2 / member
                                    :ARG1-of (p / pathway
                                          :ARG1-of (m3 / MAPK)
                                          :ARG2 (d / downstream
                                                :ARG1-of (r / RAS)
                                                :ARG2 (b / BRAF)))))))
            :ARG1 (p2 / perform-01
                  :ARG0 (a3 / analysis
                        :ARG1 (b / blot
                              :mod (w / Western)))
                  :ARG2 (c / cell
                        :mod (m4 / melanoma)
                        :ARG1-of (l2 / line))))
        :snt2 (r2 / reference
            :ARG1 (t / table
                  :ARG1-of (x / xref
                        :ARG1 (t2 / tbl2)
                        :ARG2 (a4 / analysis))))","(p / perform-01
    :ARG0 (a / analysis
        :mod (b / blot
            :mod (w / western)))
    :ARG1 (c / cell-line
        :mod (m / melanoma
            :mod (u / uveal)))
    :instrument (a2 / assess-01
        :ARG1 (l / level
            :domain (e / expression))
        :ARG1 (a3 / activate-01
            :ARG1 (m2 / member
                :part (p2 / pathway
                    :mod (m3 / MAPK)))
            :instrument (p3 / phosphorylation)))
    :condition (d / downstream
        :ARG1 (a4 / and
            :op1 (r / RAS)
            :op2 (b2 / BRAF))))
    :location (t / table
        :name (n / name :op1 ""2A"")))",-1.0,-1.0
pmid_1592_8660.92,"The levels of total ERK were remarkably similar across all cell lines, with the exception of two cell lines Mel 285 and Mel 290, which had significantly higher levels of total ERK than the others.","(r2 / resemble-01
    :ARG1 (l / level
        :topic (e / enzyme
            :name (n / name
                :op1 ""ERK"")
            :ARG1-of (t / total-01
                :ARG1 ""ERK"")))
    :ARG1-of (r / remarkable-02)
    :ARG2-of (e2 / except-01
        :ARG1 (l4 / line
            :name (n2 / name
                :op1 ""Mel""
                :op2 285)
            :quant 2
            :consist-of (a3 / and
                :ARG0-of (h / have-03
                    :ARG1 (l2 / level
                        :ARG1-of (h2 / have-degree-91
                            :ARG2 (h3 / high-02
                                :ARG1 l2)
                            :ARG3 (m / more
                                :ARG1-of (s / significant-02))
                            :ARG4 (o / other))))
                :op1 l4
                :op2 290)
            :mod (c2 / cell)))
    :manner (a / across
        :op1 (l3 / line
            :mod (c / cell)
            :mod (a2 / all))))
",test,bio_amr0.8,"(r2 / resemble-01
      :ARG1 (l / level
            :quant-of (e / enzyme :name (n / name :op1 ""ERK"")
                  :mod (t / total)))
      :ARG1-of (r / remarkable-02)
      :location (a / across
            :op1 (c / cell-line
                  :mod (a2 / all)
                  :ARG2-of (e2 / except-01
                        :ARG1 (a3 / and
                              :op1 (c3 / cell-line :name (n3 / name :op1 ""Mel"" :op2 ""285"")
                                    :ARG0-of (h / have-03
                                          :ARG1 (l2 / level
                                                :ARG1-of (h2 / high-02
                                                      :degree (m / more)
                                                      :ARG1-of (s / significant-02)
                                                      :compared-to (c2 / cell-line
                                                            :mod (o / other)))
                                                :quant-of e)))
                              :op2 (c4 / cell-line :name (n5 / name :op1 ""Mel"" :op2 ""290"")
                                    :ARG0-of h))))))","The levels of total ERK were remarkably similar across all cell lines, with the exception of two cell lines Mel 285 and Mel 290, which had significantly higher levels of total ERK than the others.","(z1 / resemble-01
    :ARG1 (z2 / level
              :mod (z3 / enzyme
                       :wiki ""Extracellular_signal-regulated_kinase""
                       :name (z4 / name
                                 :op1 ""ERK"")
                       :mod (z5 / total)))
    :ARG2 (z6 / level
              :mod z3)
    :ARG1-of (z7 / remarkable-02)
    :location (z8 / across
                  :op1 (z9 / line
                           :mod (z10 / cell)
                           :mod (z11 / all)
                           :ARG2-of (z12 / except-01
                                         :ARG1 (z13 / and
                                                    :op1 (z14 / line
                                                              :wiki ""Mitogen-activated_protein_kinase""
                                                              :name (z15 / name
                                                                         :op1 ""Mel""
                                                                         :op2 285)
                                                              :mod (z16 / cell))
                                                    :op2 (z17 / line
                                                              :wiki ""Mitogen-activated_protein_kinase""
                                                              :name (z18 / name
                                                                         :op1 ""Mel""
                                                                         :op2 290)
                                                              :mod z16)
                                                    :ARG0-of (z19 / have-03
                                                                  :ARG1 (z20 / level
                                                                             :mod z3
                                                                             :ARG1-of (z21 / have-degree-91
                                                                                           :ARG2 (z22 / high-02
                                                                                                      :ARG1 z20
                                                                                                      :ARG1-of (z23 / significant-02))
                                                                                           :ARG3 (z24 / more)
                                                                                           :ARG4 (z25 / level
                                                                                                      :mod (z26 / other))))))))))",0.6434782608695652,0.4660194174757281,"(m / multi-sentence
        :snt1 (b / be-01
            :ARG1 (l / level
                  :mod (t / total)
                  :mod (e / ERK))
            :ARG2 (s / similar
                  :ARG1 (a / across
                        :ARG2 (c / cell-line))))
        :snt2 (h / have-03
            :ARG1 (l2 / level
                  :mod (t2 / total)
                  :mod (e2 / ERK))
            :ARG2 (h2 / high
                  :degree (s2 / significantly))
            :ARG3 (c2 / cell-line
                  :op1 (n / name :op1 ""Mel_285"")
                  :op2 (n2 / name :op1 ""Mel_290"")))
        :snt3 (e3 / exception
            :ARG1 (t3 / two
                  :mod (c3 / cell-line
                        :op1 (n3 / name :op1 ""Mel_285"")
                        :op2 (n4 / name :op1 ""Mel_290"")))
            :ARG2 (l3 / level
                  :mod (t4 / total)
                  :mod (e3 / ERK))
            :ARG3 (o / other)))","(s / similar-01
    :ARG1 (l / level
        :quant (t / total)
        :topic (e / ERK))
    :ARG2 (l2 / level
        :quant (t2 / total)
        :topic e)
    :degree (r / remarkable)
    :location (c / cell-line
        :quant (a / all))
    :except (c2 / cell-line
        :name (n / name :op1 ""Mel"" :op2 ""285"")
        :name (n2 / name :op1 ""Mel"" :op2 ""290"")
        :ARG1-of (h / have-03
            :ARG2 l2
            :degree (s / significant)
            :comparison (o / other
                :ARG1-of (m / more-02
                    :ARG1 l2)))))",-1.0,-1.0
pmid_1592_8660.94,"<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref> shows that there is no significant influence of serum on the activity of ERK1/2 in these cell lines, as reported recently by <xref ref-type=""other"" rid=""bib3"">Calipel <i>et al</i> (2003)</xref>.","(s2 / show-01
    :ARG0 (f / figure
        :mod 2)
    :ARG1 (i / influence-01
        :ARG0 (s / serum)
        :ARG1 (a / activity-06
            :ARG0 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2""))
            :location (l / line
                :mod (c / cell)
                :mod (t / this)))
        :ARG1-of (s3 / significant-02)
        :ARG1-of (r2 / report-01
            :time (r / recent)
            :time (d / date-entity
                :year 2003))
        :polarity -)
    :ARG1 (s4 / statistic
        :value 2)
    :rel (p / publication
        :name (n2 / name)))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (f / figure :mod 2)
      :ARG1 (i / influence-01
            :ARG0 (s3 / serum)
            :ARG1 (a / activity-06
                  :ARG0 (e / enzyme :name (n / name :op1 ""ERK1/2"")))
            :ARG1-of (s2 / significant-02 :polarity -)
            :location (c / cell-line
                  :mod (t / this)))
      :ARG1-of (r / report-01
            :ARG0 (p4 / publication-91
                  :ARG0 (a2 / and
                        :op1 (p / person :name (n2 / name :op1 ""Calipel""))
                        :op2 (p2 / person
                              :mod (o / other)))))
      :ARG1-of (d / describe-01
            :ARG0 (p3 / publication-91
                  :time (d2 / date-entity :year 2003))))","<xref ref-type=""fig"" rid=""fig2"">Figure 2</xref> shows that there is no significant influence of serum on the activity of ERK1/2 in these cell lines, as reported recently by <xref ref-type=""other"" rid=""bib3"">Calipel <i>et al</i> (2003)</xref>.","(z1 / show-01
    :ARG0 (z2 / figure
              :mod 2
              :ARG1-of (z3 / hyperlink-91
                           :ARG3 (z4 / url-entity
                                     :value ""Figure_2"")))
    :ARG1 (z5 / influence-01
              :polarity -
              :ARG0 (z6 / serum)
              :ARG1 (z7 / activity-06
                        :ARG0 (z8 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z9 / name
                                            :op1 ""ERK1/2""))
                        :location (z10 / line
                                       :mod (z11 / cell)
                                       :mod (z12 / this)))
              :ARG1-of (z13 / significant-02))
    :ARG1-of (z14 / report-01
                  :ARG0 (z15 / publication-91
                             :ARG0 (z16 / person
                                        :wiki ""Gerhard_Calipel""
                                        :name (z17 / name
                                                   :op1 ""Calipel"")
                                        :ARG1-of (z18 / cite-01
                                                      :ARG2 (z19 / date-entity
                                                                 :year 2003))
                                        :time (z21 / recent)))))",0.5054945054945055,0.4578313253012048,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (f / figure
                  :ARG1 (n / name :op1 ""Figure 2""))
            :ARG1 (i / influence-01
                  :ARG1 (s2 / serum)
                  :ARG2 (a / activity
                        :ARG1 (e / ERK1/2)
                        :ARG2 (c / cell-line
                              :mod (t / these))))
            :ARG2 (r / report-01
                  :ARG0 (c2 / Calipel)
                  :ARG1 (r2 / recent
                        :time (y / year :op1 2003))
                  :ARG2 (a2 / al
                        :op1 ""et"")))
        :snt2 (n2 / no
            :polarity -))","(s / show-01
    :ARG0 (f / figure :name (n / name :op1 ""2""))
    :ARG1 (i / influence-01
        :ARG1 (a / activity-01
            :ARG1 (e / ERK1/2))
        :ARG2 (s2 / serum)
        :location (c / cell-line)
        :degree (n2 / no)
        :mod (s3 / significant))
    :ARG2 (r / report-01
        :ARG0 (p / person :name (n3 / name :op1 ""Calipel"" :op2 ""et"" :op3 ""al"") :date (d / date-entity :year 2003))
        :time (r2 / recent-02)))",-1.0,-1.0
pmid_1592_8660.97,"In seven of the 19 primary tumours, less than 5% of the tumour cells stained positively for ERK1/2 and nine tumours for phosphorylated ERK1/2.","(a / and
    :location (t / tumor
        :quant 7
        :ARG1-of (i / include-91
            :ARG2 (t2 / tumor
                :quant 19
                :mod (p4 / primary))))
    :op1 (s / stain-01
        :ARG1 (c / cell
            :ARG1-of (i2 / include-91
                :ARG3 t)
            :part-of (t3 / tumor))
        :ARG2 (p3 / positive)
        :ARG2 (e / enzyme
            :name (n / name
                :op1 ""ERK""
                :op2 ""1/2"")))
    :op2 (s2 / stain-01)
    :rel (l / less-than
        :op1 (p / percentage-entity
            :value 5))
    :rel (c2 / cell
        :quant 9
        :ARG1-of (p2 / phosphorylate-01)))
",test,bio_amr0.8,"(a / and
      :op1 (s / stain-01
            :ARG1 (c / cell
                  :ARG1-of (i / include-91
                        :ARG2 (c2 / cell
                              :mod (t / tumor))
                        :ARG3 (l / less-than
                              :op1 (p / percentage-entity :value 5)))
                  :mod t)
            :manner (p2 / positive)
            :location (t3 / tumor :quant 7
                  :ARG1-of (i3 / include-91
                        :ARG2 (t4 / tumor :quant 19
                              :mod (p4 / primary))))
            :beneficiary (e / enzyme :name (n2 / name :op1 ""ERK1/2"")))
      :op2 (s2 / stain-01
            :ARG1 (t2 / tumor :quant 9
                  :ARG1-of (i2 / include-91
                        :ARG2 t4))
            :beneficiary (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                  :ARG3-of (p3 / phosphorylate-01))))","In seven of the 19 primary tumours, less than 5% of the tumour cells stained positively for ERK1/2 and nine tumours for phosphorylated ERK1/2.","(z1 / and
    :op1 (z2 / stain-01
             :ARG1 (z3 / cell
                       :ARG1-of (z4 / include-91
                                    :ARG2 (z5 / cell
                                              :mod (z6 / tumor))
                                    :ARG3 (z7 / less-than
                                              :op1 (z8 / percentage-entity
                                                       :value 5))))
             :ARG2 (z9 / protein
                       :wiki ""ERK1/2""
                       :name (z10 / name
                                  :op1 ""ERK1/2""))
             :ARG3 (z11 / cell
                        :quant 7
                        :ARG1-of (z12 / include-91
                                      :ARG2 (z13 / tumor
                                                 :quant 19
                                                 :mod (z14 / primary)))))
    :ARG2 (z15 / positive))",0.6117647058823529,0.5274725274725274,"(m / multi-sentence
        :snt1 (s / stain-01
            :ARG1 (c / cell
                  :mod (t / tumour
                        :mod (p / primary
                              :quant (n / number :op1 19)))
                  :ARG1-of (p2 / positively)
                  :ARG1-of (e / ERK1/2)))
        :snt2 (s2 / stain-01
            :ARG1 c
            :ARG1-of (p3 / phosphorylate-01
                  :ARG1 (e2 / ERK1/2))))","(p / primary-01
    :ARG1 (t / tumor
        :quant 19
        :part (t2 / tumor
            :quant 7
            :ARG1-of (l / less-than
                :ARG2 (p2 / percent
                    :quant 5))
            :ARG1-of (s / stain-01
                :ARG2 (c / cell
                    :part-of t2)
                :manner (p3 / positive)
                :ARG1 (e / ERK1/2))
            :ARG1-of (a / and-01
                :op2 (t3 / tumor
                    :quant 9
                    :ARG1-of (s2 / stain-01
                        :ARG2 (c2 / cell
                            :part-of t3)
                        :manner (p4 / positive)
                        :ARG1 (p5 / phosphorylate-01
                            :ARG1 e)))))))",-1.0,-1.0
pmid_1592_8660.98,"Despite the lack of mutations in the <i>RAS</i> and <i>BRAF</i> genes in this set of uveal melanomas, it is noteworthy that we observed phosphorylated (active) ERK1/2 expression in 10 of 19 tumours.","(n5 / note-01
    :ARG1 (o / observe-01
        :ARG0 (w2 / we)
        :ARG1 (e2 / express-03
            :ARG1-of (a / activity-06)
            :ARG2 (e / enzyme
                :name (n4 / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :location (t2 / tumor
            :quant 10
            :ARG1-of (i / include-91
                :ARG2 (t3 / tumor
                    :quant 19))))
    :concession (l / lack-01
        :ARG1 (m / mutate-01
            :ARG1 (a2 / and
                :op1 (g / gene
                    :name (n / name
                        :op1 ""shit""))
                :op2 (g2 / gene
                    :name (n2 / name))))
        :part-of (s / set
            :consist-of (d / disease
                :name (n3 / name
                    :op1 ""uveal""
                    :op2 ""melanomas""))
            :mod (t / this)))
    :rel (w / we)
    :rel (p / phosphorylate-01))
",test,bio_amr0.8,"(n / note-01
      :ARG1 (o / observe-01
            :ARG0 (w / we)
            :ARG1 (e / express-01
                  :ARG2 (e2 / enzyme :name (n2 / name :op1 ""ERK1/2"")
                        :ARG3-of (p / phosphorylate-01
                              :ARG1-of (m / mean-01
                                    :ARG2 (a / activity-06)))))
            :location (t / tumor :quant 10
                  :ARG1-of (i / include-91
                        :ARG2 (t2 / tumor :quant 19)))
            :concession (l / lack-01
                        :ARG1 (m2 / mutate-01
                              :ARG1 (a2 / and
                                    :op1 (g / gene :name (n3 / name :op1 ""RAS"")
                                          :location (s / set
                                                :mod (t3 / this)
                                                :consist-of (m3 / medical-condition :name (n5 / name :op1 ""melanoma"")
                                                      :mod (u / uveal))))
                                    :op2 (g2 / gene :name (n4 / name :op1 ""BRAF"")
                                          :location s)))))
      :ARG1-of (r / recommend-01))","Despite the lack of mutations in the <i>RAS</i> and <i>BRAF</i> genes in this set of uveal melanomas, it is noteworthy that we observed phosphorylated (active) ERK1/2 expression in 10 of 19 tumours.","(z1 / have-concession-91
    :ARG1 (z2 / note-02
              :ARG1 (z3 / observe-01
                        :ARG0 (z4 / we)
                        :ARG1 (z5 / express-03
                                  :ARG1 (z6 / enzyme
                                            :wiki ""ERK1/2""
                                            :name (z7 / name
                                                      :op1 ""ERK1/2""
                                                      :op2 ""expression"")
                                            :ARG1-of (z8 / phosphorylate-01
                                                         :ARG1-of (z9 / mean-01
                                                                      :ARG2 (z10 / activity-06
                                                                                 :ARG0 z6)))))
                        :location (z11 / tumor
                                       :quant 10
                                       :ARG1-of (z12 / include-91
                                                     :ARG2 (z13 / tumor
                                                                :quant 19))))
              :ARG1-of (z14 / notable-04))
    :ARG2 (z15 / lack-01
               :ARG1 (z16 / mutate-01
                          :ARG1 (z17 / and
                                     :op1 (z18 / gene
                                               :wiki ""BRAF_(g3000 / gene)""
                                               :name (z19 / name
                                                          :op1 ""RAS""))
                                     :op2 (z20 / gene
                                               :wiki ""BRAF_(g3001 / gene)""
                                               :name (z21 / name
                                                          :op1 ""BRAF""))))
               :location (z22 / set
                              :consist-of (z23 / melanoma
                                               :mod (z24 / uveal))
                              :mod (z25 / this))))",0.5982905982905983,0.5636363636363636,"(m / multi-sentence
        :snt1 (d / despite
            :ARG1 (l / lack-01
                  :ARG2 (m2 / mutation
                        :ARG1-of (g2 / gene
                              :name (n2 / name :op1 ""RAS""))))
            :ARG2 (l2 / lack-01
                  :ARG2 (m3 / mutation
                        :ARG1-of (g3 / gene
                              :name (n3 / name :op1 ""BRAF"")))))
        :snt2 (n / note-01
            :ARG1 (o / observe-01
                  :ARG0 (w / we)
                  :ARG1 (e / expression
                        :ARG1 (p / phosphorylate-01
                              :ARG1 (e2 / ERK1/2))
                        :ARG2 (t / tumour
                              :quant (n4 / number :op1 19)
                              :ARG1-of (o2 / observe-01
                                    :ARG0 w
                                    :ARG1 e))))))","(d / despite-91
    :ARG2 (l / lack-01
        :ARG1 (m / mutation
            :location (g / gene
                :name (n / name :op1 ""RAS"")
                :name (n2 / name :op1 ""BRAF""))
            :part (s / set
                :consist-of (m2 / melanoma
                    :mod (u / uveal)))))
    :ARG1 (o / observe-01
        :ARG0 (w / we)
        :ARG1 (e / express-01
            :ARG1 (p / phosphorylate-01
                :ARG1 (a / active)
                :ARG2 (e2 / ERK1/2))
            :location (t / tumor
                :quant 19
                :part (t2 / tumor
                    :quant 10)))
        :mod (n3 / noteworthy)))",-1.0,-1.0
pmid_1684_6534.10,"Additional changes were seen at the protein level, such as increased expression of c-Myc, heightened phosphorylation of AKT, and decreased activation of MEK1/2 and ERK1/2.","(s / see-01
    :ARG1 (c / change-01
        :example (a3 / and
            :op1 (i / increase-01
                :ARG1 (e4 / express-03
                    :ARG1 (e / enzyme
                        :name (n / name
                            :op1 ""C""))))
            :op2 (p / phosphorylate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""AKT""))
                :ARG1-of (h / heighten-01))
            :op3 (d / decrease-01
                :ARG1 (a / activate-01
                    :ARG1 (p3 / protein
                        :name (n3 / name
                            :op1 ""MEK""
                            :op2 ""1/2"")
                        :ARG0 (a4 / and
                            :op1 p3
                            :op2 (e3 / enzyme
                                :name (n4 / name
                                    :op1 ""ERK""
                                    :op2 ""1/2"")))))))
        :location (l / level
            :op1 (p2 / protein))
        :mod (a2 / additional)))
",test,bio_amr0.8,"(s / see-01
      :ARG1 (c / change-01
            :ARG1 (l / level
                  :quant-of (p / protein))
            :mod (a / additional)
            :example (a2 / and
                        :op1 (e / express-03
                              :ARG2 (p3 / protein :name (n / name :op1 ""c-Myc""))
                              :ARG1-of (i / increase-01))
                        :op2 (p2 / phosphorylate-01
                              :ARG1 (e2 / enzyme :name (n2 / name :op1 ""AKT""))
                              :ARG1-of (h / heighten-01))
                        :op3 (a3 / activate-01
                              :ARG1 (a4 / and
                                    :op1 (e3 / enzyme :name (n3 / name :op1 ""MEK1""))
                                    :op2 (e4 / enzyme :name (n4 / name :op1 ""MEK2""))
                                    :op3 (e5 / enzyme :name (n5 / name :op1 ""ERK1""))
                                    :op4 (e6 / enzyme :name (n6 / name :op1 ""ERK2"")))
                              :ARG1-of (d / decrease-01)))))","Additional changes were seen at the protein level, such as increased expression of c-Myc, heightened phosphorylation of AKT, and decreased activation of MEK1/2 and ERK1/2.","(z1 / see-01
    :ARG1 (z2 / change-01
              :mod (z3 / additional)
              :mod (z4 / level
                       :mod (z5 / protein))
              :example (z6 / and
                           :op1 (z7 / increase-01
                                    :ARG1 (z8 / express-02
                                              :ARG1 (z9 / small-molecule
                                                        :wiki ""Cyclin-Myc""
                                                        :name (z10 / name
                                                                   :op1 ""c-Myc""))))
                           :op2 (z11 / phosphorylate-01
                                     :ARG1 (z12 / enzyme
                                                :wiki ""AKT""
                                                :name (z13 / name
                                                           :op1 ""AKT""))
                                     :ARG1-of (z14 / heighten-01))
                           :op3 (z15 / activate-01
                                     :ARG1 (z16 / and
                                                :op1 (z17 / enzyme
                                                          :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                          :name (z18 / name
                                                                     :op1 ""MEK1/2""))
                                                :op2 (z19 / enzyme
                                                          :wiki ""ERK1/2""
                                                          :name (z20 / name
                                                                     :op1 ""ERK1/2"")))
                                     :ARG1-of (z21 / decrease-01)))))",0.5471698113207547,0.4952380952380952,"(c / change-01
        :ARG1 (s / see-01
              :ARG1 (p / protein
                    :mod (l / level))
              :ARG2 (e / expression-01
                    :ARG1 (e2 / entity
                          :name (c2 / c-Myc)))
              :ARG2 (p2 / phosphorylation-01
                    :ARG1 (e3 / entity
                          :name (a / AKT)))
              :ARG2 (a2 / activation-01
                    :ARG1 (e4 / entity
                          :name (m / MEK1/2)))
              :ARG2 (a3 / activation-01
                    :ARG1 (e5 / entity
                          :name (e6 / ERK1/2))))
        :ARG2 (i / increase-01
              :ARG1 e2)
        :ARG2 (h / heighten-01
              :ARG1 e3)
        :ARG2 (d / decrease-01
              :ARG1 (a4 / activation-01
                    :ARG1 e4))
        :ARG2 (d2 / decrease-01
              :ARG1 (a5 / activation-01
                    :ARG1 e5)))","(c / change-01
    :ARG1 (p / protein)
    :mod (a / additional)
    :ARG2 (m / multi-sentence
        :snt1 (e / express-01
            :ARG1 (c2 / c-Myc)
            :degree (i / increase-01))
        :snt2 (p2 / phosphorylate-01
            :ARG1 (a2 / AKT)
            :degree (h / heighten-01))
        :snt3 (a3 / activate-01
            :ARG1 (m2 / MEK1/2)
            :degree (d / decrease-01))
        :snt4 (a4 / activate-01
            :ARG1 (e2 / ERK1/2)
            :degree d)))",-1.0,-1.0
pmid_1684_6534.11,"These were correlated with cellular events, as MUC1 siRNA in the MDA-MB-468 line decreased proliferation and invasion, and increased stress-induced apoptosis.","(c3 / correlate-01
    :ARG1 (t / this)
    :ARG1-of (c / cause-01
        :ARG0 (a2 / and
            :op1 (d / decrease-01
                :ARG0 (e / enzyme
                    :name (n / name
                        :op1 ""MUC1""
                        :op2 ""siRNA"")
                    :part-of (l / line
                        :name (n2 / name
                            :op1 4)))
                :ARG1 (a / and
                    :op1 (p / proliferate-01)
                    :op2 (i3 / invade-01)))
            :op2 (i / increase-01
                :ARG0 e
                :ARG1 (a3 / apoptosis
                    :ARG1-of (i2 / induce-01
                        :ARG2 (s / stress-02))))))
    :ARG2 (e2 / event
        :mod (c2 / cell)))
",test,bio_amr0.8,"(c / correlate-01
      :ARG1 (t / this)
      :ARG2 (e / event
            :mod (c2 / cell))
      :ARG1-of (c4 / cause-01
            :ARG0 (a / and
                  :op1 (d / decrease-01
                        :ARG0 (n4 / nucleic-acid :name (n / name :op1 ""siRNA"")
                              :ARG0-of (e2 / encode-01
                                    :ARG1 (p / protein :name (n2 / name :op1 ""MUC1""))))
                        :ARG1 (a3 / and
                              :op1 (p2 / proliferate-01)
                              :op2 (i / invade-01)))
                  :op2 (i2 / increase-01
                        :ARG0 n4
                        :ARG1 (a2 / apoptosis
                              :ARG2-of (i3 / induce-01
                                    :ARG0 (s / stress))))
                  :location (c3 / cell-line :name (n3 / name :op1 ""MDA-MB-468"")))))","These were correlated with cellular events, as MUC1 siRNA in the MDA-MB-468 line decreased proliferation and invasion, and increased stress-induced apoptosis.","(z1 / correlate-01
    :ARG1 (z2 / this)
    :ARG2 (z3 / event
              :mod (z4 / cell))
    :ARG1-of (z5 / cause-01
                 :ARG0 (z6 / and
                           :op1 (z7 / decrease-01
                                    :ARG0 (z8 / siRNA
                                              :wiki ""Mitogen-activated_protein_kinase_1""
                                              :name (z9 / name
                                                        :op1 ""MUC1""
                                                        :op2 ""siRNA"")
                                              :part-of (z10 / line
                                                            :wiki ""MDA-MB-468""
                                                            :name (z11 / name
                                                                       :op1 ""MDA-MB-468"")))
                                    :ARG1 (z12 / and
                                               :op1 (z13 / proliferate-01)
                                               :op2 (z14 / invade-01)))
                           :op2 (z15 / increase-01
                                     :ARG0 z8
                                     :ARG1 (z16 / apoptose-01
                                                :ARG1-of (z17 / induce-01
                                                              :ARG0 (z18 / stress-02)))))))",0.6818181818181819,0.6744186046511628,"(m / multi-sentence
        :snt1 (c / correlate-01
            :ARG1 (e / event
                  :mod (c2 / cellular))
            :ARG2 (w / with
                  :ARG1 (d / decrease-01
                        :ARG1 (p / proliferation)
                        :ARG2 (l / line
                              :mod (m / MDA-MB-468)))
                  :ARG2 (i / increase-01
                        :ARG1 (a / apoptosis
                              :mod (s / stress-induced))
                        :ARG2 (i2 / invasion)))))","(c / correlate-01
    :ARG1 (e / event
        :mod (c2 / cell))
    :ARG2 (m / multi-sentence
        :snt1 (d / decrease-01
            :ARG0 (s / siRNA
                :mod (m2 / MUC1))
            :ARG1 (p / proliferate-01
                :ARG0 (l / line
                    :name (n / name :op1 ""MDA-MB-468""))))
        :snt2 (d2 / decrease-01
            :ARG0 s
            :ARG1 (i / invade-01
                :ARG0 l))
        :snt3 (i2 / increase-01
            :ARG0 s
            :ARG1 (a / apoptosis
                :mod (s2 / stress-induced)))))
    :location (l2 / line
        :name (n2 / name :op1 ""MDA-MB-468"")))",-1.0,-1.0
pmid_1684_6534.118,"Three genes whose transcription was changed by less than two-fold are shown, two of which (<i>PDGFB </i>and <i>ITGB1</i>) are listed because they relate closely to genes altered by two-fold (<i>PDGFA </i>and <i>ITGAV</i>).","(s / show-01
    :ARG1 (g / gene
        :quant 3
        :ARG2-of (e / express-03
            :ARG1-of (c2 / change-01
                :ARG2 (l / less-than
                    :op1 (p / product-of
                        :op1 2))))
        :ARG2-of (i / include-91
            :ARG1 (g2 / gene
                :quant 2
                :ARG1-of (l2 / list-01
                    :ARG1-of (c / cause-01
                        :ARG0 (r / relate-01
                            :ARG1 g
                            :ARG1-of (c3 / close-10)
                            :ARG2 (g3 / gene
                                :ARG1-of (a / alter-01
                                    :ARG2 (p2 / product-of
                                        :op1 2
                                        :op2 g2))))))
                :mod (p3 / protein
                    :name (n / name))))))
",test,bio_amr0.8,"(s / show-01
      :ARG1 (g / gene :quant 3
            :ARG1-of (t / transcribe-01
                  :ARG1-of (c / change-01
                        :ARG2 (l / less-than
                              :op1 (p / product-of :op1 2))))
            :ARG2-of (i / include-91
                  :ARG1 (g2 / gene :quant 2
                        :ARG1-of (m / mean-01
                              :ARG2 (a / and
                                    :op1 (g3 / gene :name (n / name :op1 ""PDGFB""))
                                    :op2 (g4 / gene :name (n2 / name :op1 ""ITGB1""))))
                        :ARG1-of (l2 / list-01
                              :ARG1-of (c2 / cause-01
                                    :ARG0 (r / relate-01
                                          :ARG1 g2
                                          :ARG2 (g5 / gene
                                                :ARG1-of (a2 / alter-01
                                                      :degree p)
                                                :ARG1-of (m2 / mean-01
                                                      :ARG2 (a3 / and
                                                            :op1 (g6 / gene :name (n3 / name :op1 ""PDGFA""))
                                                            :op2 (g7 / gene :name (n4 / name :op1 ""ITGAV"")))))
                                          :manner (c3 / close-10))))))))","Three genes whose transcription was changed by less than two-fold are shown, two of which (<i>PDGFB </i>and <i>ITGB1</i>) are listed because they relate closely to genes altered by two-fold (<i>PDGFA </i>and <i>ITGAV</i>).","(z1 / show-01
    :ARG1 (z2 / gene
              :quant 3
              :ARG1-of (z3 / include-91
                           :ARG2 (z4 / gene
                                     :quant 2
                                     :ARG2-of (z5 / list-01
                                                  :ARG1-of (z6 / cause-01
                                                               :ARG0 (z7 / relate-01
                                                                         :ARG1 z2
                                                                         :ARG2 (z8 / gene
                                                                                   :ARG1-of (z9 / alter-01
                                                                                                :ARG2 (z10 / less-than
                                                                                                           :op1 (z11 / product-of
                                                                                                                     :op1 2
                                                                                                                     :op2 z5)))
                                                                                   :example (z12 / and
                                                                                                 :op1 (z13 / gene
                                                                                                           :wiki ""PHLDA-Gene""
                                                                                                           :name (z14 / name
                                                                                                                      :op1 ""PDGFA""))
                                                                                                 :op2 (z15 / gene
                                                                                                           :wiki ""ITGAV""
                                                                                                           :name (z16 / name
                                                                                                                      :op1 ""ITGAV""))))
                                                                         :ARG1-of (z17 / close-10)))))))
    :ARG1-of (z18 / transcription-01
                  :ARG1-of (z19 / change-01
                                :ARG2 (z20 / less-than
                                           :op1 (z21 / product-of
                                                     :op1 2
                                                     :op2 z5)))))",0.5263157894736842,0.5346534653465346,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (g / gene
                  :quant (t / three)
                  :mod (c / change-01
                        :ARG1 g
                        :ARG2 (l / less-than
                              :op1 (f / fold
                                    :op1 two
                                    :op2 (n / number :op1 2))))
                  :ARG2 (t2 / transcription
                        :ARG1 g))
            :ARG2 (l2 / list-01
                  :ARG1 (r / relate-01
                        :ARG1 (l3 / list-01
                              :ARG1 (n2 / name :op1 ""PDGFB""))
                        :ARG2 (l4 / list-01
                              :ARG1 (n3 / name :op1 ""ITGB1""))))
            :ARG2-of (a / alter-01
                  :ARG1 (g2 / gene
                        :mod (c2 / change-01
                              :ARG1 g2
                              :ARG2 (f2 / fold
                                    :op1 two))
                        :ARG2 (l5 / list-01
                              :ARG1 (n4 / name :op1 ""PDGFA""))
                        :ARG2 (l6 / list-01
                              :ARG1 (n5 / name :op1 ""ITGAV""))))))
        :snt2 (h / have-rel-role-91
            :ARG1 (g3 / gene)
            :ARG2 (f3 / father)))","(g / gene
    :quant (n / number :value 3)
    :ARG1-of (c / change-01
        :ARG1 (t / transcription)
        :degree (l / less
            :quant (n2 / number :value 2)
            :unit (f / fold)))
    :example (s / show-01
        :ARG1 g)
    :example (l2 / list-01
        :ARG1 (g2 / gene
            :name (n3 / name :op1 ""PDGFB"")
            :name (n4 / name :op1 ""ITGB1""))
        :reason (r / relate-01
            :ARG1 g2
            :ARG2 (g3 / gene
                :name (n5 / name :op1 ""PDGFA"")
                :name (n6 / name :op1 ""ITGAV""))
            :degree (c2 / close)
            :ARG1-of (a / alter-01
                :degree (t2 / two
                    :unit f)))))
    :quant (n7 / number :value 2))",-1.0,-1.0
pmid_1684_6534.122,"We examined MEK1 and MEK2 levels by western blot to confirm decreased protein in MUC1 siRNA-treated cells (Figure <xref ref-type=""fig"" rid=""F3"">3a</xref>), and found that not only were total MEK1/2 levels lower in 468.siMUC1 and BT.siMUC1 compared to controls (0.48 and 0.68 relative to siLuc, respectively), but so were the basal amounts of active (phosphorylated) MEK1/2 (pMEK1/2; 0.12 and 0.42 relative to siLuc, respectively).","(a4 / and
    :op1 (e4 / examine-01
        :purpose (c3 / confirm-01
            :ARG0 (w2 / we)
            :ARG1 (d / decrease-01
                :ARG1 (p4 / protein)
                :location (c / cell
                    :ARG1-of (t2 / treat-04
                        :ARG2 (e / enzyme
                            :name (n / name
                                :op1 ""MEK1""))))))
        :ARG0 w2
        :ARG1 (a3 / and
            :op1 (l / level
                :mod e)
            :op2 (l2 / level
                :mod (p3 / protein
                    :name (n2 / name
                        :op1 ""MUC1""
                        :op2 ""siRNA"")
                    :name (n5 / name
                        :op1 ""hmm""
                        :value ""1/2""))))
        :instrument (b2 / blot
            :mod (w3 / world-region
                :name (n4 / name
                    :op1 ""Western""))))
    :op2 (f2 / find-01
        :ARG0 w2
        :ARG1 (h / have-degree-91
            :ARG1 (l3 / level
                :ARG1-of (r / relative-05
                    :ARG2 (w / way))
                :ARG2-of (t / total-01)
                :mod (e2 / enzyme
                    :name n))
            :ARG1-of (c2 / compare-01
                :ARG2 (a5 / and
                    :op1 r
                    :op2 (r2 / relative-05
                        :ARG2-of (r4 / relative-05
                            :ARG1 0.42)
                        :value 3)))
            :ARG2 (l4 / low-04)
            :ARG3 (m / more)))
    :rel (p2 / protein
        :name (n3 / name
            :op1 ""MEK2""))
    :rel (a2 / amount
        :ARG1-of c2
        :ARG1-of (r3 / relative-05
            :ARG2 a5)
        :mod (b / basal)
        :quant-of (e3 / enzyme
            :name (n7 / name
                :op3 ""1/2"")
            :ARG0-of (a / activity-06)
            :ARG1-of (p / phosphorylate-01)
            :domain e2))
    :rel (c4 / control-01)
    :rel (f / figure)
    :rel 0.48
    :rel ""1/2""
    :rel 0.68
    :rel (n6 / name)
    :rel 468
    :rel 0.12)
",test,bio_amr0.8,"(a / and
      :op1 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (a2 / and
                  :op1 (l / level
                        :quant-of (e2 / enzyme :name (n / name :op1 ""MEK1"")))
                  :op2 (l2 / level
                        :quant-of (e3 / enzyme :name (n2 / name :op1 ""MEK2""))))
            :manner (i / immunoblot-01)
            :purpose (c / confirm-01
                  :ARG0 w
                  :ARG1 (p / protein
                        :ARG1-of (d / decrease-01
                              :location (c2 / cell
                                    :ARG1-of (t2 / treat-04
                                          :ARG2 (n11 / nucleic-acid :name (n4 / name :op1 ""siRNA"")
                                                :ARG0-of (e4 / encode-01
                                                      :ARG1 (p2 / protein :name (n5 / name :op1 ""MUC1"")))))))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (f / figure :mod ""3a"")))
      :op2 (f2 / find-01
            :ARG0 w
            :ARG1 (a3 / and
                  :op1 (a4 / and
                        :op1 (l3 / level
                              :quant-of e2)
                        :op2 (l4 / level
                              :quant-of e3)
                        :mod (t3 / total)
                        :ARG1-of (l5 / low-04
                              :degree (m / more)
                              :compared-to (c3 / control))
                        :ARG1-of (m2 / mean-01
                              :ARG2 (a14 / and
                                    :op1 (l6 / level :quant 0.48)
                                    :op2 (l7 / level :quant 0.68)
                                    :manner r2
                                    :ARG1-of (r3 / relative-05
                                          :ARG3 (c6 / cell-line :name (n8 / name :op1 ""siLuc"")))
                                    :mod t3)))
                  :op2 (a7 / and
                        :op1 (a8 / amount
                              :quant-of (e5 / enzyme :name (n9 / name :op1 ""MEK1"")
                                    :ARG1-of (a10 / activate-01
                                          :ARG1-of (m3 / mean-01
                                                :ARG2 (p3 / phosphorylate-01
                                                      :ARG3 e5)))))
                        :op2 (a9 / amount
                              :quant-of (e6 / enzyme :name (n10 / name :op1 ""MEK2"")
                                    :ARG1-of (a11 / activate-01
                                          :ARG1-of (m5 / mean-01
                                                :ARG2 (p4 / phosphorylate-01
                                                      :ARG3 e6)))))
                        :mod (b / basal)
                        :ARG1-of l5
                        :ARG1-of (m4 / mean-01
                              :ARG2 (a12 / and
                                    :op1 (a6 / amount :quant 0.12)
                                    :op2 (a13 / amount :quant 0.42)
                                    :manner (r2 / respective)
                                    :ARG1-of r3
                                    :mod b))))
            :location (a5 / and
                  :op1 (c4 / cell-line :name (n6 / name :op1 ""468.siMUC1""))
                  :op2 (c5 / cell-line :name (n7 / name :op1 ""BT.siMUC1"")))))","We examined MEK1 and MEK2 levels by western blot to confirm decreased protein in MUC1 siRNA-treated cells (Figure <xref ref-type=""fig"" rid=""F3"">3a</xref>), and found that not only were total MEK1/2 levels lower in 468.siMUC1 and BT.siMUC1 compared to controls (0.48 and 0.68 relative to siLuc, respectively), but so were the basal amounts of active (phosphorylated) MEK1/2 (pMEK1/2; 0.12 and 0.42 relative to siLuc, respectively).","(z1 / and
    :op1 (z2 / examine-01
             :ARG0 (z3 / we)
             :ARG1 (z4 / and
                       :op1 (z5 / level
                                :mod (z6 / enzyme
                                         :wiki ""Mitogen-activated_protein_kinase_1""
                                         :name (z7 / name
                                                   :op1 ""MEK1"")))
                       :op2 (z8 / level
                                :mod (z9 / enzyme
                                         :wiki ""Mitogen-activated_protein_kinase_2""
                                         :name (z10 / name
                                                    :op1 ""MEK2"")))))
    :instrument (z11 / blot
                     :mod (z12 / west))
    :purpose (z13 / confirm-01
                  :ARG0 z3
                  :ARG1 (z14 / protein
                             :ARG1-of (z15 / decrease-01)
                             :location (z16 / cell
                                            :ARG1-of (z17 / treat-04
                                                          :ARG2 (z18 / siRNA))))))",0.2617801047120419,0.3295019157088122,"(m / multi-sentence
        :snt1 (e / examine-01
            :ARG0 (w / we)
            :ARG1 (l / level
                  :ARG0-of (m2 / mek1)
                  :ARG0-of (m3 / mek2)
                  :mod (d / decrease-01
                        :ARG1 (p / protein
                              :mod (m4 / muc1
                                    :ARG1-of (t / treat-01
                                          :ARG1 (c / cell
                                                :ARG1-of (s / sirna-01
                                                      :ARG0-of (f / find-01
                                                            :ARG1 (t2 / total
                                                                  :ARG0-of (l2 / lower-02
                                                                        :ARG1 (l3 / level
                                                                              :ARG0-of (m5 / mek1)
                                                                              :ARG0-of (m6 / mek2)
                                                                              :mod (c2 / compare-01
                                                                                    :ARG1 (c3 / control
                                                                                          :mod (b / bt.siMUC1)
                                                                                          :mod (f2 / 468.siMUC1)
                                                                                          :mod (s2 / siLuc))))
                                                                        :degree (n / number
                                                                              :op1 0.48))
                                                                  :ARG1 (l4 / level
                                                                        :ARG0-of (b2 / basal-02
                                                                              :ARG1 (a / amount
                                                                                    :mod (p2 / phosphorylate-01
                                                                                          :ARG1 (m7 / mek1)
                                                                                          :ARG1 (m8 / mek2)
                                                                                          :mod (a2 / active
                                                                                                :ARG1 (p3 / pMEK1/2)
                                                                                                :degree (n2 / number
                                                                                                      :op1 0.12))))
                                                                              :degree (n3 / number
                                                                                    :op1 0.42)))))))))))
        :snt2 (f3 / figure
            :op1 (x / xref
                  :ref-type ""fig""
                  :rid ""F3"")
            :op2 ""3a""))","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (l / level
        :mod (p / protein)
        :ARG1-of (d / decrease-01)
        :location (c / cell
            :mod (t / treat-01
                :ARG1 (s / siRNA
                    :mod (m / MUC1)))))
    :instrument (b / blot-01
        :mod (w2 / western))
    :ARG2 (a / and
        :op1 (m2 / MEK1)
        :op2 (m3 / MEK2))
    :purpose (c2 / confirm-01)
    :medium (f / figure
        :mod (x / xref
            :ref-type ""fig""
            :rid ""F3""
            :op1 ""3a"")))
(f2 / find-01
    :ARG0 w
    :ARG1 (l2 / level
        :mod (p2 / protein)
        :ARG1-of (d2 / decrease-01)
        :location (c2 / cell
            :mod (t2 / treat-01
                :ARG1 s)
            :name (n / name
                :op1 ""468.siMUC1""
                :op2 ""BT.siMUC1""))
        :compared-to (c3 / control
            :mod (s2 / siLuc))
        :quant (r / relative-quantity
            :op1 ""0.48""
            :op2 ""0.68""))
    :ARG2 (a2 / and
        :op1 (m4 / MEK1)
        :op2 (m5 / MEK2))
    :condition (n2 / not-only)
    :concession (b2 / but)
    :degree (s3 / so)
    :mod (a3 / active
        :mod (p3 / phosphorylate-01))
    :quant (r2 / relative-quantity
        :op1 ""0.12""
        :op2 ""0.42""))",-1.0,-1.0
pmid_1684_6534.125,"Notably, MUC1 siRNA impairs this important oncogenic pathway in MDA-MB-468 cells, as 468.siMUC1 display less pMEK1/2 in response to EGF than do 468.siLuc (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(i / impede-01
    :ARG0 (e / enzyme
        :name (n / name
            :op1 ""MUC1""
            :op2 ""siRNA""))
    :ARG1 (p / pathway
        :ARG1-of (i2 / important-01)
        :location (c2 / cell
            :name (n2 / name
                :op1 4
                :op2 ""B"")
            :mod (u / url-entity
                :value 3))
        :mod (p3 / proto-oncogene)
        :mod (t / this))
    :ARG1-of (n6 / notable-04)
    :ARG1-of (c / cause-01
        :ARG0 (d2 / display-01
            :ARG0 e
            :ARG1 (e2 / enzyme
                :name (n3 / name
                    :op1 ""pMEK""
                    :op2 ""1/2"")
                :ARG1-of (h / have-quant-91
                    :ARG3 (l / less)))
            :ARG2-of (r / respond-01
                :ARG0 d2)))
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod u))
    :rel (d3 / display-01
        :ARG1 (w / way
            :name (n5 / name
                :op1 4)
            :part-of c2)
        :ARG4 (p2 / protein
            :name (n4 / name
                :op1 ""EGF""))))
",test,bio_amr0.8,"(i / impair-01
      :ARG0 (n11 / nucleic-acid :name (n / name :op1 ""siRNA"")
            :ARG0-of (e3 / encode-01
                  :ARG1 (p / protein :name (n2 / name :op1 ""MUC1""))))
      :ARG1 (p2 / pathway
            :mod (t / this)
            :mod (i2 / important)
            :ARG0-of (c / cause-01
                  :ARG1 (d4 / disease :wiki ""Cancer"" :name (n10 / name :op1 ""cancer""))))
      :location (c3 / cell-line :name (n3 / name :op1 ""MDA-MB-468""))
      :ARG1-of (n4 / notable-04)
      :ARG1-of (c4 / cause-01
            :ARG0 (d / display-01
                  :ARG0 (c5 / cell-line :name (n8 / name :op1 ""468.siMUC1""))
                  :ARG1 (s / slash
                        :op1 (e / enzyme :name (n5 / name :op1 ""MEK1""))
                        :op2 (e2 / enzyme :name (n6 / name :op1 ""MEK2""))
                        :ARG3-of (p3 / phosphorylate-01)
                        :quant (l / less))
                  :ARG2-of (r2 / respond-01
                        :ARG1 (p4 / protein :name (n7 / name :op1 ""EGF"")))
                  :compared-to (d2 / display-01
                        :ARG0 (c6 / cell-line :name (n9 / name :op1 ""468.siLuc""))
                        :ARG1 (s3 / slash
                              :op1 e
                              :op2 e2))))
      :ARG1-of (d3 / describe-01
            :ARG0 (f / figure :mod ""3b"")))","Notably, MUC1 siRNA impairs this important oncogenic pathway in MDA-MB-468 cells, as 468.siMUC1 display less pMEK1/2 in response to EGF than do 468.siLuc (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(z1 / impair-01
    :ARG0 (z2 / small-molecule
              :wiki ""Mitogen-activated_protein_kinase_1""
              :name (z3 / name
                        :op1 ""MUC1""
                        :op2 ""siRNA""))
    :ARG1 (z4 / pathway
              :mod (z5 / oncogenic)
              :ARG1-of (z6 / important-01)
              :mod (z7 / this))
    :ARG1-of (z8 / note-01)
    :location (z9 / cell
                  :wiki ""Mitogen-activated_protein_kinase_1""
                  :name (z10 / name
                             :op1 ""MDA-MB-468""))
    :ARG1-of (z11 / cause-01
                  :ARG0 (z12 / display-01
                             :ARG0 (z13 / enzyme
                                        :wiki ""Mitogen-activated_protein_kinase_1/2""
                                        :name (z14 / name
                                                   :op1 ""pMEK1/2""))
                             :ARG1-of (z15 / have-quant-91
                                           :ARG3 (z16 / less)
                                           :ARG4 (z17 / enzyme
                                                      :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                      :name (z18 / name
                                                                 :op1 ""468.siMUC1"")))
                             :ARG0-of (z19 / respond-01
                                           :ARG1 (z20 / small-molecule
                                                      :wiki ""EGF_(g3000 / gene)""
                                                      :name (z21 / name
                                                                 :op1 ""EGF""))))
                  :ARG1-of (z22 / describe-01
                                :ARG0 (z23 / figure
                                           :mod ""3b""
                                           :ARG1-of (z24 / hyperlink-91
                                                         :ARG3 (z25 / url-entity
                                                                    :value ""xref_ref-type=fig""
                                                                    :ARG1-of (z26 / rid-01)))))))",0.3561643835616438,0.3724137931034483,"(m / multi-sentence
        :snt1 (i / impair-01
            :ARG1 (p / pathway
                  :mod (o / oncogenic))
            :ARG2 (s / siRNA
                  :mod (m / MUC1)))
        :snt2 (d / display-01
            :ARG0 (d2 / do-02
                  :ARG0 (d3 / do-02
                        :ARG0 (d4 / do-02
                              :ARG0 (d5 / do-02
                                    :ARG0 (d6 / do-02
                                          :ARG0 (d7 / do-02
                                                :ARG0 (d8 / do-02
                                                      :ARG0 (d9 / do-02
                                                            :ARG0 (d10 / do-02
                                                                  :ARG0 (d11 / do-02
                                                                        :ARG0 (d12 / do-02
                                                                              :ARG0 (d13 / do-02
                                                                                    :ARG0 (d14 / do-02
                                                                                          :ARG0 (d15 / do-02
                                                                                                :ARG0 (d16 / do-02
                                                                                                      :ARG0 (d17 / do-02
                                                                                                            :ARG0 (d18 / do-02
                                                                                                                  :ARG0 (d19 / do-02
                                                                                                                        :ARG0 (d20 / do-02
                                                                                                                              :ARG0 (d21 / do-02
                                                                                                                                    :ARG0 (d22 / do-02
                                                                                                                                          :ARG0 (d23 / do-02
                                                                                                                                                :ARG0 (d24 / do-02
                                                                                                                                                      :ARG0 (d25 / do-02
                                                                                                                                                            :ARG0 (d26 / do-02
                                                                                                                                                                  :ARG0 (d27 / do-02
                                                                                                                                                                        :ARG0 (d28 / do-02
                                                                                                                                                                              :ARG0 (d29 / do-02
                                                                                                                                                                                    :ARG0 (d30 / do-02
                                                                                                                                                                                          :ARG0 (d31 / do-02
                                                                                                                                                                                                :ARG0 (d32 / do-02
                                                                                                                                                                                                      :ARG0 (d33 / do-02
                                                                                                                                                                                                            :ARG0 (d34 / do-02
                                                                                                                                                                                                                  :ARG0 (d35 / do-02
                                                                                                                                                                                                                        :ARG0 (d36 / do-02
                                                                                                                                                                                                                              :ARG0 (d37 / do-02
                                                                                                                                                                                                                                    :ARG0 (d38 / do-02
                                                                                                                                                                                                                                          :ARG0 (d39 / do-02
                                                                                                                                                                                                                                                :ARG0 (d40 / do-02
                                                                                                                                                                                                                                                      :ARG0 (d41 / do-02
                                                                                                                                                                                                                                                            :ARG0 (d42 / do-02
                                                                                                                                                                                                                                                                  :ARG0 (d43 / do-02
                                                                                                                                                                                                                                                                        :ARG0 (d44 / do-02
                                                                                                                                                                                                                                                                              :ARG0 (d45 / do-02
                                                                                                                                                                                                                                                                                    :ARG0 (d46 / do-02
                                                                                                                                                                                                                                                                                          :ARG0 (d47 / do-02
                                                                                                                                                                                                                                                                                                :ARG0 (d48 / do-02
                                                                                                                                                                                                                                                                                                      :ARG0 (d49 / do-02
                                                                                                                                                                                                                                                                                                            :ARG0 (d50 / do-02
                                                                                                                                                                                                                                                                                                                  :ARG0 (d51 / do-02
                                                                                                                                                                                                                                                                                                                        :ARG0 (d52 / do-02
                                                                                                                                                                                                                                                                                                                              :ARG0 (d53 / do-02
                                                                                                                                                                                                                                                                                                                                    :ARG0 (d54 / do-02
                                                                                                                                                                                                                                                                                                                                          :ARG0 (d55 / do-02
                                                                                                                                                                                                                                                                                                                                                :ARG0 (d56 / do-02
                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d57 / do-02
                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d58 / do-02
                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d59 / do-02
                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d60 / do-02
                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d61 / do-02
                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d62 / do-02
                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d63 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d64 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d65 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d66 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d67 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d68 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d69 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d70 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d71 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d72 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d73 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d74 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d75 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d76 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d77 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d78 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d79 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d80 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d81 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d82 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d83 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d84 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d85 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d86 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d87 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d88 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d89 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d90 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d91 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d92 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d93 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d94 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d95 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d96 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d97 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d98 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d99 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d100 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d101 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d102 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d103 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d104 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d105 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d106 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d107 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d108 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d109 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d110 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d111 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d112 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d113 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d114 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d115 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d116 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d117 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d118 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d119 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d120 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d121 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d122 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d123 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d124 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d125 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    :ARG0 (d126 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          :ARG0 (d127 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                :ARG0 (d128 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      :ARG0 (d129 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            :ARG0 (d130 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  :ARG0 (d131 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        :ARG0 (d132 / do-02
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              :ARG0 (d133 / do-02","(n / note-01
    :ARG1 (i / impair-01
        :ARG0 (s / siRNA
            :mod (m / MUC1))
        :ARG1 (p / pathway
            :mod (o / oncogenic)
            :mod (i2 / important))
        :location (c / cell
            :name (n / name :op1 ""MDA-MB-468""))
        :time (r / respond-01
            :ARG1 (d / display-01
                :ARG0 (s2 / siMUC1
                    :mod (n2 / number :value 468))
                :ARG1 (l / less
                    :op1 (p2 / pMEK1/2))
                :compared-to (d2 / do-02
                    :ARG1 (s3 / siLuc
                        :mod (n3 / number :value 468))))
            :ARG2 (e / EGF))
        :mod (n4 / notable))
    :medium (f / figure
        :name (n5 / name :op1 ""3b"")))",-1.0,-1.0
pmid_1684_6534.129,"Thus, it appears that basal pMEK1/2 levels are not greatly affected by Raf-1 overexpression in BT.siMUC1 cells, likely because MEK is regulated primarily by B-Raf under normal growth conditions.","(i / infer-01
    :ARG1 (a2 / appear-02
        :ARG1 (a / affect-01
            :ARG0 (e / engineer-01
                :ARG1 (e3 / enzyme
                    :name (n2 / name
                        :op1 ""B-Raf""
                        :op2 ""1/2"")
                    :name (n3 / name
                        :op1 ""serine""))
                :location (c2 / cell
                    :name (n4 / name
                        :op1 ""you""
                        :op1 ""siMUC1"")
                    :mod (s / small-molecule
                        :name (n5 / name))))
            :ARG1 (l / level
                :consist-of (e2 / enzyme
                    :name (n / name
                        :op1 ""pMEK""
                        :op1 ""serine""))
                :mod (b / basal))
            :ARG1-of (c / cause-01
                :ARG0 (r / regulate-01
                    :ARG0 e3
                    :ARG1 e2
                    :condition (c3 / condition
                        :ARG1-of (n6 / normal-02)
                        :mod (g2 / grow-01))
                    :mod (p / primary))
                :ARG1-of (l2 / likely-01))
            :degree (g / great)
            :polarity -)))
",test,bio_amr0.8,"(c2 / cause-01
      :ARG0 (r / regulate-01
            :ARG0 (e2 / enzyme :name (n3 / name :op1 ""B-Raf""))
            :ARG1 (e5 / enzyme :name (n / name :op1 ""MEK""))
            :ARG1-of (l2 / likely-01)
            :manner (p / primary)
            :condition (g2 / grow-01
                  :ARG1-of (n7 / normal-02)))
      :ARG1 (a / appear-02
            :ARG1 (a2 / affect-01 :polarity -
                  :ARG0 (o / overexpress-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""Raf-1""))
                        :location (c / cell-line :name (n6 / name :op1 ""BT.siMUC1"")))
                  :ARG1 (l / level
                        :quant-of (s / slash
                              :op1 (e3 / enzyme :name (n4 / name :op1 ""MEK1""))
                              :op2 (e4 / enzyme :name (n5 / name :op1 ""MEK2""))
                              :ARG3-of (p2 / phosphorylate-01))
                        :mod (b / basal))
                  :extent (g / great))))","Thus, it appears that basal pMEK1/2 levels are not greatly affected by Raf-1 overexpression in BT.siMUC1 cells, likely because MEK is regulated primarily by B-Raf under normal growth conditions.","(z1 / infer-01
    :ARG1 (z2 / appear-02
              :ARG1 (z3 / affect-01
                        :polarity -
                        :ARG0 (z4 / overexpress-00
                                  :ARG0 (z5 / cell
                                            :wiki ""BRAF_(g3000 / gene)""
                                            :name (z6 / name
                                                      :op1 ""BRAF""))
                                  :ARG1 (z7 / enzyme
                                            :wiki ""BRAF1""
                                            :name (z8 / name
                                                      :op1 ""Raf-1""))
                                  :location (z9 / cell
                                                :wiki ""BRAF1""
                                                :name (z10 / name
                                                           :op1 ""BT.siMUC1"")))
                        :ARG1 (z11 / level
                                   :mod (z12 / enzyme
                                             :wiki ""PHLDA1/2""
                                             :name (z13 / name
                                                        :op1 ""pMEK1/2"")
                                             :mod (z14 / basal)))
                        :degree (z15 / great))
              :ARG1-of (z16 / likely-01
                            :ARG1-of (z17 / cause-01
                                          :ARG0 (z18 / regulate-01
                                                     :ARG0 (z19 / enzyme
                                                                :wiki ""BRAF_(g3001 / gene)""
                                                                :name (z20 / name
                                                                           :op1 ""B-Raf""))
                                                     :ARG1 z12
                                                     :mod (z21 / primary)
                                                     :condition (z22 / condition
                                                                     :mod (z23 / grow-01)
                                                                     :ARG1-of (z24 / normal-02)))))))",0.4033613445378151,0.4347826086956522,"(m / multi-sentence
        :snt1 (a / appear-01
            :ARG1 (l / level
                  :mod (b / basal)
                  :mod (m2 / mek1/2
                        :mod (p / p))))
        :snt2 (a2 / affect-01
            :ARG1 l
            :ARG2 (o / overexpression
                  :ARG1 (r / raf-1))
            :ARG3 (c / cell
                  :mod (b2 / bt.simuc1)))
        :snt3 (r2 / regulate-01
            :ARG1 (m3 / mek)
            :ARG2 (b3 / b-raf)
            :ARG3 (c2 / condition
                  :mod (g / growth)
                  :mod (n / normal))))","(a / appear-01
    :ARG1 (a2 / affect-01
        :ARG0 (o / overexpress-01
            :ARG0 (g / gene :name (n / name :op1 ""Raf-1""))
            :ARG1 (c / cell :name (n2 / name :op1 ""BT.siMUC1"")))
        :ARG1 (l / level
            :mod (b / basal)
            :ARG1-of (p / protein :name (n3 / name :op1 ""pMEK1/2""))))
    :degree (n4 / not)
    :degree (g2 / great)
    :condition (r / regulate-01
        :ARG0 (g3 / gene :name (n5 / name :op1 ""B-Raf""))
        :ARG1 (g4 / gene :name (n6 / name :op1 ""MEK""))
        :time (c2 / condition
            :mod (n / normal)
            :ARG1-of (g3 / grow-01)))
    :concession (l2 / likely)
    :mode (t / thus))",-1.0,-1.0
pmid_1684_6534.130,"In contrast, when the cells are stimulated (EGF), increased Raf-1 levels in BT.siMUC1 leads to heightened pMEK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(c2 / contrast-01
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :ARG1-of (r / refer-03
                :ARG0 (p2 / publication
                    :name (n2 / name
                        :op2 ""siMUC1"")))))
    :ARG2 (l / lead-03
        :ARG0 (i / increase-01
            :ARG1 (l2 / level
                :mod (e / enzyme
                    :name n2)))
        :ARG2 (h / heighten-01
            :ARG1 (e2 / enzyme
                :name (n3 / name
                    :mod ""1/2""
                    :op1 ""pMEK"")))
        :time (s / stimulate-01
            :ARG1 (c / cell)))
    :rel (n / name
        :op1 ""Raf-1"")
    :rel (p / protein
        :name l2))
",test,bio_amr0.8,"(c / contrast-01
      :ARG2 (l / lead-03
            :ARG0 (l2 / level
                  :quant-of (e / enzyme :name (n / name :op1 ""Raf-1""))
                  :location (c2 / cell-line :name (n2 / name :op1 ""BT.siMUC1""))
                  :ARG1-of (i / increase-01))
            :ARG2 (s / slash
                  :op1 (e2 / enzyme :name (n3 / name :op1 ""MEK1""))
                  :op2 (e3 / enzyme :name (n4 / name :op1 ""MEK2""))
                  :ARG3-of (p / phosphorylate-01)
                  :ARG1-of (h / heighten-01))
            :time (s2 / stimulate-01
                  :ARG1 (c3 / cell)
                  :ARG2 (p2 / protein :name (n5 / name :op1 ""EGF""))))
      :ARG1-of (d / describe-01
            :ARG0 (f / figure :mod ""3b"")))","In contrast, when the cells are stimulated (EGF), increased Raf-1 levels in BT.siMUC1 leads to heightened pMEK1/2 (Figure <xref ref-type=""fig"" rid=""F3"">3b</xref>).","(z1 / contrast-01
    :ARG2 (z2 / lead-03
              :ARG0 (z3 / increase-01
                        :ARG1 (z4 / level
                                  :mod (z5 / small-molecule
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z6 / name
                                                     :op1 ""Raf-1"")))
                        :location (z7 / small-molecule
                                      :wiki ""BRAF_(g3001 / gene)""
                                      :name (z8 / name
                                                :op1 ""BT.siMUC1"")))
              :ARG2 (z9 / increase-01
                        :ARG1 (z10 / protein
                                   :wiki ""PHLDA1/2""
                                   :name (z11 / name
                                              :op1 ""pMEK1/2"")
                                   :ARG1-of (z12 / heighten-01)))
              :time (z13 / stimulate-01
                         :ARG1 (z14 / cell)
                         :ARG2 (z15 / enzyme
                                    :wiki ""Erythropoietin""
                                    :name (z16 / name
                                               :op1 ""EGF""))))
    :ARG1-of (z17 / describe-01
                  :ARG0 (z18 / figure
                             :mod ""3b""
                             :ARG1-of (z19 / hyperlink-91
                                           :ARG3 (z20 / url-entity
                                                      :value ""xref"")))))",0.4791666666666666,0.3953488372093023,"(s / sentence
        :ARG0 (c / contrast-01
              :ARG1 (w / when
                    :ARG1 (s2 / stimulate-01
                          :ARG0 (c2 / cell)
                          :ARG1 (e / EGF)))
              :ARG2 (l / lead-01
                    :ARG0 (l2 / level
                          :mod (r / Raf-1)
                          :mod (i / increase-01))
                    :ARG1 (b / BT.siMUC1)))
        :ARG1 (h / heighten-01
              :ARG1 (p / pMEK1/2)
              :ARG2 (f / figure
                    :ARG1-of (x / xref
                          :ref-type ""fig""
                          :rid ""F3""
                          :op1 ""3b""))))","(i / increase-01
    :ARG1 (l / level
        :quant (r / Raf-1)
        :location (b / BT.siMUC1))
    :ARG2 (h / heighten-01
        :ARG1 (p / pMEK1/2))
    :time (w / when
        :ARG1 (s / stimulate-01
            :ARG1 (c / cell)))
    :condition (e / EGF)
    :contrast (c2 / contrast)
    :mod (f / figure
        :ARG1-of (x / xref
            :ref-type ""fig""
            :rid ""F3""
            :op1 ""3b"")))",-1.0,-1.0
pmid_1901_8267.141,"Next, we examined the prognostic effect of <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression.","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (a / affect-01
        :ARG0 (a2 / and
            :op1 (m / mutate-01
                :ARG1 (l / language
                    :name (n / name
                        :op1 ""i""))
                :mode expressive)
            :op2 (e2 / express-03
                :ARG2 ""1/2""))
        :ARG2 (p / predict-01))
    :rel (l2 / location
        :name (n2 / name
            :mod ""executive""
            :op2 ""he""))
    :time (n3 / next))
",test,bio_amr0.8,"(e / examine-01
      :ARG0 (w / we)
      :ARG1 (a / affect-01
            :ARG0 (a2 / and
                  :op1 (m / mutate-01
                        :ARG1 (s / slash
                              :op1 (g / gene :name (n / name :op1 ""KRAS""))
                              :op2 (g2 / gene :name (n2 / name :op1 ""BRAF""))))
                  :op2 (e2 / express-03
                        :ARG2 (e3 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                              :ARG3-of (p2 / phosphorylate-01))))
            :mod (p / prognostic))
      :time (n4 / next))","Next, we examined the prognostic effect of <i>KRAS/BRAF</i> mutations and p-ERK1/2 expression.","(z1 / examine-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / affect-01
              :ARG0 (z4 / and
                        :op1 (z5 / mutate-01
                                 :ARG1 (z6 / enzyme
                                           :wiki ""BRAF_(g3000 / gene)""
                                           :name (z7 / name
                                                     :op1 ""KRAS/BRAF"")))
                        :op2 (z8 / express-02
                                 :ARG1 (z9 / enzyme
                                           :wiki ""P-ERK1/2""
                                           :name (z10 / name
                                                      :op1 ""p-ERK1/2""
                                                      :op2 ""expression""))))
              :ARG1 (z11 / prognostic-01))
    :time (z12 / next))",0.46875,0.5079365079365079,"(e / examine-01
    :ARG0 (w / we)
    :ARG1 (e2 / effect-01
        :ARG1 (p / prognostic
            :mod (e3 / expression
                :ARG1 (a / and
                    :op1 (m / mutation
                        :ARG1 (k / KRAS/BRAF))
                    :op2 (e4 / expression
                        :ARG1 (p2 / phosphorylate-01
                            :ARG1 (e5 / ERK1/2)))))))","(e / examine-01
    :ARG0 (w / we)
    :ARG1 (e2 / effect-01
        :ARG1-of (p / prognostic-01)
        :ARG2 (m / mutation
            :ARG1 (g / gene
                :name (n / name :op1 ""KRAS"" :op2 ""/"" :op3 ""BRAF""))))
    :ARG2 (e3 / express-01
        :ARG1 (p2 / protein
            :name (n2 / name :op1 ""p-ERK1/2""))))
    :time (n3 / next))",-1.0,-1.0
pmid_1901_8267.148,"Mutational status was correlated with growth inhibition and apoptosis induction by the MEK inhibitor CI-1040 that prevented activation of the downstream target, ERK1/2.","(c / correlate-01
    :ARG1 (s / status
        :mod (g / gene))
    :ARG2 (a2 / and
        :op1 (i2 / inhibit-01
            :ARG1 (g2 / grow-01))
        :op2 (i / induce-01
            :ARG2 (a3 / apoptosis)))
    :rel (i3 / inhibit-01
        :ARG0-of (p / prevent-01
            :ARG1 (a / activate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""MEK""
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG1-of (t / target-01
                        :mod (d / downstream)))))
        :ARG1 (e / enzyme
            :name (n / name
                :op1 ""i""
                :op2 1040)
            :name n2)))
",test,bio_amr0.8,"(c / correlate-01
      :ARG0 (s2 / small-molecule :name (n2 / name :op1 ""CI-1040"")
            :ARG0-of (i / inhibit-01
                  :ARG1 (p2 / protein-family :name (n / name :op1 ""MEK"")))
            :ARG0-of (p / prevent-01
                  :ARG1 (a3 / activate-01
                        :ARG1 (t2 / target
                              :ARG1-of (m2 / mean-01
                                    :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")))
                              :location (d / downstream)))))
      :ARG1 (s / status
            :mod (m / mutate-01))
      :ARG2 (a / and
            :op1 (i2 / inhibit-01
                  :ARG1 (g / grow-01))
            :op2 (i3 / induce-01
                  :ARG2 (a2 / apoptosis))))","Mutational status was correlated with growth inhibition and apoptosis induction by the MEK inhibitor CI-1040 that prevented activation of the downstream target, ERK1/2.","(z1 / correlate-01
    :ARG1 (z2 / status
              :mod (z3 / mutational))
    :ARG2 (z4 / and
              :op1 (z5 / inhibit-01
                       :ARG0 (z6 / inhibitor
                                 :wiki ""C-1040""
                                 :name (z7 / name
                                           :op1 ""CI-1040"")
                                 :ARG0-of (z8 / prevent-01
                                              :ARG1 (z9 / activate-01
                                                        :ARG1 (z10 / enzyme
                                                                   :wiki ""ERK1/2""
                                                                   :name (z11 / name
                                                                              :op1 ""ERK1/2"")
                                                                   :ARG1-of (z12 / target-01
                                                                                 :mod (z13 / downstream))))))
                       :ARG1 (z14 / grow-01))
              :op2 (z15 / induce-01
                        :ARG0 z6
                        :ARG2 (z16 / apoptose-01))))",0.6,0.6024096385542168,"(m / mutational-status
        :ARG1 (c / correlate-01
              :ARG1 (s / status
                    :ARG1-of (w / was)
                    :ARG2 (g / growth-inhibition
                          :ARG1-of (a / and
                                :op1 (i / induce-01
                                      :ARG1 (a2 / apoptosis)
                                      :ARG2 (i2 / inhibit-01
                                            :ARG1 (m2 / MEK-inhibitor
                                                  :ARG1-of (p / prevent-01
                                                        :ARG1 (a3 / activation)
                                                        :ARG2 (t / target
                                                              :mod (d / downstream)
                                                              :ARG1-of (e / ERK1/2))))))))))","(m / multi-sentence
    :snt1 (c / correlate-01
        :ARG1 (s / status
            :mod (m / mutation))
        :ARG2 (a / and
            :op1 (i / inhibit-01
                :ARG1 (g / grow-01))
            :op2 (i2 / induce-01
                :ARG1 (a2 / apoptosis))))
    :snt2 (p / prevent-01
        :ARG0 (t / thing
            :name (n / name :op1 ""CI-1040"")
            :mod (i3 / inhibitor
                :mod (m2 / MEK)))
        :ARG1 (a3 / activate-01
            :ARG1 (t2 / target
                :mod (d / downstream)
                :name (n2 / name :op1 ""ERK1/2"")))))",-1.0,-1.0
pmid_1901_8267.149,"Western blot analysis showed a dose-dependent effect on the expression of active ERK1/2 in ES2 cells, and active ERK1/2 was not detectable 6 h after treating the cells with CI-1040 at a concentration of 5 <i>μ</i><sc>M</sc> (<xref ref-type=""fig"" rid=""fig4"">Figure 4</xref>).","(a5 / and
    :op1 (s / show-01
        :ARG0 (a4 / analyze-01
            :manner (b / blot
                :mod (w / world-region
                    :name (n / name
                        :op1 ""West""))))
        :ARG1 (a2 / affect-01
            :ARG1 (e2 / express-03
                :ARG1 (e / enzyme
                    :name (n2 / name
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG0-of (a / activity-06))
                :location (c / cell
                    :name (n3 / name
                        :op1 ""ES2"")))
            :ARG1-of (d / depend-01
                :ARG0 (d3 / dose-01))))
    :op2 (p / possible-01
        :ARG1 (d2 / detect-01
            :quant (c3 / concentration-quantity
                :quant 6
                :unit (h / hour))
            :ARG1 e
            :time (a3 / after
                :op1 (t / treat-03
                    :ARG1 c
                    :ARG1-of (c2 / concentrate-02)
                    :ARG2 (s2 / small-molecule
                        :name (n4 / name
                            :op1 40)))))
        :polarity -)
    :op3 (f / figure
        :mod 4)
    :rel 5)
",test,bio_amr0.8,"(a / and
      :op1 (s / show-01
            :ARG0 (a2 / analyze-01
                  :manner (i / immunoblot-01))
            :ARG1 (a3 / affect-01
                  :ARG1 (e / express-03
                        :ARG2 (e2 / enzyme :name (n3 / name :op1 ""ERK1/2"")
                              :ARG1-of (a4 / activate-01)
                              :location (c / cell-line :name (n4 / name :op1 ""ES2""))))
                  :ARG0-of (d / depend-01
                        :ARG1 (d2 / dose))))
      :op2 (p / possible-01 :polarity -
            :ARG1 (d3 / detect-01
                  :ARG1 e2
                  :time (a5 / after
                        :op1 (t3 / treat-04
                              :ARG1 c
                              :ARG2 (s2 / small-molecule :name (n5 / name :op1 ""CI-1040"")
                                    :quant (c3 / concentration-quantity :quant 5
                                          :unit (m / micromolar))))
                        :quant (t2 / temporal-quantity :quant 6
                              :unit (h / hour)))))
      :ARG1-of (d4 / describe-01
            :ARG0 (f / figure :mod 4)))","Western blot analysis showed a dose-dependent effect on the expression of active ERK1/2 in ES2 cells, and active ERK1/2 was not detectable 6 h after treating the cells with CI-1040 at a concentration of 5 <i>μ</i><sc>M</sc> (<xref ref-type=""fig"" rid=""fig4"">Figure 4</xref>).","(z1 / and
    :op1 (z2 / show-01
             :ARG0 (z3 / analyze-01
                       :ARG1 (z4 / blot
                                 :mod (z5 / world-region
                                          :wiki ""Western_world""
                                          :name (z6 / name
                                                    :op1 ""West""))))
             :ARG1 (z7 / affect-01
                       :ARG0 (z8 / enzyme
                                 :wiki ""Erythropoietin""
                                 :name (z9 / name
                                           :op1 ""ERK1/2"")
                                 :ARG0-of (z10 / activity-06))
                       :ARG1 (z11 / express-03
                                  :ARG1 z8
                                  :location (z12 / cell
                                                 :wiki ""Escherichia_coli""
                                                 :name (z13 / name
                                                            :op1 ""ES2""))))
             :ARG0-of (z14 / depend-01
                           :ARG1 (z15 / dose))))",0.3789473684210526,0.4915254237288135,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG1 (a / analysis
                  :ARG1 (b / blot
                        :mod (w / western))
                  :ARG2 (e / effect-01
                        :ARG1 (d / dose-dependent)
                        :ARG2 (e2 / expression
                              :ARG1 (a2 / active
                                    :ARG1 (e3 / ERK1/2))))
                  :ARG3 (c / cell
                        :mod (e4 / ES2))))
        :snt2 (d / detect-01
            :ARG1 (a3 / active
                  :ARG1 (e5 / ERK1/2))
            :ARG2 (t / treat-01
                  :ARG1 (c2 / cell)
                  :ARG2 (c3 / CI-1040)
                  :ARG3 (c4 / concentration
                        :quant (n / number :op1 5)
                        :unit (m2 / micro)
                        :unit (m3 / M)))
            :time (a4 / after
                  :op1 (t2 / treat-01)
                  :op2 (n2 / number :op1 6)
                  :unit (h / hour))
            :polarity (n3 / not))
        :snt3 (r / refer
            :ARG1 (f / figure
                  :ARG1-of (x / xref
                        :ref-type ""fig""
                        :rid ""fig4"")
                  :op1 ""Figure 4"")))","(s / show-01
    :ARG0 (a / analyze-01
        :ARG0 (w / western-blot)
        :ARG1 (e / effect
            :mod (d / depend-01
                :ARG1 (d2 / dose))
            :ARG1-of (e2 / express-01
                :ARG1 (e3 / ERK1/2
                    :mod (a2 / active))
                :ARG2 (c / cell
                    :name (n / name :op1 ""ES2""))))))
    :ARG1 (a3 / and
        :op1 (d3 / detect-01
            :ARG1 e3
            :ARG2 c
            :time (a4 / after
                :op1 (t / treat-01
                    :ARG0 (t2 / time
                        :quant 6
                        :unit (h / hour))
                    :ARG1 c
                    :ARG2 (c2 / CI-1040))
                :op2 (c3 / concentrate-01
                    :ARG1 c2
                    :ARG2 (m / measure-01
                        :ARG1 (n2 / number :value 5)
                        :ARG2 (u / unit :name (n3 / name :op1 ""μM""))))))
        :op2 (r / refer-01
            :ARG1 (f / figure
                :name (n4 / name :op1 ""4"")))))",-1.0,-1.0
pmid_1956_8237.9,We identified Src as a kinase that is associated with ERK1/2 activation in UM.,"(i / identify-01
    :ARG0 (w / we)
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""Src""))
    :ARG2 (k / kinase
        :ARG1-of (a2 / associate-01
            :ARG2 (a / activate-01
                :ARG1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""ERK""
                        :op2 ""1/2""))
                :part-of (e3 / enzyme
                    :name (n3 / name
                        :op1 ""UM""))))))
",test,bio_amr0.8,"(i / identify-01
      :ARG0 (w / we)
      :ARG1 (p / protein :name (n / name :op1 ""Src""))
      :ARG2 (k / kinase
            :ARG1-of (a / associate-01
                  :ARG2 (a2 / activate-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
                        :location (m / medical-condition :name (n3 / name :op1 ""melanoma"")
                              :mod (u / uveal))))))",We identified Src as a kinase that is associated with ERK1/2 activation in UM.,"(z1 / identify-01
    :ARG0 (z2 / we)
    :ARG1 (z3 / small-molecule
              :wiki ""Selective_serotonin_reuptake_inhibitor""
              :name (z4 / name
                        :op1 ""Src""))
    :ARG2 (z5 / kinase
              :ARG1-of (z6 / associate-01
                           :ARG2 (z7 / activate-01
                                     :ARG1 (z8 / enzyme
                                               :wiki ""ERK1/2""
                                               :name (z9 / name
                                                         :op1 ""ERK1/2""))
                                     :location (z10 / enzyme
                                                    :wiki ""Mitogen-activated_protein_kinase""
                                                    :name (z11 / name
                                                               :op1 ""UM""))))))",0.6545454545454545,0.6037735849056604,"(i / identify-01
    :ARG0 (w / we)
    :ARG1 (k / kinase
        :ARG0-of (a / associate-01
            :ARG1 (s / Src))
        :ARG1-of (a2 / activate-01
            :ARG1 (e / ERK1/2)
            :ARG2 (u / UM))))","(i / identify-01
    :ARG0 (w / we)
    :ARG1 (s / Src)
    :ARG2 (k / kinase
        :ARG1-of (a / associate-01
            :ARG2 (a2 / and
                :op1 (e / ERK1/2)
                :op2 (a3 / activate-01
                    :ARG1 e))
            :location (u / UM))))",-1.0,-1.0
pmid_1956_8237.10,"However, low Src levels and reduced ERK1/2 activation in metastatic cell lines suggest that proliferation in metastases can become independent of Src and RAS/RAF/MEK/ERK signalling.","(c2 / contrast-01
    :ARG2 (s3 / suggest-01
        :ARG0 (a2 / and
            :op1 (l / level
                :ARG1-of (l4 / low-04))
            :op2 (r / reduce-01
                :ARG1 (a / activate-01
                    :ARG1 (e / enzyme
                        :name (n / name
                            :op1 ""ERK""))
                    :location (l2 / line
                        :mod (c / cell
                            :mod (m / metastatic)))
                    :mod ""1/2"")))
        :ARG1 (p / possible-01
            :ARG1 (b / become-01
                :ARG1 (p2 / proliferate-01
                    :ARG0 (l3 / location
                        :mod c))
                :ARG2 (d / depend-01
                    :ARG0 p2
                    :ARG1 (a3 / and
                        :op1 (d2 / disease
                            :name (n2 / name
                                :op1 ""RAS""))
                        :op2 (p3 / ""protein""
                            :name (n3 / name
                                :op1 ""RAF""))
                        :op2 (s / signal-07
                            :ARG0 e
                            :ARG1 a3)
                        :op3 (e2 / enzyme
                            :name (n4 / name
                                :op1 p3))
                        :op4 (e3 / enzyme
                            :name (n5 / name
                                :op1 ""MEK""))
                        :op5 (p4 / protein
                            :name (n6 / name
                                :op1 ""ERK""))
                        :op6 (s2 / signal-07
                            :ARG0 e
                            :ARG1 p4)))))))
",test,bio_amr0.8,"(h / have-concession-91
      :ARG1 (s / suggest-01
            :ARG0 (a / and
                  :op1 (l / level
                        :ARG1-of (l2 / low-04)
                        :quant-of (p / protein :name (n / name :op1 ""Src"")))
                  :op2 (a4 / activate-01
                        :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
                        :ARG1-of (r / reduce-01))
                  :location (c / cell-line
                        :ARG1-of (m / metastasize-101)))
            :ARG1 (p2 / possible-01
                  :ARG1 (b / become-01
                        :ARG1 (p3 / proliferate-01
                              :location m)
                        :ARG2 (d / depend-01 :polarity -
                              :ARG0 p3
                              :ARG1 (a3 / and
                                    :op1 p
                                    :op2 (s2 / signal-07
                                          :ARG0 (p4 / pathway :name (n3 / name :op1 ""RAS/RAF/MEK/ERK"")))))))))","However, low Src levels and reduced ERK1/2 activation in metastatic cell lines suggest that proliferation in metastases can become independent of Src and RAS/RAF/MEK/ERK signalling.","(z1 / contrast-01
    :ARG2 (z2 / suggest-01
              :ARG0 (z3 / and
                        :op1 (z4 / level
                                 :ARG1-of (z5 / low-04)
                                 :quant-of (z6 / small-molecule
                                               :wiki ""Selective_serotonin_reuptake_inhibitor""
                                               :name (z7 / name
                                                         :op1 ""Src"")))
                        :op2 (z8 / activate-01
                                 :ARG1 (z9 / enzyme
                                           :wiki ""ERK1/2""
                                           :name (z10 / name
                                                      :op1 ""ERK1/2""))
                                 :location (z11 / line
                                                :consist-of (z12 / cell
                                                                 :mod (z13 / metastatic)))))
              :ARG1-of (z14 / reduce-01))
    :ARG1 (z15 / possible-01
               :ARG1 (z16 / become-01
                          :ARG1 (z17 / proliferate-01
                                     :ARG0 z13)
                          :ARG2 (z18 / depend-01
                                     :polarity -
                                     :ARG0 z17
                                     :ARG1 (z19 / and
                                                :op1 (z20 / signal-07
                                                          :ARG0 (z21 / and
                                                                     :op1 z6
                                                                     :op2 (z22 / enzyme
                                                                               :wiki ""BRAF_(g3000 / gene)""
                                                                               :name (z23 / name
                                                                                          :op1 ""RAS""))
                                                                     :op3 (z24 / enzyme
                                                                               :wiki ""BRAF_(g3001 / gene)""
                                                                               :name (z25 / name
                                                                                          :op1 ""RAF""))
                                                                     :op4 (z26 / signal-07
                                                                               :ARG0 (z27 / enzyme
                                                                                          :wiki ""MEK""
                                                                                          :name (z28 / name
                                                                                                     :op1 ""MEK"")))
                                                                     :op5 (z29 / signal-07
                                                                               :ARG0 (z30 / enzyme
                                                                                          :wiki ""ERK""
                                                                                          :name (z31 / name
                                                                                                     :op1 ""ERK""))))))))))",0.4566929133858268,0.4628099173553719,"(m / multi-sentence
        :snt1 (s / suggest-01
            :ARG1 (l / level
                  :mod (s2 / Src))
            :ARG2 (a / activation
                  :ARG1 (e / ERK1/2))
            :ARG3 (p / proliferation
                  :ARG1-of (i / independent-02
                        :ARG2 (s3 / signalling
                              :ARG1-of (m2 / metastasis)
                              :mod (r / reduced
                                    :ARG1 (l2 / level
                                          :mod (e2 / ERK1/2)
                                          :mod (c / cell
                                                :mod (m3 / metastatic))))))))
        :snt2 (b / become-01
            :ARG1 (p2 / proliferation
                  :ARG1-of (i2 / independent-02
                        :ARG2 (s4 / signalling
                              :ARG1-of (m4 / metastasis)
                              :mod (r2 / reduced
                                    :ARG1 (l3 / level
                                          :mod (e3 / ERK1/2)
                                          :mod (c2 / cell
                                                :mod (m5 / metastatic))))))))","(h / however
    :op1 (a / and
        :op1 (r / reduce-01
            :ARG1 (a2 / activate-01
                :ARG1 (e / ERK1/2)
                :ARG0 (l / level
                    :degree (l2 / low)
                    :domain (s / Src))))
        :op2 (s2 / suggest-01
            :ARG0 (l3 / line
                :mod (c / cell)
                :mod (m / metastatic))
            :ARG1 (b / become-01
                :ARG1 (p / proliferate-01
                    :location (m2 / metastasis))
                :ARG2 (i / independent
                    :domain (a3 / and
                        :op1 (s3 / Src)
                        :op2 (s4 / signal-01
                            :ARG1 (a4 / and
                                :op1 (r2 / RAS)
                                :op2 (r3 / RAF)
                                :op3 (m3 / MEK)
                                :op4 (e2 / ERK)))))))))",-1.0,-1.0
pmid_1956_8237.93,"<sec-title level=""2"">ERK1/2 activation in UM</sec-title>","(a / activate-01
    :ARG1 (r / reactor
        :name (n / name)
        :ARG1-of (s / secure-02))
    :mod (p / product-of
        :op1 ""1/2"")
    :rel 2)
",test,bio_amr0.8,"(a / activate-01
      :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2""))
      :location (m / medical-condition :name (n2 / name :op1 ""melanoma"")
            :mod (u / uveal)))","<sec-title level=""2"">ERK1/2 activation in UM</sec-title>","(z1 / activate-01
    :ARG1 (z2 / enzyme
              :wiki ""ERK1/2""
              :name (z3 / name
                        :op1 ""ERK1/2""))
    :ARG2 (z4 / enzyme
              :wiki ""Mitogen-activated_protein_kinase""
              :name (z5 / name
                        :op1 ""UM"")))",0.4285714285714285,0.3846153846153846,"(e / erk1/2-activation
    :ARG1 (u / um))","(a / activate-01
    :ARG1 (e / ERK1/2)
    :location (u / UM)
    :medium (t / text
        :mod (s / section
            :level 2)))",-1.0,-1.0
pmid_1956_8237.96,"UMs displaying activated ERK1/2 as well as phosphorylated HSP27 were most common, whereas signals for phosphorylated ERK1/2 were low in metastasis tissue (MET1-3) and metastatic UM cell lines (OMM1, OMM2.3 and OMM2.5) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(c3 / contrast-01
    :ARG1 (h / have-degree-91
        :ARG1 (a2 / and
            :op1 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2"")
                :ARG1-of (a / activate-01))
            :op2 (p3 / protein
                :name (n3 / name
                    :op1 ""HSP27"")
                :ARG1-of (p / phosphorylate-01)))
        :ARG2 (c2 / common)
        :ARG3 (m3 / most))
    :ARG2 (l4 / low-04
        :ARG1 (s / signal-07
            :ARG1 (e2 / enzyme
                :name (n2 / name
                    :op1 ""ERK""
                    :op2 ""1/2""
                    :op2 ""wise"")))
        :location (a3 / and
            :op1 (t / tissue
                :mod (m / metastasis))
            :op2 (l / line
                :name (n6 / name
                    :op1 ""UM"")
                :mod (c / cell))
            :op2 (a4 / and
                :op1 (l2 / line
                    :name c
                    :name (n7 / name
                        :op1 ""OMM1""))
                :op2 l2
                :op3 (l3 / line
                    :name (n8 / name
                        :op1 ""OMM""
                        :op2 ""2.3"")
                    :mod 2.5))))
    :ARG2 (f / figure
        :mod 1)
    :rel (p4 / protein
        :name (n4 / name)
        :name (n5 / name
            :op1 ""MET""
            :op2 ""1-3"")
        :ARG1-of (p2 / phosphorylate-01))
    :rel (d / display-01)
    :rel (m2 / metastatic))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (c2 / common
            :domain (m4 / medical-condition :name (n / name :op1 ""melanoma"")
                  :mod (u / uveal)
                  :ARG0-of (d2 / display-01
                        :ARG1 (a / and
                              :op1 (e / enzyme :name (n2 / name :op1 ""ERK1/2"")
                                    :ARG1-of (a2 / activate-01))
                              :op2 (p2 / protein :name (n3 / name :op1 ""HSP27"")
                                    :ARG3-of (p / phosphorylate-01)))))
            :degree (m / most))
      :ARG2 (l / low-04
            :ARG1 (s / signal-07
                  :beneficiary (e2 / enzyme :name (n4 / name :op1 ""ERK1/2"")
                        :ARG3-of (p3 / phosphorylate-01)))
            :location (a3 / and
                  :op1 (t / tissue
                        :ARG1-of (m2 / metastasize-101)
                        :ARG1-of (l2 / label-01
                              :ARG2 (t2 / thing :name (n5 / name :op1 ""MET"")
                                    :value (v / value-interval :op1 1 :op2 3))))
                  :op2 (c3 / cell-line
                        :mod m4
                        :mod m2
                        :ARG1-of (m3 / mean-01
                              :ARG2 (a4 / and
                                    :op1 (c4 / cell-line :name (n6 / name :op1 ""OMM1""))
                                    :op2 (c5 / cell-line :name (n7 / name :op1 ""OMM2.3""))
                                    :op3 (c6 / cell-line :name (n8 / name :op1 ""OMM2.5"")))))))
      :ARG1-of (d3 / describe-01
            :ARG0 (f / figure :mod 1)))","UMs displaying activated ERK1/2 as well as phosphorylated HSP27 were most common, whereas signals for phosphorylated ERK1/2 were low in metastasis tissue (MET1-3) and metastatic UM cell lines (OMM1, OMM2.3 and OMM2.5) (<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>).","(z1 / contrast-01
    :ARG1 (z2 / have-degree-91
              :ARG1 (z3 / display-01
                        :ARG0 (z4 / enzyme
                                  :wiki ""Umegla_(m3000 / multivitamin)""
                                  :name (z5 / name
                                            :op1 ""UMs"")
                                  :ARG0-of (z6 / display-01
                                               :ARG1 (z7 / and
                                                         :op1 (z8 / enzyme
                                                                  :wiki ""ERK1/2""
                                                                  :name (z9 / name
                                                                            :op1 ""ERK1/2"")
                                                                  :ARG1-of (z10 / activate-01))
                                                         :op2 (z11 / enzyme
                                                                   :wiki ""HSP27""
                                                                   :name (z12 / name
                                                                              :op1 ""HSP27"")
                                                                   :ARG1-of (z13 / phosphorylate-01))))))
              :ARG2 (z14 / common)
              :ARG3 (z15 / most))
    :ARG2 (z16 / low-04
               :ARG1 (z17 / signal-07
                          :ARG1 (z18 / enzyme
                                     :wiki ""ERK1/2""
                                     :name (z19 / name
                                                :op1 ""ERK1/2"")
                                     :ARG1-of (z20 / phosphorylate-01)))
               :location (z21 / and
                              :op1 (z22 / tissue
                                        :ARG0-of (z23 / metastase-01)
                                        :example (z24 / enzyme
                                                      :wiki ""Mitogen-activated_protein_kinase_1/3""
                                                      :name (z25 / name
                                                                 :op1 ""MET1-3"")))
                              :op2 (z26 / cell-line
                                        :wiki ""OMM1/3""
                                        :name (z27 / name
                                                   :op1 ""OMM1""
                                                   :op2 "",""
                                                   :op3 ""OMM2.3""
                                                   :op4 ""and""
                                                   :op5 ""OMM2.5"")
                                        :ARG0-of (z28 / display-01
                                                      :ARG1 (z29 / cell
                                                                 :mod z5)))))
    :ARG1-of (z30 / describe-01
                  :ARG0 (z31 / figure
                             :mod 1
                             :ARG1-of (z32 / hyperlink-91
                                           :ARG3 (z33 / url-entity
                                                      :value ""ref-type=fig"")))))",0.4117647058823529,0.3614457831325302,"(m / multi-sentence
        :snt1 (d / display-01
            :ARG0 (u / um)
            :ARG1 (a / activate-01
                  :ARG0 (e / erk1/2)
                  :ARG1 (p / phosphorylate-01
                        :ARG1 (h / hsp27))))
        :snt2 (c / common-01
            :ARG1 (m2 / most)
            :ARG2 (s / signal-01
                  :ARG1 (p2 / phosphorylate-01
                        :ARG1 (e2 / erk1/2))))
        :snt3 (l / low-02
            :ARG1 (s2 / signal-01
                  :ARG1 p2)
            :ARG2 (t / tissue
                  :mod (m3 / metastasis)))
        :snt4 (l2 / low-02
            :ARG1 s2
            :ARG2 (l3 / line
                  :mod (c2 / cell
                        :mod (u2 / um
                              :mod (m4 / metastatic)))))
        :snt5 (r / reference
            :ARG1 (f / figure
                  :ARG1 (n / number :op1 ""1""))
            :ARG2 (x / xref
                  :ARG1 f)))","(d / display-01
    :ARG0 (u / UM)
    :ARG1 (a / and
        :op1 (e / ERK1/2
            :mod (a2 / activate-01))
        :op2 (h / HSP27
            :mod (p / phosphorylate-01)))
    :ARG1-of (c / common-02
        :degree (m / most))
    :contrast (s / signal
        :ARG1 (e2 / ERK1/2
            :mod (p2 / phosphorylate-01))
        :location (a3 / and
            :op1 (t / tissue
                :mod (m2 / metastasis)
                :name (n / name :op1 ""MET1-3""))
            :op2 (l / line
                :mod (c2 / cell)
                :mod (m3 / metastatic)
                :mod (u2 / UM)
                :name (n2 / name :op1 ""OMM1"" :op2 ""OMM2.3"" :op3 ""OMM2.5"")))
        :degree (l2 / low))
    :medium (f / figure
        :name (n3 / name :op1 ""1"")))",-1.0,-1.0
pmid_1956_8237.97,"Remarkably, two of the metastatic cell lines (OMM2.3, OMM2.5) are derived from the same patient as cell line Mel270 but contained far less activated ERK1/2.","(r / remarkable-02
    :ARG0 (d / derive-01
        :ARG1 (l2 / line
            :quant 2
            :ARG1-of (i / include-91
                :ARG2 (l3 / line
                    :name (n / name
                        :op2 ""2.3"")
                    :name (n2 / name
                        :op1 ""OMM""
                        :op2 ""2.5"")
                    :mod (c / cell)
                    :mod (m / metastatic)))
            :mod (c2 / cell))
        :ARG1-of (c5 / contrast-01
            :ARG2 (c4 / contain-01
                :ARG0 l2
                :ARG1 (e / enzyme
                    :name (n4 / name
                        :op1 ""ERK""
                        :op2 ""1/2"")
                    :ARG1-of (h / have-quant-91
                        :ARG2 (a / activate-01
                            :ARG1 e)
                        :ARG3 (l / less
                            :quant (f / far))))))
        :ARG2 (p / patient
            :ARG1-of (s / same-01
                :ARG2 (l4 / line
                    :name (n3 / name
                        :op1 ""Mel""
                        :op2 270)
                    :mod (c3 / cell))))))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (d / derive-01
            :ARG1 (c2 / cell-line :quant 2
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a / and
                              :op1 (c4 / cell-line :name (n / name :op1 ""OMM2.3""))
                              :op2 (c5 / cell-line :name (n2 / name :op1 ""OMM2.5"")))
                        :ARG1-of (m / metastasize-101))
                  :ARG1-of (i / include-91
                        :ARG2 (c3 / cell-line)))
            :ARG2 (p / person
                  :ARG0-of (h / have-rel-role-91
                        :ARG2 (p2 / patient))
                  :ARG1-of (s / same-01))
            :ARG4 (c6 / cell-line :name (n3 / name :op1 ""Mel270"")))
      :ARG2 (c7 / contain-01
            :ARG0 c2
            :ARG1 (e / enzyme :name (n4 / name :op1 ""ERK1/2"")
                  :ARG1-of (a2 / activate-01)
                  :quant (l / less
                        :degree (f / far))))
      :ARG1-of (r / remarkable-02))","Remarkably, two of the metastatic cell lines (OMM2.3, OMM2.5) are derived from the same patient as cell line Mel270 but contained far less activated ERK1/2.","(z1 / contrast-01
    :ARG1 (z2 / derive-01
              :ARG1 (z3 / cell-line
                        :quant 2
                        :ARG1-of (z4 / include-91
                                     :ARG2 (z5 / cell-line
                                               :wiki ""Omelebrus_erythrocyte""
                                               :name (z6 / name
                                                         :op1 ""OMM2.3"")
                                               :ARG1-of (z7 / metastate-01
                                                            :ARG1 z9)))
                        :ARG1-of (z8 / include-91
                                     :ARG2 (z9 / cell-line
                                               :wiki ""Omelebrus_erythrocyte""
                                               :name (z10 / name
                                                          :op1 ""OMM2.5""))))
              :ARG2 (z11 / patient
                         :ARG1-of (z12 / same-01
                                       :ARG2 (z13 / cell-line
                                                  :wiki ""Mel270""
                                                  :name (z14 / name
                                                             :op1 ""Mel270""))))))",0.3695652173913044,0.3392857142857143,"(r / remarkably
        :ARG1 (d / derive-01
              :ARG0 (l / line
                    :mod (c / cell
                          :mod (m / metastatic))
                    :ARG1 (n / name :op1 ""OMM2.3""))
              :ARG1 (p / patient
                    :mod (s / same)
                    :ARG1-of (l2 / line
                          :mod (c2 / cell
                                :mod (m2 / metastatic))
                          :ARG1 (n2 / name :op1 ""Mel270""))))
        :ARG2 (c3 / contain-01
              :ARG1 l
              :ARG2 (e / ERK1/2
                    :mod (a / activate-01
                          :ARG1 (f / far)
                          :ARG2 (l3 / less)))))","(r / remarkable-01
    :ARG1 (d / derive-01
        :ARG1 (c / cell-line
            :name (n / name :op1 ""OMM2.3"" :op2 ""OMM2.5"")
            :mod (m / metastatic))
        :ARG2 (p / patient
            :ARG0-of (h / have-03
                :ARG1 (c2 / cell-line
                    :name (n2 / name :op1 ""Mel270""))))
        :ARG1-of (c3 / contain-01
            :ARG2 (e / ERK1/2
                :ARG1-of (a / activate-01)
                :quant (l / less
                    :degree (f / far))))))",-1.0,-1.0
pmid_1956_8237.99,Reduction of ERK1/2 activation in metastatic cell lines compared with that in primary UM cell lines provides a model to identify the underlying mechanism of ERK1/2 activation in the absence of <i>BRAF</i> and <i>NRAS</i> mutations.,"(p2 / provide-01
    :ARG0 (r / reduce-01
        :ARG1 (a2 / activate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op1 ""ERK""
                    :op2 ""1/2"")))
        :ARG1-of (c2 / compare-01
            :ARG2 (a3 / activate-01))
        :location (l / line
            :mod (c / carrier
                :name (n2 / name
                    :op1 ""UM"")
                :mod (p / primary)
                :mod (l3 / location
                    :name (n3 / name
                        :op1 ""i"")
                    :op2 (m4 / mutate-01
                        :ARG1 l3)))))
    :ARG1 (m2 / model
        :purpose (i / identify-01
            :ARG1 (m / mechanism
                :ARG0-of (u / underlie-01)
                :mod (a4 / activate-01
                    :ARG1 e
                    :condition (a / absent-01
                        :ARG1 (a5 / and
                            :op1 (m3 / mutate-01
                                :ARG2 e)))))))
    :rel (o / option
        :name n3)
    :rel (l2 / load))
",test,bio_amr0.8,"(p / provide-01
      :ARG0 (r / reduce-01
            :ARG1 (a / activate-01
                  :ARG1 (e / enzyme :name (n / name :op1 ""ERK1/2""))
                  :location (c / cell-line
                        :ARG1-of (m / metastasize-101)))
            :ARG1-of (c2 / compare-01
                  :ARG2 (r2 / reduce-01
                        :ARG1 a
                        :location (c3 / cell-line
                              :mod (m6 / medical-condition :name (n2 / name :op1 ""melanoma"")
                                    :mod (u / uveal)
                                    :mod (p2 / primary))))))
      :ARG1 (m2 / model-01
            :purpose (i / identify-01
                  :ARG1 (m3 / mechanism
                        :ARG1-of (u2 / underlie-01)
                        :mod (a2 / activate-01
                              :ARG1 e
                              :condition (a3 / absent-01
                                    :ARG1 (a4 / and
                                          :op1 (m4 / mutate-01
                                                :ARG1 (g / gene :name (n3 / name :op1 ""BRAF"")))
                                          :op2 (m5 / mutate-01
                                                :ARG1 (g2 / gene :name (n4 / name :op1 ""NRAS""))))))))))",Reduction of ERK1/2 activation in metastatic cell lines compared with that in primary UM cell lines provides a model to identify the underlying mechanism of ERK1/2 activation in the absence of <i>BRAF</i> and <i>NRAS</i> mutations.,"(z1 / provide-01
    :ARG0 (z2 / reduce-01
              :ARG1 (z3 / activate-01
                        :ARG1 (z4 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z5 / name
                                            :op1 ""ERK1/2""))
                        :location (z6 / line
                                      :mod (z7 / cell
                                               :mod (z8 / metastatic))))
              :ARG1-of (z9 / compare-01
                           :ARG2 (z10 / activate-01
                                      :ARG1 z4
                                      :location (z11 / line
                                                     :mod (z12 / cell
                                                               :mod (z13 / primary)
                                                               :mod (z14 / cell
                                                                         :wiki ""Mitogen-activated_protein_kinase""
                                                                         :name (z15 / name
                                                                                    :op1 ""UM""))))))))",0.3789473684210526,0.5689655172413793,"(m / multi-sentence
        :snt1 (c / compare-01
            :ARG1 (a / activate-01
                  :ARG0 (e / ERK1/2)
                  :ARG1 (l / line
                        :mod (m2 / metastatic))
                  :ARG1-of (c2 / compare-01
                        :ARG2 (l2 / line
                              :mod (p / primary)
                              :ARG1-of (u / UM))))
            :ARG2 (m3 / model
                  :ARG1 (i / identify-01
                        :ARG1 (m4 / mechanism
                              :ARG1-of (a2 / activate-01
                                    :ARG0 (e2 / ERK1/2)
                                    :ARG1 (l3 / line
                                          :mod (u2 / underlying)
                                          :ARG1-of (i2 / in
                                                :ARG2 (a3 / absence
                                                      :op1 (b / BRAF)
                                                      :op2 (n / NRAS)
                                                      :mod (m5 / mutation))))))))
        :snt2 (p2 / provide-01
            :ARG0 (r / reduction
                  :ARG1 (a4 / activate-01
                        :ARG0 (e3 / ERK1/2)
                        :ARG1 (l4 / line
                              :mod (m6 / metastatic))))
            :ARG1 (m7 / model
                  :ARG1 (i3 / identify-01
                        :ARG1 (m8 / mechanism
                              :ARG1-of (a5 / activate-01
                                    :ARG0 (e4 / ERK1/2)
                                    :ARG1 (l5 / line
                                          :mod (u3 / underlying)
                                          :ARG1-of (i4 / in
                                                :ARG2 (a6 / absence
                                                      :op1 (b2 / BRAF)
                                                      :op2 (n2 / NRAS)
                                                      :mod (m9 / mutation)))))))))","(r / reduce-01
    :ARG1 (a / activate-01
        :ARG0 (e / ERK1/2)
        :ARG1 (c / cell-line
            :mod (m / metastatic)))
    :ARG2 (a2 / activate-01
        :ARG0 e
        :ARG1 (c2 / cell-line
            :mod (p / primary)
            :mod (u / UM)))
    :purpose (p2 / provide-01
        :ARG1 (m2 / model
            :purpose (i / identify-01
                :ARG1 (m3 / mechanism
                    :mod (u2 / underlying)
                    :ARG1-of (a3 / activate-01
                        :ARG0 e
                        :ARG1 (c3 / cell-line
                            :mod (a4 / absent)
                            :ARG1-of (m4 / mutation-01
                                :ARG1 (b / BRAF)
                                :ARG2 (n / NRAS)))))))))",-1.0,-1.0
pmid_1956_8237.109,"We added PP1 and PP2 (10 <i>μ</i><sc>M</sc>) to lysates of primary UM tissue and of a primary UM cell line and measured the inhibitory effect of these Src inhibitors using kinase array (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(a5 / and
    :ARG1-of (d / describe-01
        :ARG0 (f / figure
            :mod 3))
    :op1 (a / add-02
        :ARG0 (w / we)
        :ARG1 (a3 / and
            :op1 (p2 / protein
                :name (n / name
                    :op1 ""PP1""))
            :op2 (p3 / protein
                :name (n2 / name
                    :op1 ""PP2""
                    :op3 ""phosphate"")))
        :ARG2 (a4 / and
            :op1 (s / site
                :name (n3 / name
                    :op1 ""fund""
                    :op2 ""of"")
                :part-of (t2 / tissue
                    :mod (d2 / disease
                        :name (n4 / name
                            :op1 ""UM""))
                    :mod (p / primary)))
            :op2 (l / line
                :mod (c / cell
                    :mod d2)
                :mod d2)))
    :op2 (m / measure-01
        :ARG0 w
        :ARG1 (a2 / affect-01
            :ARG2 (i / inhibit-01))
        :instrument (u / use-01
            :ARG1 (a6 / array
                :instrument-of (i2 / inhibit-01
                    :ARG1 (s2 / small-molecule
                        :name (n5 / name
                            :op1 ""Src"")))
                :mod (k / kinase))))
    :rel (t / this)
    :rel 10)
",test,bio_amr0.8,"(a / and
      :op1 (a2 / add-02
            :ARG0 (w / we)
            :ARG1 (a3 / and
                  :op1 (s / small-molecule)
                  :op2 (s2 / small-molecule)
                  :quant (c2 / concentration-quantity :quant 10
                        :unit (m / micromolar)))
            :ARG2 (a7 / and
                  :op1 (l / lysate
                        :source (t / tissue
                              :mod (m3 / medical-condition :name (n3 / name :op1 ""melanoma"")
                                    :mod (u / uveal)
                                    :mod (p / primary))))
                  :op1 (l2 / lysate
                        :source (c / cell-line
                              :mod m3))))
      :op2 (m2 / measure-01
            :ARG0 w
            :ARG1 (a5 / affect-01
                  :ARG0 (s3 / small-molecule
                        :ARG0-of (i2 / inhibit-01
                              :ARG1 (p2 / protein-family :name (n4 / name :op1 ""Src""))))
                  :ARG2 (i / inhibit-01))
            :instrument (a6 / array-01
                  :ARG1 (k / kinase)))
      :ARG1-of (d2 / describe-01
            :ARG0 (f / figure :mod ""3A"")))","We added PP1 and PP2 (10 <i>μ</i><sc>M</sc>) to lysates of primary UM tissue and of a primary UM cell line and measured the inhibitory effect of these Src inhibitors using kinase array (<xref ref-type=""fig"" rid=""fig3"">Figure 3A</xref>).","(z1 / and
    :op1 (z2 / add-02
             :ARG0 (z3 / we)
             :ARG1 (z4 / and
                       :op1 (z5 / enzyme
                                :wiki ""Cyclin-dependent_protein""
                                :wiki ""PP1""
                                :name (z6 / name
                                          :op1 ""PP1""))
                       :op2 (z7 / enzyme
                                :wiki ""PP2""
                                :name (z8 / name
                                          :op1 ""PP2""))
                       :ARG1-of (z9 / equal-01
                                    :ARG2 (z10 / molecular-mass
                                               :quant 10
                                               :unit (z11 / microsievert))))
             :ARG2 (z12 / and
                        :op1 (z13 / tissue
                                  :part-of (z14 / cell
                                                :mod (z15 / primary)
                                                :part-of (z16 / university
                                                              :wiki ""University_of_Maryland""
                                                              :name (z17 / name
                                                                         :op1 ""UM""))))
                        :op2 (z18 / line
                                  :consist-of (z19 / cell
                                                   :mod z15)))))",0.3148148148148148,0.5230769230769231,"(m / multi-sentence
        :snt1 (a / add-01
            :ARG0 (w / we)
            :ARG1 (p / pp1)
            :ARG2 (p2 / pp2
                  :quant (m2 / million)))
        :snt2 (l / lysate-01
            :ARG0 (t / tissue
                  :mod (u / um
                        :mod (p2 / primary)))
            :ARG1 (c / cell-line
                  :mod (u2 / um
                        :mod (p3 / primary))))
        :snt3 (m3 / measure-01
            :ARG0 (i / inhibit-01
                  :ARG1 (e / effect
                        :mod (i2 / inhibitory)))
            :ARG1 (a2 / array
                  :ARG0 (k / kinase)
                  :ARG1 (f / figure
                        :op1 ""3A"")))
        :snt4 (u3 / use-01
            :ARG0 (i3 / inhibitor
                  :mod (s / src))
            :ARG1 a2))","(a / add-01
    :ARG0 (w / we)
    :ARG1 (m / molecule
        :name (n / name :op1 ""PP1"")
        :mod (m2 / molecule
            :name (n2 / name :op1 ""PP2"")
            :quant (q / quantity
                :unit (u / unit :name (n3 / name :op1 ""μM""))
                :value 10))))
    :ARG2 (l / lysate
        :source (t / tissue
            :mod (u2 / um-01)
            :mod (p / primary))
        :source (c / cell-line
            :mod (u3 / um-01)
            :mod (p2 / primary)))
    :ARG3 (m3 / measure-01
        :ARG0 w
        :ARG1 (e / effect
            :mod (i / inhibit-01
                :ARG1 (k / kinase
                    :mod (a / array))
                :ARG0 (m4 / molecule
                    :name (n4 / name :op1 ""Src"")
                    :mod (i2 / inhibitor-01))))
        :instrument (r / refer-01
            :ARG1 (f / figure
                :name (n5 / name :op1 ""3A""))
            :mode (x / external))))",-1.0,-1.0
pmid_1956_8237.112,"The peptide representing FAK1 Y576/Y577 is a genuine substrate for Src, which was not detected in the UM cell line comparison, but phosphorylation was significantly downregulated by PP1 and PP2 treatments.","(s2 / substrate
    :beneficiary (e / enzyme
        :name (n2 / name
            :op1 ""Src""))
    :domain (p / peptide
        :name (n / name
            :op1 ""FAK1""
            :op2 ""basic""
            :op3 577)
        :ARG0-of (r / represent-01)
        :ARG1-of (d / detect-01
            :ARG1-of (c3 / contrast-01
                :ARG2 (d2 / down-03
                    :ARG0 (a / and
                        :ARG2-of (t / treat-04)
                        :op1 (p3 / protein
                            :name (n4 / name
                                :op1 ""PP1""))
                        :op2 (p4 / protein
                            :name (n5 / name
                                :op1 ""PP2"")))
                    :ARG1 (p2 / phosphorylate-01)
                    :ARG1-of (s / significant-02)))
            :location (c2 / compare-01
                :ARG1 (l / line
                    :name (n3 / name
                        :op1 ""UM"")
                    :mod (c / cell)))
            :polarity -))
    :mod (g / genuine))
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (s / substrate
            :mod (g / genuine)
            :domain (p / peptide
                  :ARG0-of (r / represent-01
                        :ARG1 (o / or
                              :op1 (a / amino-acid :mod 576 :name (n / name :op1 ""tyrosine""))
                              :op2 (a2 / amino-acid :mod 577 :name (n2 / name :op1 ""tyrosine""))
                              :part-of (e / enzyme :mod 1 :name (n3 / name :op1 ""FAK"")))))
            :beneficiary (p2 / protein :name (n4 / name :op1 ""Src""))
            :ARG1-of (d / detect-01 :polarity -
                  :time (c2 / compare-01
                        :ARG1 (c3 / cell-line
                              :mod (m / medical-condition :name (n5 / name :op1 ""melanoma"")
                                    :mod (u / uveal))))))
      :ARG2 (d3 / downregulate-01
            :ARG1 (p3 / phosphorylate-01)
            :ARG2 (t / treat-04
                  :ARG2 (a3 / and
                        :op1 (p4 / protein :name (n6 / name :op1 ""PP1""))
                        :op2 (p5 / protein :name (n7 / name :op1 ""PP2""))))
            :ARG1-of (s4 / significant-02)))","The peptide representing FAK1 Y576/Y577 is a genuine substrate for Src, which was not detected in the UM cell line comparison, but phosphorylation was significantly downregulated by PP1 and PP2 treatments.","(z1 / contrast-01
    :ARG1 (z2 / substrate
              :mod (z3 / genuine)
              :domain (z4 / peptide
                          :ARG0-of (z5 / represent-01
                                       :ARG1 (z6 / enzyme
                                                 :wiki ""Fibroblast_growth_factor_receptor_1""
                                                 :name (z7 / name
                                                           :op1 ""FAK1""
                                                           :op2 ""Y576/Y577""))))
              :purpose (z8 / enzyme
                           :wiki ""Selective_protein_receptor""
                           :name (z9 / name
                                     :op1 ""Src"")
                           :ARG1-of (z10 / detect-01
                                         :polarity -
                                         :ARG0 (z11 / compare-01
                                                    :ARG1 (z12 / cell-line
                                                               :wiki ""Mitogen-activated_protein_kinase""
                                                               :name (z13 / name
                                                                          :op1 ""UM""
                                                                          :op2 ""cell""
                                                                          :op3 ""line"")))))))",0.3333333333333333,0.423728813559322,"(m / multi-sentence
        :snt1 (r / represent-01
            :ARG0 (p / peptide)
            :ARG1 (f / FAK1
                  :ARG1-of (y / Y576/Y577)))
        :snt2 (s / substrate-01
            :ARG0 p
            :ARG1 (s2 / src)
            :mod (g / genuine))
        :snt3 (d / detect-01
            :ARG0 s2
            :ARG1 (c / comparison
                  :ARG1-of (l / line
                        :mod (u / UM))))
        :snt4 (d2 / downregulate-01
            :ARG0 (p2 / phosphorylation)
            :ARG1 (t / treatment
                  :ARG1-of (p3 / PP1))
            :ARG1-of (t2 / treatment
                  :ARG1-of (p4 / PP2))))","(p / peptide
    :mod (r / represent-01
        :ARG1 (f / FAK1
            :mod (y / Y576/Y577)))
    :ARG1-of (s / substrate-01
        :ARG2 (g / genuine)
        :ARG0 (s2 / Src))
    :ARG1-of (d / detect-01
        :polarity -
        :location (c / comparison
            :ARG1 (l / line
                :mod (c2 / cell)
                :mod (u / UM))))
    :ARG1-of (p2 / phosphorylate-01
        :ARG1-of (d2 / downregulate-01
            :degree (s3 / significant)
            :instrument (a / and
                :op1 (t / treatment
                    :mod (p3 / PP1))
                :op2 (t2 / treatment
                    :mod (p4 / PP2))))
        :ARG1-of (c3 / contrast-01)))",-1.0,-1.0
pmid_1991_9690.11,"There is a high level of ERK1/2 phosphorylation in WM9 cells, indicating an activated Ras-Raf-MEK-ERK1/2 MAPK pathway.","(p / phosphorylate-01
    :ARG0-of (i / indicate-01
        :ARG1 (e2 / enzyme
            :name (n2 / name
                :op1 ""B-Raf""
                :op2 ""MAPK""
                :op3 ""pathway"")
            :ARG1-of (a / activate-01)))
    :ARG1 (e / enzyme
        :name (n / name
            :op1 ""ERK""
            :op2 ""1/2""))
    :location (c / cell
        :name (n3 / name
            :op1 ""WM9""))
    :mod (l / level
        :ARG1-of (h / high-02))
    :rel ""1/2"")
",test,bio_amr0.8,"(l2 / level
      :ARG1-of (h / high-02)
      :quant-of (p / phosphorylate-01
            :ARG1 (e / enzyme :name (n2 / name :op1 ""ERK1/2""))
            :location (c / cell-line :name (n3 / name :op1 ""WM9"")))
      :ARG0-of (i / indicate-01
            :ARG1 (p3 / pathway :name (n4 / name :op1 ""Ras-Raf-MEK-ERK1/2"" :op2 ""MAPK"")
                  :ARG1-of (a / activate-01))))","There is a high level of ERK1/2 phosphorylation in WM9 cells, indicating an activated Ras-Raf-MEK-ERK1/2 MAPK pathway.","(z1 / phosphorylate-01
    :ARG1 (z2 / enzyme
              :wiki ""Extracellular_signal–regulated_kinase_1/2""
              :name (z3 / name
                        :op1 ""ERK1/2""
                        :op2 ""phosphorylate""
                        :op3 ""phosphorylate""))
    :location (z4 / cell
                  :wiki ""Mitogen-activated_protein_kinase""
                  :name (z5 / name
                            :op1 ""WM9""))
    :ARG0-of (z6 / indicate-01
                 :ARG1 (z7 / activate-01
                           :ARG1 (z8 / pathway
                                     :wiki ""BRAF/MEK""
                                     :name (z9 / name
                                               :op1 ""Ras-Raf-MEK-ERK1/2""
                                               :op2 ""MAPK"")))))",0.4150943396226415,0.5454545454545454,"(s / sentence
        :snt (i / indicate-01
              :ARG1 (l / level
                    :mod (h / high))
              :ARG2 (p / phosphorylation
                    :ARG1 (e / ERK1/2))
              :ARG3 (c / cell
                    :mod (w / WM9)))
        :snt (a / activate-01
              :ARG0 (p2 / pathway
                    :mod (m / MAPK
                          :mod (e2 / ERK1/2
                                :mod (r / Ras-Raf-MEK-ERK1/2))))))","(e / exist-01
    :ARG1 (l / level
        :degree (h / high)
        :topic (p / phosphorylate-01
            :ARG1 (e2 / ERK1/2))
        :location (c / cell
            :name (n / name :op1 ""WM9""))))
    :condition (i / indicate-01
        :ARG1 (a / activate-01
            :ARG1 (p2 / pathway
                :name (n2 / name :op1 ""Ras-Raf-MEK-ERK1/2"" :op2 ""MAPK"")))))",-1.0,-1.0
pmid_1991_9690.61,"Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref> shows that human melanoma cell lines express both full-length and the 785 splice variant HIF-1α mRNA at a level that appeared to be higher than normal human melanocytes.","(s / show-01
    :ARG0 (f / figure)
    :ARG1 (e / express-01
        :quant (l / level
            :ARG1-of (h2 / high-02
                :ARG1-of (a / appear-02)
                :ARG2-of (h / have-degree-91
                    :ARG1 l
                    :ARG3 (m2 / more)
                    :ARG4 (c2 / cell
                        :ARG1-of (n3 / normal-02)
                        :mod (h3 / human)))))
        :ARG0 (l2 / line
            :consist-of (c / cell
                :mod h3))
        :ARG1 (o / organization
            :name (n2 / name
                :op1 785
                :op2 (m3 / ""mutate-01""
                    :ARG2 (s2 / splice)))
            :ARG1-of m3
            :mod (l3 / long-03
                :mod (f2 / full))))
    :rel (n / name
        :op1 ""Dem""
        :op2 ""mRNA"")
    :rel (m / melanoma))
",test,bio_amr0.8,"(s / show-01
      :ARG0 (f / figure :mod ""2B"")
      :ARG1 (e / express-03
            :ARG2 (a / and
                  :op1 (n6 / nucleic-acid :name (n2 / name :op1 ""mRNA"")
                        :ARG0-of (e2 / encode-01
                              :ARG1 (p / protein :name (n3 / name :op1 ""HIF-1α"")
                                    :ARG1-of (l3 / long-03
                                          :degree (f2 / full)))))
                  :op2 (n7 / nucleic-acid :name (n4 / name :op1 ""mRNA"")
                        :ARG0-of (e3 / encode-01
                              :ARG1 (v / variant
                                    :ARG1-of (s2 / splice-01)
                                    :ARG1-of (m2 / mean-01
                                          :ARG2 (p2 / protein :name (n5 / name :op1 ""HIF-1α785"")))))))
            :ARG3 (c / cell-line
                  :mod (m4 / medical-condition :name (n / name :op1 ""melanoma""))
                  :mod (h2 / human))
            :manner (l2 / level
                  :ARG1-of (a2 / appear-01)
                  :ARG1-of (h / high-02
                        :degree (m / more)
                        :compared-to (m3 / melanocyte
                              :ARG1-of (n8 / normal-02)
                              :mod (h3 / human))))))","Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref> shows that human melanoma cell lines express both full-length and the 785 splice variant HIF-1α mRNA at a level that appeared to be higher than normal human melanocytes.","(z1 / show-01
    :ARG0 (z2 / figure
              :mod ""2B"")
    :ARG1 (z3 / express-01
              :ARG0 (z4 / cell
                        :mod (z5 / melanoma
                                 :mod (z6 / human)))
              :ARG1 (z7 / and
                        :op1 (z8 / protein
                                 :wiki ""Mitogen-activated_protein_kinase_1α""
                                 :name (z9 / name
                                           :op1 ""HIF-1α""
                                           :op2 ""mRNA"")
                                 :ARG1-of (z10 / long-03
                                               :degree (z11 / full)))
                        :op2 (z12 / protein
                                  :wiki ""HIF-1α""
                                  :name (z13 / name
                                             :op1 ""HIF-1α""
                                             :op2 ""mRNA"")
                                  :ARG1-of (z14 / mutate-01
                                                :ARG2 (z15 / splice-01))
                                  :ARG1-of (z16 / statistical-test-91
                                                :ARG2 785))))
    :ARG2 (z17 / level
               :ARG1-of (z18 / have-degree-91
                             :ARG2 (z19 / high-02
                                        :ARG1 z17)
                             :ARG3 (z20 / more)
                             :ARG4 (z21 / level
                                        :ARG1-of (z22 / appear-02))
                             :ARG4 (z23 / melanocyte
                                        :ARG1-of (z24 / normal-02)
                                        :mod z6))))",0.3770491803278689,0.336283185840708,"(m / multi-sentence
        :snt1 (s / show-01
            :ARG0 (f / figure
                  :ARG1 (i / id
                        :op1 ""2B"")
                  :ARG2 (c / cell-line
                        :mod (h / human
                              :mod (m / melanoma)))
                  :ARG3 (e / express-01
                        :ARG0 c
                        :ARG1 (a / and
                              :op1 (f2 / full-length
                                    :mod (v / variant
                                          :ARG1 (m2 / mRNA
                                                :mod (h2 / HIF-1α
                                                      :mod (h3 / human))))
                                    :mod (l / level
                                          :ARG1 (a2 / appear-01
                                                :ARG1 (h4 / higher
                                                      :mod (n / normal
                                                            :mod (m3 / melanocyte))))))))))","(s / show-01
    :ARG0 (f / figure :name (n / name :op1 ""2B""))
    :ARG1 (a / and
        :op1 (e / express-01
            :ARG0 (l / line
                :mod (c / cell
                    :mod (m / melanoma
                        :mod (h / human))))
            :ARG1 (m2 / mRNA
                :mod (h2 / HIF-1α)
                :mod (f2 / full-length)))
        :op2 (e2 / express-01
            :ARG0 l
            :ARG1 (m3 / mRNA
                :mod h2
                :mod (v / variant
                    :mod (s / splice)
                    :mod (n2 / number :value 785))))
    :ARG2 (a2 / appear-01
        :ARG1 (h3 / high-02
            :degree (t / than
                :op1 (e3 / express-01
                    :ARG0 (m4 / melanocyte
                        :mod (h4 / human)
                        :mod (n3 / normal))
                    :ARG1 (m5 / mRNA
                        :mod h2
                        :mod f2)
                    :ARG1-of (t2 / than-01
                        :ARG2 e2))
                :op2 e3))))",-1.0,-1.0
pmid_1991_9690.82,"Hypoxia independent expression of HIF-1α is thought to be regulated by growth signaling pathways [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B19"">19</xref>] and the majority of melanomas have constitutively active ERK1/2 MAPK pathway due to BRAF or N-Ras mutations [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>].","(a2 / and
    :op1 (t / think-01
        :ARG1 (r / regulate-01
            :ARG0 (s2 / stage
                :ARG0-of (s / signal-07
                    :ARG1 (g / grow-01)))
            :ARG1 (e3 / express-03
                :ARG0-of (d / depend-01)
                :ARG1 (e / enzyme
                    :name (n3 / name
                        :op1 ""ERK""
                        :op1 ""BRAF""
                        :op2 ""white""
                        :op2 ""1/2""
                        :op3 ""MAPK"")))))
    :op2 (h / have-03
        :ARG0 (d3 / disease
            :name (n4 / name
                :op1 ""kilogram""))
        :ARG1 (p / pathway
            :ARG0-of (a / activity-06
                :ARG1-of (c2 / constitute-01))
            :mod (e2 / enzyme
                :name n3))
        :ARG1-of (c / cause-01
            :ARG0 (o / or
                :op1 (m2 / mutate-01
                    :ARG1 e)
                :op2 (m3 / mutate-01
                    :ARG1 e2))))
    :rel (n / name
        :op1 ""Hypoxia"")
    :rel (n2 / name
        :op1 ""histidine-rich"")
    :rel (d2 / disease
        :name n3
        :quant (m / majority))
    :rel (n5 / name
        :op1 ""nuke""))
",test,bio_amr0.8,"(a2 / and
      :op1 (t / think-01
            :ARG1 (r / regulate-01
                  :ARG0 (p3 / pathway
                        :ARG0-of (s / signal-07
                              :ARG1 (g / grow-01)))
                  :ARG1 (e / express-03
                        :ARG2 (p2 / protein :name (n2 / name :op1 ""HIF-1α""))
                        :ARG0-of (d / depend-01 :polarity -
                              :ARG1 (h / hypoxia))))
            :ARG1-of (d2 / describe-01
                  :ARG0 (p4 / publication
                        :ARG1-of (c / cite-01
                              :ARG2 (a / and :op1 18 :op2 19)))))
      :op2 (h2 / have-03
            :ARG0 (m4 / medical-condition :name (n3 / name :op1 ""melanoma"")
                  :quant (m / majority)
                  :ARG1-of (i / include-91
                        :ARG2 (m5 / medical-condition :name (n4 / name :op1 ""melanoma""))))
            :ARG1 (p5 / pathway :name (n5 / name :op1 ""ERK1/2"" :op2 ""MAPK"")
                  :mod (c2 / constitutive)
                  :ARG1-of (c3 / cause-01
                        :ARG0 (o / or
                              :op1 (m2 / mutate-01
                                    :ARG1 (e2 / enzyme :name (n6 / name :op1 ""BRAF"")))
                              :op2 (m3 / mutate-01
                                    :ARG1 (e3 / enzyme :name (n7 / name :op1 ""N-Ras"")))))
                  :ARG0-of (a5 / activity-06))
            :ARG1-of (d5 / describe-01
                  :ARG0 (p6 / publication
                        :ARG1-of (c4 / cite-01
                              :ARG2 (a4 / and :op1 14 :op2 15))))))","Hypoxia independent expression of HIF-1α is thought to be regulated by growth signaling pathways [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B19"">19</xref>] and the majority of melanomas have constitutively active ERK1/2 MAPK pathway due to BRAF or N-Ras mutations [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>].","(z1 / think-01
    :ARG1 (z2 / regulate-01
              :ARG0 (z3 / pathway
                        :ARG0-of (z4 / signal-07
                                     :ARG1 (z5 / grow-01))
                        :ARG0-of (z6 / channel-01
                                     :ARG1 (z7 / protein
                                               :wiki ""Mitogen-activated_protein_kinase_1""
                                               :name (z8 / name
                                                         :op1 ""HIF-1α"")
                                               :ARG1-of (z9 / express-01
                                                            :ARG0-of (z10 / depend-01
                                                                          :polarity -
                                                                          :ARG0 (z11 / hypoxia))))))
              :ARG1-of (z12 / hyperlink-91
                            :ARG3 (z13 / url-entity
                                       :value 18))))",0.2372881355932203,0.4313725490196078,"(m / multi-sentence
        :snt1 (t / think-01
            :ARG0 (e / expression
                  :ARG1 (i / independent
                        :ARG1-of (h / hypoxia))
                  :ARG2 (h2 / HIF-1α)))
        :snt2 (r / regulate-01
            :ARG0 (p / pathway
                  :mod (s / signaling)
                  :mod (g / growth))
            :ARG1 e)
        :snt3 (h3 / have-03
            :ARG0 (m2 / majority)
            :ARG1 (m3 / melanoma)
            :ARG2 (a / active
                  :ARG1 (p2 / pathway
                        :mod (m4 / MAPK)
                        :mod (e2 / ERK1/2)))
            :ARG3 (d / due-to
                  :ARG1 (m5 / mutation
                        :mod (b / BRAF)
                        :mod (n / N-Ras))))
        :snt4 (c / constitutively)
        :snt5 (a2 / and
            :op1 (x / xref
                  :ref-type ""bibr""
                  :rid ""B18""
                  :op1 ""18"")
            :op2 (x2 / xref
                  :ref-type ""bibr""
                  :rid ""B19""
                  :op1 ""19""))
        :snt6 (a3 / and
            :op1 (x3 / xref
                  :ref-type ""bibr""
                  :rid ""B14""
                  :op1 ""14"")
            :op2 (x4 / xref
                  :ref-type ""bibr""
                  :rid ""B15""
                  :op1 ""15"")))","(t / think-01
    :ARG1 (r / regulate-01
        :ARG1 (e / express-01
            :ARG0 (h / HIF-1α)
            :condition (i / independent
                :ARG1 (h2 / hypoxia)))
        :ARG2 (p / pathway
            :mod (g / grow-01)
            :mod (s / signal-01)))
    :source (p2 / person
        :quant (m / majority)
        :ARG0-of (h3 / have-03
            :ARG1 (p3 / pathway
                :mod (a / active-04
                    :degree (c / constant))
                :mod (m2 / MAPK)
                :mod (e2 / ERK1/2)
                :ARG1-of (d / due-01
                    :ARG2 (m3 / mutation
                        :ARG1 (o / or
                            :op1 (b / BRAF)
                            :op2 (n / N-Ras)))))))",-1.0,-1.0
pmid_1991_9690.83,"Therefore, we determined whether HIF-1α expression in human metastatic melanoma WM9 cells was dependent on activation of ERK1/2 MAPK signaling.","(c / cause-01
    :ARG1 (d2 / determine-01
        :ARG0 (w / we)
        :ARG1 (t / truth-value
            :polarity-of (d / depend-01
                :ARG0 (c2 / cell
                    :name (n / name
                        :op1 ""CHO-K1"")
                    :ARG1-of (e3 / express-03
                        :ARG1 (e / enzyme
                            :name (n4 / name
                                :op1 ""ERK"")
                            :ARG0-of (e4 / express-03
                                :ARG1 e)))
                    :part-of (d3 / disease
                        :name (n3 / name
                            :op1 ""melanoma"")
                        :mod (m / metastatic)))
                :ARG1 (a / activate-01))))
    :rel (n2 / name
        :op1 ""histidine-rich""
        :op1 ""WM9"")
    :rel (e2 / enzyme
        :name (n5 / name
            :op2 ""1/2""
            :op3 ""MAPK""))
    :rel (h / human))
",test,bio_amr0.8,"(c / cause-01
      :ARG1 (d / determine-01
            :ARG0 (w / we)
            :ARG1 (d2 / depend-01 :mode interrogative
                  :ARG0 (e / express-03
                        :ARG2 (p2 / protein :name (n2 / name :op1 ""HIF-1α""))
                        :ARG3 (c2 / cell-line :name (n3 / name :op1 ""WM9"")
                              :mod (m / medical-condition :name (n4 / name :op1 ""melanoma""))
                              :mod (h / human)
                              :ARG1-of (m2 / metastasize-101)))
                  :ARG1 (a / activate-01
                        :ARG1 (s / signal-07
                              :ARG0 (p3 / pathway :name (n5 / name :op1 ""ERK1/2"" :op2 ""MAPK"")))))))","Therefore, we determined whether HIF-1α expression in human metastatic melanoma WM9 cells was dependent on activation of ERK1/2 MAPK signaling.","(z1 / cause-01
    :ARG1 (z2 / determine-01
              :ARG0 (z3 / we)
              :ARG1 (z4 / truth-value
                        :polarity-of (z5 / depend-01
                                         :ARG0 (z6 / express-03
                                                   :ARG1 (z7 / small-molecule
                                                             :wiki ""Histidine-rich_factor_receptor_1""
                                                             :name (z8 / name
                                                                       :op1 ""HIF-1α""))
                                                   :location (z9 / cell
                                                                 :wiki ""Mitogen-activated_protein_kinase""
                                                                 :name (z10 / name
                                                                            :op1 ""WM9"")
                                                                 :part-of (z11 / melanoma
                                                                               :mod (z12 / metastatic)
                                                                               :mod (z13 / human))))
                                         :ARG1 (z14 / activate-01
                                                    :ARG1 (z15 / activate-01
                                                               :ARG1 (z16 / channel-01
                                                                          :ARG1 (z17 / protein
                                                                                     :wiki ""ERK1/2""
                                                                                     :name (z18 / name
                                                                                                :op1 ""ERK1/2""
                                                                                                :op2 ""MAPK"")))))))))",0.4578313253012048,0.3720930232558139,"(d / determine-01
    :ARG0 (w / we)
    :ARG1 (e / expression
        :ARG0 (h / HIF-1α)
        :ARG1 (c / cell
            :mod (m / metastatic)
            :mod (m2 / melanoma
                :mod (h2 / human
                    :mod (w2 / WM9))))
        :ARG2 (d2 / depend-01
            :ARG1 (a / activation
                :ARG0 (s / signal
                    :mod (m3 / MAPK)
                    :mod (e2 / ERK1/2))))))","(d / determine-01
    :ARG0 (w / we)
    :ARG1 (d2 / depend-01
        :ARG1 (e / express-01
            :ARG0 (p / protein :name ""HIF-1α"")
            :ARG1 (c / cell
                :mod (m / melanoma
                    :mod (m2 / metastatic)
                    :mod (h / human))
                :name ""WM9""))
        :ARG2 (a / activate-01
            :ARG1 (s / signal-01
                :mod (m3 / MAPK)
                :mod (e2 / ERK1/2))))
    :condition (t / therefore))",-1.0,-1.0
pmid_1991_9690.85,"Treatment of WM9 cells with 30 μM U0126, a selective U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and led to a time-dependent decrease in HIF-1α protein expression (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(a / and
    :ARG1-of (d4 / describe-01
        :ARG0 (f / figure
            :mod 6))
    :op1 (d / decrease-01
        :ARG0 (t2 / treat-03
            :ARG1 (c / cell-line
                :name (n / name
                    :op1 ""WM9""))
            :ARG2 (p2 / protein
                :name (n3 / name
                    :op1 ""MEK"")
                :quant (c2 / concentration-quantity
                    :quant 30
                    :unit (n7 / nanomolar))
                :ARG1-of (s / select-01)))
        :ARG1 (p / phosphorylate-01
            :ARG1 (e2 / enzyme
                :name (n4 / name
                    :op1 ""ERK""
                    :op2 ""1/2""))))
    :op2 (l / lead-03
        :ARG0 t2
        :ARG2 (d2 / decrease-01
            :ARG0-of (d3 / depend-01
                :ARG1 (t / time))
            :ARG1 (e3 / express-03
                :ARG2 (p3 / protein
                    :name (n6 / name
                        :op1 10
                        :op2 ""histidine-rich"")))))
    :rel (n5 / name
        :op1 ""10"")
    :rel (e / enzyme
        :name (n2 / name)
        :ARG0-of (i / inhibit-01
            :ARG1 e)))
",test,bio_amr0.8,"(a / and
      :op1 (d / decrease-01
            :ARG0 (t2 / treat-04
                  :ARG1 (c / cell-line :name (n3 / name :op1 ""WM9""))
                  :ARG2 (s2 / small-molecule :name (n4 / name :op1 ""U0126"")
                        :quant (c2 / concentration-quantity :quant 30
                              :unit (m / micromolar))
                        :ARG1-of (m2 / mean-01
                              :ARG2 (s3 / small-molecule :name (n5 / name :op1 ""U0126"")
                                    :ARG0-of (i / inhibit-01
                                          :ARG1 (p / protein-family :name (n2 / name :op1 ""MEK"")))
                                    :ARG0-of (s / select-01)))))
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (e / enzyme :name (n6 / name :op1 ""ERK1/2""))))
      :op2 (l / lead-03
            :ARG1 t2
            :ARG2 (d2 / decrease-01
                  :ARG1 (e2 / express-03
                        :ARG2 (p3 / protein :name (n7 / name :op1 ""HIF-1α"")))
                  :ARG0-of (d3 / depend-01
                        :ARG1 (t3 / time))))
      :ARG1-of (d4 / describe-01
            :ARG0 (f / figure :mod ""6A"")))","Treatment of WM9 cells with 30 μM U0126, a selective U0126 MEK inhibitor, decreased ERK1/2 phosphorylation and led to a time-dependent decrease in HIF-1α protein expression (Fig. <xref ref-type=""fig"" rid=""F6"">6A</xref>).","(z1 / and
    :op1 (z2 / decrease-01
             :ARG0 (z3 / treat-03
                       :ARG1 (z4 / cell
                                 :wiki ""Mitogen-activated_protein_kinase_1""
                                 :name (z5 / name
                                           :op1 ""WM9""))
                       :ARG2 (z6 / inhibitor
                                 :wiki ""U0126""
                                 :name (z7 / name
                                           :op1 ""U0126"")
                                 :ARG0-of (z8 / inhibit-01
                                              :ARG1 (z9 / enzyme
                                                        :wiki ""Mitogen-activated_protein_kinase_1/2""
                                                        :name (z10 / name
                                                                   :op1 ""MEK"")))
                                 :ARG1-of (z11 / select-01))
                       :quant (z12 / product-of
                                   :op1 (z13 / concentration-quantity
                                             :quant 30
                                             :unit (z14 / μM))
                                   :op2 (z15 / concentration-quantity
                                             :quant 1
                                             :unit (z16 / nanomolar)))))
    :ARG1 (z17 / phosphorylate-01
               :ARG1 (z18 / protein
                          :wiki ""ERK1/2""
                          :name (z19 / name
                                     :op1 ""ERK1/2""))))",0.3928571428571428,0.5396825396825397,"(t / treatment-01
    :ARG0 (c / cell-line :wiki ""WM9"")
    :ARG1 (d / decrease-01
        :ARG1 (p / phosphorylation
            :ARG0 (e / ERK1/2))
        :time (d2 / depend
            :ARG1 (d3 / decrease-01
                :ARG1 (e2 / expression
                    :ARG0 (p2 / protein
                        :mod (a / alpha)
                        :mod (h / HIF-1))))))","(t / treat-01
    :ARG0 (c / chemical
        :name (n / name :op1 ""U0126"")
        :mod (c2 / chemical
            :name (n2 / name :op1 ""U0126"")
            :mod (i / inhibit-01
                :ARG1 (p / protein
                    :name (n3 / name :op1 ""MEK""))
                :mod (s / selective))))
    :ARG1 (c3 / cell
        :name (n4 / name :op1 ""WM9""))
    :ARG2 (m / measure-01
        :ARG1 (u / unit-of-measure :name (n5 / name :op1 ""μM""))
        :value 30)
    :result (a / and
        :op1 (d / decrease-01
            :ARG1 (p2 / phosphorylate-01
                :ARG1 (p3 / protein
                    :name (n6 / name :op1 ""ERK1/2""))))
        :op2 (l / lead-01
            :ARG1 (d2 / decrease-01
                :ARG1 (e / express-01
                    :ARG1 (p4 / protein
                        :name (n7 / name :op1 ""HIF-1α""))
                    :ARG2 (t2 / time
                        :mod (d3 / depend-01)))
                :mod (t3 / time)))))
    :medium (f / figure
        :name (n8 / name :op1 ""6A"")))",-1.0,-1.0
pmid_2000_3375.133,"<sec-title level=""2"">Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the Ras<sup>V12 </sup>transformants</sec-title>","(i / increase-01
    :li 2
    :ARG0 (e / engineer-01
        :ARG1-of (o / over-03))
    :ARG1 (a2 / and
        :op1 (s2 / status
            :ARG1-of (p / phosphorylate-01)
            :domain (a3 / and
                :op1 (e2 / enzyme
                    :name (n2 / name
                        :op1 ""MEK""))
                :op2 (p2 / protein
                    :name (n4 / name
                        :op1 ""AKT""
                        :op1 ""RalA""))))
        :op2 (a / activity-06
            :ARG0 p2))
    :rel (n / name
        :op1 ""a"")
    :rel (s / slash
        :op1 e2
        :op2 (e3 / enzyme
            :name (n3 / name
                :op1 ""ERK""))))
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (o / overexpress-01
            :ARG1 (e2 / enzyme :name (n / name :op1 ""Aurora-A"")))
      :ARG1 (a2 / and
            :op1 (s / status
                  :mod (p / phosphorylate-01)
                  :poss (a / and
                        :op1 (p2 / pathway :name (n2 / name :op1 ""MEK/ERK""))
                        :op2 (p4 / pathway :name (n3 / name :op1 ""AKT""))))
            :op2 (a3 / activity-06
                  :ARG0 (p3 / protein :name (n4 / name :op1 ""RalA""))
                  :location (e3 / enzyme :name (n5 / name :op1 ""Ras"")
                        :ARG2-of (t / transform-01 :value ""V12"")))))","<sec-title level=""2"">Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the Ras<sup>V12 </sup>transformants</sec-title>","(z1 / increase-01
    :ARG0 (z2 / overexpress-00
              :ARG1 (z3 / enzyme
                        :wiki ""Aurora-A""
                        :name (z4 / name
                                  :op1 ""Aurora-A"")))
    :ARG1 (z5 / status
              :mod (z6 / phosphorylate-01
                       :ARG1 (z7 / and
                                 :op1 (z8 / enzyme
                                          :wiki ""Mitogen-activated_protein_kinase""
                                          :name (z9 / name
                                                    :op1 ""MEK/ERK""))
                                 :op2 (z10 / enzyme
                                           :wiki ""AKT""
                                           :name (z11 / name
                                                      :op1 ""AKT""))
                                 :op3 (z12 / enzyme
                                           :wiki ""BRAF-activated_protein_kinase""
                                           :name (z13 / name
                                                      :op1 ""Ras""
                                                      :op2 ""V12""
                                                      :op3 ""transformants""))))))",0.4102564102564102,0.4146341463414634,"(m / multi-sentence
        :snt1 (i / increase-01
            :ARG1 (o / overexpression
                  :ARG0 (a / Aurora-A))
            :ARG2 (s / status
                  :ARG1 (p / phosphorylation
                        :ARG1 (m / MEK/ERK)))
            :ARG2-of (a2 / as-well-as
                  :op1 (a3 / activity
                        :ARG1 (r / RalA)))
            :ARG2-of (a4 / as-well-as
                  :op1 (a5 / activity
                        :ARG1 (t / transformant
                              :mod (v / V12
                                    :op1 ""Ras""))))))
        :snt2 (n / name
            :op1 ""Aurora-A overexpression increases phosphorylation status of MEK/ERK and AKT as well as the activity of RalA in the RasV12 transformants""))","(o / overexpress-01
    :ARG0 (a / aurora-A)
    :ARG1 (i / increase-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (s / status
                :mod (m / MEK/ERK)
                :mod (a2 / AKT)))
        :ARG2 (a3 / activity
            :mod (r / RalA)
            :location (t / transformant
                :mod (r2 / Ras^V12))))
    :medium (t2 / text
        :mod (t3 / title
            :level 2)))",-1.0,-1.0
pmid_2000_3375.152,"Our results confirmed that wild-type-Aurora-A enhance Ras downstream signaling pathways including MEK/ERK, AKT and RalA.","(c / confirm-01
    :ARG0 (t / thing
        :ARG2-of (r / result-01
            :ARG0 (w / we)))
    :ARG1 (e / enhance-01
        :ARG0 ""amr-unknown""
        :ARG1 (e2 / enzyme
            :name (n / name)
            :mod (t2 / type
                :mod (w2 / wild)))
        :ARG1 (e3 / enzyme
            :ARG0-of (s / signal-07)
            :ARG2-of (i / include-01
                :ARG1 (s2 / slash
                    :op1 (e5 / enzyme
                        :name (n4 / name
                            :op1 ""ERK""))
                    :op2 (e4 / enzyme
                        :name (n3 / name
                            :op1 ""MEK"")))
                :ARG1 (a / and
                    :op1 e4
                    :op2 (p / protein
                        :name (n5 / name
                            :op1 ""AKT""
                            :op1 ""RalA""))))
            :mod (d / downstream)))
    :rel (n2 / name
        :op1 ""amr-unknown""
        :op1 ""Ras""))
",test,bio_amr0.8,"(c / confirm-01
      :ARG0 (t / thing
            :poss (w / we)
            :ARG2-of (r / result-01))
      :ARG1 (e2 / enhance-01
            :ARG0 (e4 / enzyme :name (n3 / name :op1 ""Aurora-A"")
                  :mod (w2 / wild-type))
            :ARG1 (p3 / pathway
                  :location (d / downstream)
                  :ARG0-of (s / signal-07
                        :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")))
                  :ARG2-of (i / include-91
                        :ARG1 (a / and
                              :op1 (p / pathway :name (n2 / name :op1 ""MEK/ERK""))
                              :op2 (p2 / pathway :name (n4 / name :op1 ""AKT""))
                              :op3 (p4 / pathway :name (n5 / name :op1 ""RalA"")))))))","Our results confirmed that wild-type-Aurora-A enhance Ras downstream signaling pathways including MEK/ERK, AKT and RalA.","(z1 / confirm-01
    :ARG0 (z2 / thing
              :ARG2-of (z3 / result-01
                           :ARG0 (z4 / we)))
    :ARG1 (z5 / enhance-01
              :ARG0 (z6 / small-molecule
                        :wiki ""Aurora-Aurora_glycoprotein""
                        :name (z7 / name
                                  :op1 ""Aurora-A"")
                        :mod (z8 / wild-type))
              :ARG1 (z9 / pathway
                        :wiki ""Ras–regulated_protein_system""
                        :name (z10 / name
                                   :op1 ""Ras""
                                   :op2 ""downstream""
                                   :op3 ""signaling""
                                   :op4 ""pathway"")
                        :ARG2-of (z11 / include-01
                                      :ARG1 (z12 / and
                                                 :op1 (z13 / enzyme
                                                           :wiki ""Mitogen-activated_protein_kinase""
                                                           :name (z14 / name
                                                                      :op1 ""MEK/ERK""))
                                                 :op2 (z15 / enzyme
                                                           :wiki ""AKT""
                                                           :name (z16 / name
                                                                      :op1 ""AKT""))
                                                 :op3 (z17 / enzyme
                                                           :wiki ""RalA""
                                                           :name (z18 / name
                                                                      :op1 ""RalA"")))))))",0.5833333333333334,0.4848484848484848,"(m / multi-sentence
        :snt1 (c / confirm-01
            :ARG0 (r / result)
            :ARG1 (e / enhance-01
                  :ARG0 (a / Aurora-A
                        :mod (w / wild-type))
                  :ARG1 (p / pathway
                        :ARG1-of (s / signal-01
                              :ARG1 (d / downstream
                                    :mod (r2 / Ras))))
                  :ARG1-of (i / include-91
                        :op1 (m2 / MEK/ERK)
                        :op2 (a2 / AKT)
                        :op3 (r3 / RalA)))))","(c / confirm-01
    :ARG0 (r / result
        :poss (w / we))
    :ARG1 (e / enhance-01
        :ARG0 (a / Aurora-A
            :mod (w2 / wild)
            :mod (t / type))
        :ARG1 (p / pathway
            :mod (s / signal-01
                :ARG1 (r2 / Ras))
            :include (m / MEK/ERK)
            :include (a2 / AKT)
            :include (r3 / RalA))))",-1.0,-1.0
pmid_2000_3375.154,"The involvement of MEK/ERK, PI3K/AKT and RalGDS/RalA signaling pathways in Aurora-A-related cell aggregation (Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref>, WT + IPTG) was clarified by treatment of the cells with the following inhibitors: FTI-277, a farnesylation inhibitor of Ras; PD-98059, the inhibitor of MEK kinase and LY-294002, the inhibitor of PI3K kinase and RalASa94A, a mutant of Ral.","(c3 / clarify-10
    :ARG0 (t2 / treat-04
        :ARG1 (c2 / cell)
        :ARG2 (c / cell
            :ARG1-of (r / relate-01
                :ARG2 (p4 / protein)))
        :ARG2 (s4 / small-molecule
            :ARG0-of (i / inhibit-01)
            :ARG0-of (i2 / inhibit-01)
            :ARG0-of (i3 / inhibit-01)
            :ARG1-of (f3 / follow-04)
            :domain (t / thing
                :name f3
                :ARG1 (a2 / and
                    :op1 (e / enzyme
                        :name (n / name
                            :op1 ""MEK""))
                    :op2 (e2 / enzyme
                        :name (n2 / name
                            :op1 ""PI3K""
                            :op2 ""kinase""))
                    :op3 (p2 / protein
                        :name (n5 / name
                            :op1 ""RalA""))
                    :op4 p4))))
    :ARG1 (i4 / involve-01
        :ARG1 (s2 / slash
            :op1 e
            :op2 e2
            :op3 (s3 / slash
                :op1 e
                :op2 p2
                :op3 (p3 / protein
                    :name (n6 / name
                        :op1 ""AKT""))))
        :location (j / join-04
            :ARG1 c))
    :ARG1-of (d / describe-01
        :ARG0 (f2 / figure))
    :rel (p / protein
        :name (n3 / name
            :op1 ""ERK"")
        :name (n4 / name))
    :rel (k / kinase
        :name (n9 / name
            :op1 277))
    :rel (n10 / name
        :op1 ""II"")
    :rel (a / and
        :op2 (p5 / protein
            :name (n7 / name
                :op1 ""IPTG""))
        :op4 (m / mechanism
            :ARG0-of (s / signal-07)))
    :rel (p6 / protein
        :name (n8 / name
            :op1 ""RalASa94A""
            :op1 ""Ral""
            :op2 ""kinase"")
        :name (n11 / name
            :op1 ""Ras"")
        :ARG2-of (m2 / mutate-01))
    :rel (f / farnesylation)
    :rel 98059
    :rel 294002)
",test,bio_amr0.8,"(c / clarify-10
      :ARG1 (i2 / involve-01
            :ARG1 (a / and
                  :op1 (p / pathway :name (n / name :op1 ""MEK/ERK""))
                  :op2 (p2 / pathway :name (n2 / name :op1 ""PI3K/AKT""))
                  :op3 (p3 / pathway :name (n5 / name :op1 ""RalGDS/RalA""))
                  :ARG0-of (s / signal-07))
            :ARG2 (a2 / aggregate-01
                  :ARG1 (c2 / cell)
                  :ARG1-of (r / relate-01
                        :ARG2 (e2 / enzyme :name (n6 / name :op1 ""Aurora-A""))))
            :ARG1-of (d / describe-01
                  :ARG0 (f / figure :mod ""2B"")))
      :manner (t2 / treat-04
            :ARG1 c2
            :ARG2 (m / molecular-physical-entity
                  :ARG0-of (i3 / inhibit-01)
                  :ARG1-of (f2 / follow-01)
                  :ARG1-of (m2 / mean-01
                        :ARG2 (a3 / and
                              :op1 (s2 / small-molecule :name (n7 / name :op1 ""FTI-277"")
                                    :ARG0-of (i4 / inhibit-01
                                          :ARG1 (p4 / protein-family :name (n3 / name :op1 ""Ras""))
                                          :ARG2-of (f3 / farnesylate-01)))
                              :op2 (s3 / small-molecule :name (n8 / name :op1 ""PD-98059"")
                                    :ARG0-of (i5 / inhibit-01
                                          :ARG1 (k / kinase :name (n4 / name :op1 ""MEK""))))
                              :op3 (s4 / small-molecule :name (n9 / name :op1 ""LY-294002"")
                                    :ARG0-of (i6 / inhibit-01
                                          :ARG1 (a4 / and
                                                :op1 (k2 / kinase :name (n10 / name :op1 ""PI3K""))
                                                :op1 (p5 / protein :name (n11 / name :op1 ""RalASa94A"")
                                                      :ARG3-of (m6 / mutate-01
                                                            :ARG1 (p6 / protein :name (n12 / name :op1 ""Ral""))))))))))))","The involvement of MEK/ERK, PI3K/AKT and RalGDS/RalA signaling pathways in Aurora-A-related cell aggregation (Fig. <xref ref-type=""fig"" rid=""F2"">2B</xref>, WT + IPTG) was clarified by treatment of the cells with the following inhibitors: FTI-277, a farnesylation inhibitor of Ras; PD-98059, the inhibitor of MEK kinase and LY-294002, the inhibitor of PI3K kinase and RalASa94A, a mutant of Ral.","(z1 / clarify-10
    :ARG0 (z2 / treat-04
              :ARG1 (z3 / cell)
              :ARG2 (z4 / inhibitor
                        :ARG1-of (z5 / follow-04
                                     :ARG2 (z6 / and
                                               :op1 (z7 / inhibitor
                                                        :wiki ""Fritonavir/ritonavir""
                                                        :name (z8 / name
                                                                  :op1 ""FTI-277"")
                                                        :ARG0-of (z9 / inhibit-01
                                                                     :ARG1 (z10 / enzyme
                                                                                :wiki ""Ras_threonine_kinase""
                                                                                :name (z11 / name
                                                                                           :op1 ""Ras""))
                                                                     :ARG2 (z12 / farnesylate-01)))
                                               :op2 (z13 / inhibitor
                                                         :wiki ""PD-98059""
                                                         :name (z14 / name
                                                                    :op1 ""PD-98059"")
                                                         :ARG0-of (z15 / inhibit-01
                                                                       :ARG1 (z16 / kinase
                                                                                  :wiki ""Mitogen-activated_protein_kinase""
                                                                                  :name (z17 / name
                                                                                             :op1 ""MEK"")))))
                                     :op3 (z18 / inhibitor
                                               :wiki ""LY-294002""
                                               :name (z19 / name
                                                          :op1 ""LY-294002"")
                                               :ARG0-of (z20 / inhibit-01
                                                             :ARG1 (z21 / kinase
                                                                        :wiki ""PI3K""
                                                                        :name (z22 / name
                                                                                   :op1 ""PI3K""))))
                                     :op4 (z23 / mutant
                                               :wiki ""RalASa94A""
                                               :name (z24 / name
                                                          :op1 ""RalASa94A"")
                                               :domain (z25 / enzyme
                                                            :wiki ""RalASa94A""
                                                            :name (z26 / name
                                                                       :op1 ""RalASa94A"")))))))",0.3625730994152046,0.3222748815165877,"(m / multi-sentence
        :snt1 (c / clarify-01
            :ARG0 (i / involvement
                  :ARG1 (p / pathway
                        :mod (s / signal
                              :ARG0 (m2 / MEK/ERK)
                              :ARG1 (p2 / PI3K/AKT)
                              :ARG2 (r / RalGDS/RalA)))
                  :ARG2 (a / aggregation
                        :ARG1 (c2 / cell
                              :mod (a2 / Aurora-A-related))))
            :ARG1 (t / treatment-01
                  :ARG0 (c3 / cell)
                  :ARG1 (i2 / inhibitor
                        :ARG0 (f / FTI-277)
                        :ARG1 (f2 / farnesylation
                              :ARG1 (i3 / inhibitor
                                    :ARG0 (r2 / Ras))))
                  :ARG1 (i4 / inhibitor
                        :ARG0 (p3 / PD-98059)
                        :ARG1 (k / kinase
                              :ARG1 (m3 / MEK)))
                  :ARG1 (i5 / inhibitor
                        :ARG0 (l / LY-294002)
                        :ARG1 (k2 / kinase
                              :ARG1 (p4 / PI3K)))
                  :ARG1 (a3 / RalASa94A)
                  :ARG1 (m4 / mutant
                        :ARG1 (r3 / Ral))))
        :snt2 (c4 / clarify-01
            :ARG0 (i6 / involvement
                  :ARG1 (p5 / pathway
                        :mod (s4 / signal
                              :ARG0 (m5 / MEK/ERK)
                              :ARG1 (p6 / PI3K/AKT)
                              :ARG2 (r4 / RalGDS/RalA)))
                  :ARG2 (a4 / aggregation
                        :ARG1 (c5 / cell
                              :mod (a5 / Aurora-A-related))))
            :ARG1 (t2 / treatment-01
                  :ARG0 (c6 / cell)
                  :ARG1 (i7 / inhibitor
                        :ARG0 (f3 / FTI-277)
                        :ARG1 (f4 / farnesylation
                              :ARG1 (i8 / inhibitor
                                    :ARG0 (r5 / Ras))))
                  :ARG1 (i9 / inhibitor
                        :ARG0 (p7 / PD-98059)
                        :ARG1 (k3 / kinase
                              :ARG1 (m6 / MEK)))
                  :ARG1 (i10 / inhibitor
                        :ARG0 (l2 / LY-294002)
                        :ARG1 (k4 / kinase
                              :ARG1 (p8 / PI3K)))
                  :ARG1 (a6 / RalASa94A)
                  :ARG1 (m7 / mutant
                        :ARG1 (r6 / Ral)))))","(i / involve-01
    :ARG1 (p / pathway
        :mod (s / signal)
        :example (m / multi-slash
            :op1 (m2 / molecule :name (n / name :op1 ""MEK"" :op2 ""ERK""))
            :op2 (m3 / molecule :name (n2 / name :op1 ""PI3K"" :op2 ""AKT""))
            :op3 (m4 / molecule :name (n3 / name :op1 ""RalGDS"" :op2 ""RalA""))))
    :ARG2 (a / aggregate-01
        :ARG1 (c / cell)
        :mod (r / relate-01
            :ARG1 (m5 / molecule :name (n4 / name :op1 ""Aurora"" :op2 ""A""))))
    :location (f / figure :name (n5 / name :op1 ""2B""))
    :ARG1-of (c / clarify-01
        :instrument (t / treat-01
            :ARG1 c
            :ARG2 (i2 / inhibitor
                :example (m6 / multi-slash
                    :op1 (i3 / inhibitor :name (n6 / name :op1 ""FTI-277"")
                        :purpose (f2 / farnesylation-01
                            :ARG0 i3
                            :ARG1 (m7 / molecule :name (n7 / name :op1 ""Ras""))))
                    :op2 (i4 / inhibitor :name (n8 / name :op1 ""PD-98059"")
                        :purpose (i5 / inhibit-01
                            :ARG0 i4
                            :ARG1 (k / kinase :name (n9 / name :op1 ""MEK""))))
                    :op3 (i6 / inhibitor :name (n10 / name :op1 ""LY-294002"")
                        :purpose (i7 / inhibit-01
                            :ARG0 i6
                            :ARG1 (k2 / kinase :name (n11 / name :op1 ""PI3K""))))
                    :op4 (m8 / mutant :name (n12 / name :op1 ""RalASa94A"")
                        :mod (m9 / molecule :name (n13 / name :op1 ""Ral""))))))))",-1.0,-1.0
pmid_2000_3375.156,"PD-98059 decreased the phosphorylation of ERK1/2 (p-ERK1/2) but had no effect on other signaling pathways (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 4 and 5).","(c / contrast-01
    :ARG1 (d / decrease-01
        :ARG1 (p / phosphorylate-01
            :ARG1 (e / enzyme
                :name (n / name
                    :op2 ""1/2""))))
    :ARG1-of (d2 / describe-01
        :ARG0 (f / figure
            :example (a2 / and
                :op1 (l / lane
                    :mod 4)
                :op2 (f2 / figure
                    :mod 5))))
    :ARG2 (a / affect-01
        :ARG1 (m / mechanism
            :ARG0-of (s / signal-07)
            :mod (o / other))
        :polarity -)
    :rel 98059)
",test,bio_amr0.8,"(c / contrast-01
      :ARG1 (d / decrease-01
            :ARG0 (s3 / small-molecule :name (n / name :op1 ""PD-98059""))
            :ARG1 (p2 / phosphorylate-01
                  :ARG1 (s / slash
                        :op1 (e / enzyme :name (n2 / name :op1 ""ERK1""))
                        :op2 (e2 / enzyme :name (n3 / name :op1 ""ERK2"")))))
      :ARG2 (a / affect-01 :polarity -
            :ARG0 s3
            :ARG1 (p3 / pathway
                  :ARG0-of (s2 / signal-07)
                  :mod (o / other)))
      :ARG1-of (d2 / describe-01
            :ARG0 (a2 / and
                  :op1 (l2 / lane :mod 4)
                  :op2 (l3 / lane :mod 5)
                  :part-of (f / figure :mod ""4A""))))","PD-98059 decreased the phosphorylation of ERK1/2 (p-ERK1/2) but had no effect on other signaling pathways (Figure <xref ref-type=""fig"" rid=""F4"">4A</xref>, lanes 4 and 5).","(z1 / contrast-01
    :ARG1 (z2 / decrease-01
              :ARG0 (z3 / small-molecule
                        :wiki ""PHLDA-98059""
                        :name (z4 / name
                                  :op1 ""PD-98059""))
              :ARG1 (z5 / phosphorylate-01
                        :ARG1 (z6 / enzyme
                                  :wiki ""ERK1/2""
                                  :name (z7 / name
                                            :op1 ""ERK1/2""))))
    :ARG2 (z8 / affect-01
              :polarity -
              :ARG0 z3
              :ARG1 (z9 / pathway
                        :ARG0-of (z10 / signal-07)
                        :mod (z11 / other)))
    :ARG1-of (z12 / describe-01
                  :ARG0 (z13 / figure
                             :mod (z14 / lane
                                       :mod 4)
                             :mod (z15 / lane
                                       :mod 5))))",0.5569620253164557,0.5135135135135135,"(m / multi-sentence
        :snt1 (d / decrease-01
            :ARG1 (p / phosphorylation
                  :ARG1-of (e / ERK1/2
                        :mod (p2 / positive
                              :mod (p3 / phosphorylation))))
            :ARG2 (p2 / PD-98059))
        :snt2 (h / have-03
            :ARG0 p2
            :ARG1 (e2 / effect-01
                  :ARG2 (p3 / pathway
                        :mod (o / other)))
            :ARG2 (n / none)))","(d / decrease-01
    :ARG0 (c / chemical :wiki ""PD-98059"" :name (n / name :op1 ""PD-98059""))
    :ARG1 (p / phosphorylate-01
        :ARG1 (m / molecule
            :name (n2 / name :op1 ""ERK1/2"" :op2 ""p-ERK1/2""))))
    :ARG1-of (h / have-effect-on-91 :polarity -
        :ARG2 (s / signaling-pathway
            :mod (o / other)))
    :time (f / figure
        :name (n3 / name :op1 ""4A"")
        :location (l / lane
            :op1 ""4""
            :op2 ""5""))
    :ARG1-of (c2 / contrast-01))",-1.0,-1.0
pmid_2000_3375.158,"In summary, in WT cells Aurora-A increases the expression of p-ERK1/2 in a Ras dependent manner.","(i / increase-01
    :ARG1 (e2 / express-03
        :ARG1 (e / enzyme
            :name (n3 / name
                :op1 ""P""
                :op2 ""1/2"")
            :ARG0-of (d / depend-01
                :ARG1 (p / protein
                    :name (n4 / name
                        :op1 ""serine""
                        :op1 ""Ras"")))))
    :ARG2-of (s / summarize-01)
    :location (c / cell-line
        :part-of (v / variable
            :name (n2 / name
                :op1 ""Al-Qaeda"")))
    :rel (n / name))
",test,bio_amr0.8,"(i / increase-01
      :ARG0 (e5 / enzyme :name (n2 / name :op1 ""Aurora-A""))
      :ARG1 (e2 / express-03
            :ARG2 (s2 / slash
                  :op1 (e3 / enzyme :name (n3 / name :op1 ""ERK1""))
                  :op2 (e4 / enzyme :name (n4 / name :op1 ""ERK2""))
                  :ARG3-of (p2 / phosphorylate-01))
            :ARG3 (c / cell
                  :mod (w / wild-type)))
      :manner (d / depend-01
            :ARG1 (e / enzyme :name (n / name :op1 ""Ras"")))
      :ARG2-of (s / summarize-01))","In summary, in WT cells Aurora-A increases the expression of p-ERK1/2 in a Ras dependent manner.","(z1 / increase-01
    :ARG0 (z2 / enzyme
              :wiki ""Aurabenzumabenzumabenzumab""
              :name (z3 / name
                        :op1 ""Aurora-A""))
    :ARG1 (z4 / express-03
              :ARG1 (z5 / enzyme
                        :wiki ""P-ERK1/2""
                        :name (z6 / name
                                  :op1 ""p-ERK1/2"")))
    :location (z7 / cell
                  :mod (z8 / small-molecule
                           :wiki ""WT_cell""
                           :name (z9 / name
                                     :op1 ""WT"")))
    :manner (z10 / depend-01
                 :ARG0 z2
                 :ARG1 (z11 / enzyme
                            :wiki ""Ras–activated_protein_kinase""
                            :name (z12 / name
                                       :op1 ""Ras"")))
    :ARG1-of (z13 / summarize-01))",0.4507042253521127,0.3999999999999999,"(s / summary-01
    :ARG1 (i / in
        :ARG1 (c / cell
            :mod (w / wild-type))
        :ARG2 (i2 / increase-01
            :ARG1 (a / Aurora-A)
            :ARG2 (e / expression
                :ARG1 (p / phosphorylate-01
                    :ARG1 (e2 / ERK1/2)
                    :ARG2 (r / Ras)
                    :mod (d / dependent))))))","(s / summarize-01
    :ARG1 (i / increase-01
        :ARG0 (a / aurora-A)
        :ARG1 (e / express-01
            :ARG1 (p / p-ERK1/2)
            :location (c / cell
                :mod (w / wild-type)))
        :manner (d / depend-01
            :ARG1 (r / Ras))))",-1.0,-1.0
